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Abstract
Inhibitory interneurons are a heterogeneous class of GABAergic neurons, 
classified into discrete subtypes based on the expression of molecular 
markers, physiology, morphology and connectivity. However, the mechanism 
of interneuron diversification is poorly understood. hPSC-derived 
interneurons may help solve the mystery, by providing an unrestricted 
trajectory of interneuron differentiation, which is not confounded by species 
differences. Although, how well the model recapitulates native development 
remains under scrutiny. Moreover, the full extent of interneuron subtype 
diversity that can be achieved in vitro is unclear. 
Here an evaluation of hPSC model of interneuron differentiation has been 
presented. To tease apart the molecular heterogeneity, longitudinal single-
cell RNA sequencing was conducted. The analysis revealed a heterogeneous 
MGE-like enriched progenitor population that differentiated into a diverse 
population of interneuron-like cells. On examining the authenticity of the 
model, using a novel cross-comparison to the native human MGE (10WPC-
15WPC), encouraging similarities were found, especially between post-mitotic 
hPSC-derived interneurons and 15WPC MGE. However, several shortcomings 
of the model were also indicated. First, under-representation of specific genes 
encoding for transcription factors. Second, absent or low expression of late 
MGE markers and subtypes. Enforced expression of the under-expressed 
transcription factors may provide a means to enrich the interneuron-like 
population with these subtypes.
Furthermore, the molecular resemblance to foetal-derived interneurons was 
reflected in the immature intrinsic and evoked neuronal responses of hPSC-
derived interneurons, recorded using whole-cell patch clamp. Nevertheless, 
monosynaptic viral tracing demonstrated the capability of the interneuron-
like cells to make synaptic connections, which (although not extensive) may 
be enhanced in a co-culture system. 
Overall, the interneuron differentiation of hPSC holds promise as a 
neurodevelopmental model. The novel characterisation of hPSC-derived 
interneurons and human MGE, at single-cell resolution, has simultaneously 
vrevealed the limitations and refinements necessary to generate more 
authentic and defined interneuron subtypes in vitro. Thereby, widening the 
scope and validity of the model.
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1Chapter 1 - General introduction 
1.1 Introduction 
Inhibitory gamma-aminobutyric acid (GABA)-ergic interneurons represent a 
small proportion of the neuronal population (20-30%) in the brain, but have 
a dominant control over network activity (Lewis et al. 2005; Yizhar et al.
2011; Marín 2012). Primarily, inhibitory interneurons are required for 
maintaining the appropriate excitation-inhibition balance within the brain 
(Rubenstein & Merzenich 2003; Yizhar et al. 2011; Marín 2012). Moreover, 
the connectivity of a single interneuron onto multiple post-synaptic targets 
allows a synchronised, rhythmic pattern of firing. The synchronised firing 
pattern generates network oscillations necessary for stable, long distance 
transmission (Hirano et al. 2008; Sohal et al. 2009). 
1.2 Interneurons in pathology 
The brain-wide distribution of inhibitory interneurons means that this class of 
GABAergic neurons have been implicated in many different neuropathologies, 
including autism spectrum disorders (ASD), schizophrenia, and epilepsies 
(Powell et al. 2003; Rubenstein & Merzenich 2003; Lewis et al. 2005; Hirano 
et al. 2008; Cunningham et al. 2014). A common mechanism is believed to 
underpin these neurological disorders: excitation – inhibition imbalance. If 
interneuron function is compromised (either from developmental insults or 
neurodegeneration) the inappropriate shift towards excitation can occur, 
along with the disruption of synchronised network activity (Rubenstein & 
Merzenich 2003; Hirano et al. 2008). Depending on the circuits affected, this 
can manifest into affective, cognitive and motor deficits. Currently, the 
therapeutic treatments for these neurological disorders (if one exists) often 
have limited efficacy and severe side effects (Rubenstein & Merzenich 2003). 
However, the excitation – inhibition imbalance hypothesis has opened up an 
alternative, and potentially widely beneficial, therapeutic approach to pursue, 
namely enhancing inhibitory output (Rubenstein & Merzenich 2003). Although 
caution is still warranted, with questions regarding whether inhibitory 
interneuron deficit/dysfunction is a primary cause of the pathology (or a 
secondary effect) remaining unanswered. Nonetheless, the recognition of the 
critical role of inhibitory interneurons has encouraged research into 
2interneuron development and function in health and disease (Rubenstein & 
Merzenich 2003; Marín 2012; Arber & Li 2013).
1.3 Interneuron diversity  
Inhibitory interneurons represent one of the most heterogeneous class of 
neurons in the brain (Darmanis et al. 2015; Lake et al. 2016; Boldog et al.
2018). This has led to the development of a multi-factorial classification 
system to assign interneurons into different subtypes, with the system being 
refined over time to a smaller definitive set of categories (DeFelipe et al.
2013; Kepecs & Fishell 2014; Bandler et al. 2017). These categories are: 
morphology, physiology, site of connectivity onto post-synaptic targets, and 
expression of specific molecular markers (such as neuropeptides and calcium 
binding proteins) (Figure 1.1). With recognition of interneuron diversity came 
the awareness of interneuron composition being brain region-specific (Zeisel 
et al. 2015; Lake et al. 2016; Nowakowski et al. 2017; Fan et al. 2018). This 
has, in turn, focused attention on the differential impact of subtypes on 
neuronal activity in health and disease (Robbins et al. 1991; Reynolds et al.
2002; Lewis et al. 2005;  Lin & Sibille 2013; Ito-Ishida et al. 2015). Moreover, 
piecing together the intricate steps of interneuron development and 
diversification remains a core component of interneuron research. To date 
the where, when and how of interneuron diversification remains under 
investigation (Kepecs & Fishell 2014; Kessaris et al. 2014; Wamsley & Fishell 
2017). 
1.4 The region of origin 
Inhibitory interneurons are born within neighbouring regions within the 
ventral telencephalon, called the caudal and medial ganglionic eminences 
(CGE and MGE, respectively) (Zecevic et al. 2011; Hansen et al. 2013; Al-
Jaberi et al. 2015). Within these regions there is a conserved spatial 
patterning of cells, which marks the ventricular, subventricular and mantle 
zones (Flames et al. 2007; Wonders et al. 2008; Zechel et al. 2014). The 
between-species conservation of the three zones has subsequently been 
confirmed, although in humans there is a further division of the subventricular 
zone into inner and outer layers (Zecevic et al. 2011; Hansen et al. 2013; Al-
Jaberi et al. 2015). The cells within the ventricular to subventricular zone 
have a high expression of cell cycle regulation and DNA replication genes, 
3reflecting the highly proliferative nature of the early progenitors within these 
zones. Hence, the expansion of the subventricular zone in humans likely 
accounts for the larger abundance of interneurons within the human brain 
compared to rodents (Wu & Parent 2000). As the progenitors exit the cell 
cycle and become replaced by newborn progenitors, the cells proceed into 
the mantle zone to become post-mitotic interneuron precursors, ready to 
migrate to their region of destination (Flames et al. 2007; Wonders et al.
2008; Zechel et al. 2014). 
1.4.1 Spatial influence 
Investigations regarding the potential differences in the lineage commitment 
of progenitors derived from the MGE and CGE have been carried out in rodent 
models (Flames et al. 2007; Butt et al. 2008; Wonders et al. 2008; Miyoshi 
et al. 2010). One approach was to modify the proportion of CGE- and MGE-
derived interneurons, using a mouse line with tamoxifen-inducible 
oligodendrocyte transcription factor 2 (Olig2)::Cre-ER dependent knock-out 
(KO) of the transcription factor NK2 homeobox 1 (Nkx2.1) (Butt et al. 2008). 
The MGE boundary is marked by NKX2.1 positive cells, which become less 
abundant further into the neighbouring regions of the CGE and lateral 
ganglionic eminence (LGE) (Zecevic et al. 2011; Hansen et al. 2013; Onorati 
et al. 2014). Therefore, on administrating tamoxifen to pregnant dams at 
different times of gestation (corresponding to embryonic day E9.5, E10.5, or 
E12.5) a deficiency in Nkx2.1 was induced (Butt et al. 2008). The Nkx2.1
deficiency was reflected in the depletion of MGE committed cells, and ectopic 
expansion of CGE and LGE regions in the mouse embryos (irrespective of 
timing of tamoxifen administration) (Butt et al. 2008). As a result, in the adult 
brain the proportion of interneurons derived from the CGE, at the expense of 
the MGE, was elevated (Butt et al. 2008). But did this impact the interneuron 
subtype diversity in the adult mouse brain?  In short, yes. The cohort of mice 
had significantly reduced number of somatostatin (SST) and parvalbumin 
(PVALB) interneurons, with sparing/ heightened levels of the calretinin (CR), 
vasoactive intestinal peptide (VIP) and reelin (RELN) interneurons (Butt et al.
2008). This led to the conclusion that the spared 
4Figure 1.1 The main properties defining the interneuron subtype 
classification system.
The molecular and functional heterogeneities within inhibitory interneurons has 
resulted in this neuronal class being divided into distinct subtypes. The assignment 
to a particular subtype is determined using a complex multifactorial classification 
system that takes into account: the expression of molecular markers (calcium binding 
proteins and neuropeptides), morphology, connectivity onto post-synaptic partners, 
and physiology of the interneuron. Cartoon illustrations of neurons were collected 
from https://www.motifolio.com/neuroscience-all.html (Motifolio 2018).
Neuropeptide Y, NPY. Somatostatin, SST. Parvalbumin, PVALB. Calretinin, CR. 
Vasoactive intestinal peptide, VIP. Reelin, RELN.
5subtypes must be generated through Nkx2.1 independent pathway within the 
CGE, whereas the depleted subtypes were predominantly MGE-derived (Butt 
et al. 2008). Furthermore, Butt et al. investigated whether this shift in the 
interneuron subtype diversity led to any aberrant behaviours in adulthood,
possibly reflective of an excitation-inhibition imbalance (Butt et al. 2008). 
This was indeed the case, with mice displaying motor coordination 
impairments (dyskinesia and ataxia) and myoclonic seizures (Butt et al.
2008). The phenotype was most severe, and often resulted in premature 
death (by postnatal day P11), when Nkx2.1 deficiency was induced at the 
earliest time point (E9.5 administration of tamoxifen to dams) (Butt et al.
2008). This hinted at the non-overlapping roles of different interneuron 
subtypes in the brain, and the differential contributions in neuropathologies 
(Robbins et al. 1991; Reynolds et al. 2002; Lewis et al. 2005; Ito-Ishida et 
al. 2015).
With these findings and fate-mapping experiments in rodents, the following 
guide on the origin of interneuron subtypes has become established (Figure 
1.2). Classically, CR, VIP and RELN are CGE-derived interneurons, and 
neuropeptide Y (NPY), SST and PVALB are MGE-derived (Xu et al. 2004; Butt 
et al. 2005; Flames et al. 2007; Wonders et al. 2008; Miyoshi et al. 2010). 
In summary, the location of birth influences the lineage commitment of 
interneuron precursors, but how?
1.4.1.1 Sonic hedgehog signalling 
Sonic hedgehog (SHH) is an endogenous morphogen released under a dorsal-
ventral gradient across the ventral telencephalon (Flames et al. 2007; 
Wonders et al. 2008; Xu et al. 2010; Danjo et al. 2011; Anderson et al. 2016).  
SHH signalling is highest within the MGE, peaking in the dorsal MGE (Flames 
et al. 2007; Wonders et al. 2008). To determine whether changes in the 
relative strength of SHH signalling affected the lineage commitment of cells, 
a mouse line with SIX homeobox 3 (Six3)::Cre-dependent KO of SHH
receptor, Smoothened (Smo) was used (Xu et al. 2010). The MGE marker 
Six3 is expressed by early proliferating progenitors in MGE ventricular zone. 
Therefore, the reduction of SHH signalling activation was restricted to early 
MGE progenitors, and resulted in the MGE 
6Figure 1.2 Schematic coronal section of the telencephalon labelled to define 
the regions of origin and destination of different interneuron subtypes.
Within the ventral telencephalon, interneurons are born within focal neighbouring 
regions, the MGE and CGE. Region of origin (CGE/MGE) specific molecular markers 
are illustrated for CGE- and MGE-derived progenitors in green and blue respectively. 
Interneuron progenitors reach their appropriate region of destination (e.g. cerebral 
cortex) through tangential migration, and then integrate to form neuronal circuits. 
Classic CGE- and MGE- derived interneuron subtype markers are highlighted in green 
and blue respectively. Coronal outline of the telencephalon was initially derived from
mouse telencephalon figure in Brandão & Romcy-Pereira 2015. 
Neuropeptide Y, NPY. Somatostatin, SST. Parvalbumin, PVALB. Calretinin, CR. 
Vasoactive intestinal protein, VIP. Reelin, RELN. NK 2 Homeobox 1, NKX2.1. LIM 
homeobox protein 6, LHX6. SRY-box 6, SOX6. Prospero homeobox protein 1, PROX1. 
COUP transcription factor 2, COUPTF II. Zinc finger CCHC domain-containing protein 
12, ZCCHC12. MGE, medial ganglionic eminence. CGE, caudal ganglionic eminence. 
LGE, lateral ganglionic eminence. 
7region shrinking and ectopic CGE expansion during embryonic development 
(Xu et al. 2010). This, in turn, led to the higher abundance of CGE-derived 
CR interneurons at the expense of MGE-derived SST and PVALB interneurons
in the adult mouse brain (Xu et al. 2010). The similarities in the Olig2::Cre-
ER dependent KO Nkx2.1 mice and Six3::Cre-dependent KO Smo mice led to 
the conclusion that high SHH signalling activates the expression of Nkx2.1, 
which in turn promotes MGE commitment and represses CGE commitment
(Butt et al. 2008; Xu et al. 2010).  
Additionally, the differential levels of SHH activation within the ventral and 
dorsal MGE ventricular zone leads to the establishment of molecularly distinct 
progenitor pools within these subdomains (Flames et al. 2007; Wonders et 
al. 2008). The distinction between progenitors within the dorsal and ventral 
mouse MGE has been demonstrated at RNA and protein level, with many of 
the differentially expressed genes corresponding to transcription factors, 
including the dorsally elevated genes, GLI family zinc finger 1/2 (Gli1/2), NK6 
homeobox 2 (Nkx6.2), COUP transcription factor 2 (Couptf II) and ventrally 
elevated genes forkhead box J1 (Foxj1), Ets-related protein 81 (Er81) and 
LIM homeobox family genes (including Lhx 6/7/8) (Flames et al. 2007; 
Wonders et al. 2008; Mi et al. 2018). 
Moreover, evidence for the differential lineage commitment of ventral and 
dorsal MGE derived progenitors has been demonstrated using utero-
transplantation of reporter labelled whole, ventral or dorsal MGE ventricular 
zones (at E13.5), into age-matched wild-type mouse embryos (Flames et al.
2007; Wonders et al. 2008).  On analysing the interneuron composition of 
each graft at P14 in the mouse cortex, a significant preferential bias towards 
SST fate at the expense of PVALB was observed in dorsal MGE-derived grafts 
(Flames et al. 2007; Wonders et al. 2008). Whereas, PVALB bias was 
observed for ventral MGE-derived grafts (Flames et al. 2007; Wonders et al.
2008).  
1.4.1.2 WNT signalling
Another spatial patterning morphogen in the foetal brain is WNT, which is 
under a caudal-rostral and dorsal-ventral gradient (WNT gradient highest 
caudally and dorsally). To counteract WNT signalling, WNT signalling 
inhibitors, such as the endogenous morphogen dickkopf WNT signalling 
8pathway inhibitor 1 (DKK1), are released along a reciprocal gradient 
(Nicoleau et al. 2013). The restriction of canonical WNT signalling is critical 
for maintaining the pallium/ subpallium boundary (Backman et al. 2005). 
Disrupting the fine-balance between canonical WNT signalling activation and 
inhibition along caudal-rostral and dorsal-ventral gradients, as seen in Dkk1
KO mouse, led to gross abnormalities, including the loss of the anterior brain, 
additional limb formation, and was ultimately embryonic lethal (Backman et 
al. 2005). Due to the severe consequence of manipulating WNT signalling 
during development, conditional loss/gain-of-function rodent models have 
been developed to limit the WNT signalling disruption to a restricted time-
window. Canonical WNT/ β-catenin signalling was ectopically activated using 
a conditional gain-of-function β-catenin mouse model (at E8 or E11), which 
resulted in the depletion of ventral telencephalon committed cells (Backman 
et al. 2005). Furthermore, the subpallium region boundary was partially 
distorted, with the invasion of dorsal pallial cells (paired box protein 6, Pax6 
and neurogenin-2, Ngn2 co-expression) within this region (Backman et al.
2005). Whereas, the loss-of-function β-catenin mouse model at E8 (but not 
E11) had an expanded subpallium region. In conclusion, canonical WNT 
signalling appears to act at early stages of development to both repress 
ventral fate, and promote dorsal fate, with loss/gain of canonical WNT 
signalling past E11 having no apparent consequence on the fate of these
progenitors (Backman et al. 2005). 
1.4.1.3 Retinoic acid signalling
Retinoic acid signalling contributes to many pathways, including promoting 
caudal fate commitment of neuroepithelial cells and driving the maturation 
and survival of post-mitotic neurons (Li et al. 2009; Goulburn et al. 2011; 
Cambray et al. 2012). The role of retinoic acid signalling has been 
investigated in rodent models through the KO of retinaldehyde 
dehydrogenase (Raldh3), the enzyme responsible for retinoic acid production 
in the ventral telencephalon (Chatzi et al. 2011). Chatzi et al. demonstrated 
that retinoic acid signalling was required for the induction of glutamate 
decarboxylase (Gad1) expression (Chatzi et al. 2011). The Raldh3 KO mice
failed to generate ventral telencephalon derived GABAergic neurons, 
including LGE-derived medium spiny neurons (MSN) and MGE/CGE-derived 
9inhibitory interneurons due to the lack of expression of Gad1, and subsequent 
production of GABA (Chatzi et al. 2011).
1.4.2 Temporal influence 
In addition to the place of birth, differences in the birth date of CGE and MGE 
progenitors has been implicated in dictating the lineage commitment of 
interneurons. During MGE/CGE development the ventricular zone is enriched 
in proliferating progenitors, with a pool of newborn progenitors emerging 
through sequential divisions of cells from a common ancestral parent cell 
(Arendt et al. 2016). Certain developmental models suggest that 
diversification of cell types during development revolve around changes in 
the intrinsic programming of multipotent neural progenitors that occur during 
sequential divisions (Arendt et al. 2016). These models would suggest that 
each division holds the potential to generate temporally distinct progenitor 
pools that have different lineage commitments (Arendt et al. 2016). 
1.4.2.1 Early and late-born progenitors
Evidence of the temporal influence over interneuron lineage commitment has 
come about from fate-mapping studies, tracking the differentiation of 
different aged CGE/MGE grafts (E13.5 and E15.5) (Butt et al. 2005; Inan et 
al. 2012). Utero-transplantation of the reporter labelled CGE/MGE-derived 
grafts into wild-type hosts (of the matching age) were left to terminally 
differentiate until P14-21 (Butt et al. 2005; Inan et al. 2012). The reporter 
labelled cells were then identified at both the molecular and functional level 
using immunohistochemistry and whole-cell patch clamp recordings 
respectively (Butt et al. 2005; Inan et al. 2012). The grafts derived from the 
CGE at the earliest age (E13.5) had the greatest proportion of SST 
interneurons, and to a lesser extent generated CR, VIP and NPY subtypes 
(and even fewer PVALB) (Butt et al. 2005). Whereas, CGE E15.5 progenitors 
differentiated into an interneuron population equally abundant across all 
subtype markers (20-30% abundance of SST, CR, VIP, NPY and PVALB) (Butt 
et al. 2005). The composition of the MGE-derived grafts after terminal 
differentiation were distinct from that reported for CGE-derived grafts, 
supporting the spatial influence over lineage commitment described above 
(Section 1.4.1).  Namely, a high proportion of SST and PVALB interneurons 
were established in the MGE-derived grafts (at both E13.5 and E15.5), with 
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a very small proportion of alternative subtypes (with <10% VIP, CR, RELN). 
Although the proportion of SST and PVALB interneurons derived from E13.5 
and E15.5 MGE grafts were similar, a specific subtype of PVALB interneurons 
(the Chandelier cells), were only obtained from E15.5 MGE grafts (Inan et al.
2012). The difference between the differentiation potential of the newborn 
MGE/CGE progenitors at E13.5 and E15.5 provided novel evidence for early 
and late-born progenitors from the same region having differential 
interneuron lineage commitments (Butt et al. 2005; Inan et al. 2012). 
However, as these findings have only been obtained in mouse, whether the 
same temporal bias in lineage commitment is replicated in human MGE/CGE 
development is still unknown.  
1.4.2.2 Cell cycle 
The intrinsic clock mechanism describes the dual influence of when the 
progenitor is born, and for how long the progenitor has been proliferating, 
has over the differentiation potential of the progenitor (Bandler et al. 2017).  
The period of time the progenitor remains proliferating in the ventricular zone 
must be strictly controlled in order to maintain the appropriate numbers of 
early and late-born progenitors. When the cell cycle regulation becomes 
aberrant, as seen in Nxk2.1::Cre-dependent KO of Couptf II, the proportion 
of progenitors belonging to early and late-born pools can inappropriately 
shift. In the case of Couptf II deficiency, the late-born born progenitor pools 
are elevated at the expense of the early-born progenitors. The subsequent 
impact in adult mouse brain was the increase in PVALB interneurons at the 
expense of SST and choline acetyltransferase (ChAT) interneurons (Hu et al.
2017a). This has been linked to the loss of Couptf II expression in MGE 
progenitors resulting in the increased expression of cyclin D2 (Ccnd2) (Huard 
et al. 1999; Glickstein et al. 2007; Gilani et al. 2014; Hu et al. 2017a). CCND2 
acts to shorten the duration of G1-S phase of the cell cycle, thereby 
enhancing the rate of proliferation (Huard et al. 1999; Mitsuhashi et al. 2001; 
Glickstein et al. 2007).  As a result, global KO of Ccnd2 in mice causes severe 
microcephaly (Huard et al. 1999). On closer evaluation of changes in 
interneuron composition and abundance in the adult Ccnd2 KO mice, a 
selective deficit in PVALB interneurons was observed in multiple brain regions 
(cortex, hippocampus, cerebellum), with no changes reported in other 
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subtypes (Glickstein et al. 2007). The selective deficit in PVALB interneurons 
complements findings from conditional Couptf II KO mice that had enhanced
Ccdn2 expression and increased abundance of PVALB interneurons (Hu et al.
2017a). Therefore, Couptf II was concluded to have a critical role in 
downregulating Ccnd2 in order to maintain the appropriate balance of early 
and late-born progenitor pools, which will give rise to the correct SST:PVALB 
ratio (Hu et al. 2017a). Moreover, this work provided evidence for late-born 
MGE progenitors being biased towards PVALB fate (Hu et al. 2017a). 
1.5 The region of destination  
1.5.1 Tangential migration  
During early stages of gestation, typically from 8 weeks post-conception 
(WPC) in humans, immature interneuron precursors within the MGE/CGE 
have begun tangential migration to the appropriate region of destination 
(Kang et al. 2011; Onorati et al. 2014; Zhong et al. 2018). Neuronal 
migration is guided by cues released under a concentration gradient that act 
to either attract or repress migratory neurons (Elias et al. 2008; Elbert et al.
2019). The interneuron precursors predestined for a particular location are 
selectively receptive to the appropriate guidance cues by the expression of 
the complementary set of guidance receptors (such as neuropilin-2, Nrp2 and 
C-X-C motif chemokine receptor Cxcr family) (Elias et al. 2008). When this 
expression pattern becomes altered this can lead to subtype and brain region 
selective deficits in interneuron numbers in the adult brain. These changes 
were observed in Nestin::Cre-dependent CCCTC-binding factor (Ctcf) KO 
mice (Elbert et al. 2019). The Ctcf deficiency impacted selective pools of SST 
and PVALB committed precursors, and led to the poor expression of C-X-C 
motif chemokine receptors (Cxcr4 and Cxcr7), thus stunting the ability of 
these precursors to migrate to the cortex (Elbert et al. 2019). This led to the 
selective depletion of PVALB and SST interneuron numbers in the adult cortex 
(Elbert et al. 2019).
1.5.2 Circuit integration  
On arrival to the region of destination, the interneuron precursors must 
integrate appropriately with synaptic partners. Primarily, interneurons
connect directly onto the principal cells of the region (Varga et al. 2015). 
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Alternatively, a small proportion of interneurons (notedly VIP) innervate other 
inhibitory interneurons to indirectly elevate excitation through disinhibition 
(Wolff et al. 2014; Lee et al. 2019). The integration of interneurons to form 
viable synaptic connections to influence neuronal network signalling marks 
the final stages of interneuron development. During this process both the 
abundance and position of interneurons within the region becomes refined, 
in a mechanism based on the interplay of extrinsically driven factors (e.g. 
contact-dependent signalling between interneurons and principal neurons), 
and innately driven differential expression of layer markers (Darmanis et al.
2015; Lake et al. 2016; Frazer et al. 2017; Nowakowski et al. 2017; Mickelsen 
et al. 2019). 
1.5.3 Molecular and functional developmental trajectory   
The molecular transition of interneuron precursors within the region of 
destination has been monitored longitudinally for human cortical foetal tissue 
across 14WPC to 26WPC period  (Nowakowski et al. 2017; Fan et al. 2018;  
Zhong et al. 2018; Mayer et al. 2019). These studies provided evidence for 
an age-dependent rise in the abundance and heterogeneity of the cortical 
interneuron population, that was region and subtype-specific (Nowakowski et 
al. 2017; Fan et al. 2018;  Zhong et al. 2018; Mayer et al. 2019). Moreover, 
although large changes occurred in the expression profile of cortical 
interneurons, certain genes displayed constant expression throughout 
interneuron development, remaining in adulthood (Fan et al. 2018). These 
specific markers are believed to act as an early molecular signature of this 
subtype (Fan et al. 2018). 
The functional maturity of cortical interneurons is marked by the progressive 
increase in expression of voltage-gated ion channels, glutamate receptor 
(AMPA and NMDA) subunits and synaptic proteins (vesicular GABA 
transporter, synaptophysin, synapsin) (Moore et al. 2009; Moore et al. 2011; 
Mayer et al. 2019). As the expression of these physiological markers rise in 
the foetal interneuron, the physiology of the foetal interneuron transitions 
into that known of their adult counterparts (Varga et al. 2015; Lake et al.
2016; Boldog et al. 2018). 
Intracellular calcium imaging recordings detect transient rises in intracellular 
Ca2+ ion levels, using an intracellular fluorescent calcium indicator that has a 
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fluorescence intensity dependent on Ca2+ ion concentration (Sun et al. 2016; 
Xiang et al. 2017; Mayer et al. 2019). The changes in fluorescence intensity 
are used as indications of spike activity (Sun et al. 2016; Xiang et al. 2017; 
Mayer et al. 2019). Ex vivo calcium imaging recordings were performed to 
determine the responsiveness of foetal cortical neurons (14WPC-22WPC) to 
different neurotransmitters (GABA, glutamate, cholinergic and serotonergic 
receptor agonists) in the bathing solution. For the cortical interneurons, the 
calcium responses were generally absent or weak (Mayer et al. 2019). The
only response detected was AMPA glutamatergic receptor-mediated, and this 
was restricted to MGE-derived cortical interneurons (absent in CGE-derived 
subtypes) (Mayer et al. 2019).  As the expression of AMPA receptor subunits 
increased progressively with functional maturity, this implied a potential 
region of origin dependent maturation trajectory of cortical interneurons 
(Mayer et al. 2019). Alternatively, this could be linked to MGE-derived SST 
interneuron subtypes being the first to arrive in the cortex, thereby providing 
additional time to make and strengthen connections to excitatory cortical 
neurons, leading to a stronger AMPA evoked response (Zhong et al. 2018; 
Mayer et al. 2019).  
Furthermore, the functional immaturity of foetal cortical neurons was
determined using a direct measure of neuronal physiology, whole-cell patch 
clamp (Moore et al. 2009; Moore et al. 2011; Calvigioni et al. 2016; Pan et 
al. 2016; Zhong et al. 2018). In a similar manner to the calcium imaging 
studies, ex vivo recordings were performed on human foetal cortical tissue 
up to age 26WPC (Moore et al. 2009; Moore et al. 2011; Zhong et al. 2018). 
Even by the oldest age sampled, foetal cortical neurons typically remained 
passive to current injections and had limited spontaneous activity. In 
addition, foetal tissue cortical neurons did not display intrinsic physiology 
equivalent to adult primary tissue-derived cortical neurons, with a high input 
resistance, low capacitance, and weakly hyperpolarised resting membrane 
potential (Moore et al. 2009; Moore et al. 2011). Although, the identity of the 
cortical neurons remained undetermined (potentially masking any differences 
between cortical pyramidal cells and interneurons) ex vivo whole-cell patch 
clamp recordings on reporter labelled interneurons in the prenatal and early 
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postnatal mouse brain slices described a similar profile (Moore et al. 2009; 
Moore et al. 2011; Calvigioni et al. 2016; Pan et al. 2016). 
1.5.4 Region-dependent interneuron subtype composition  
The brain-wide distribution of interneurons led to investigation determining if 
interneuron composition and abundance is region-specific. So far this analysis 
has only been conducted on regions within the human adult cortex, derived 
from a single tissue source (51 year old female) (Lake et al. 2016). 
Nonetheless, this analysis provided evidence for between-region differences 
in interneuron subtypes. A prime example was SST/RELN interneurons (also 
co-expressing synaptic vesicle glycoprotein 2C SV2C), which are a widely 
abundant layer III cortical interneuron subtype, but absent from primary 
visual and auditory cortices (Lake et al. 2016). To explore between-region 
differences in a more extensive number of brain regions, molecular and 
functional analysis of adult (P21-P35) mouse primary tissue has been 
conducted. These brain regions included: primary somatosensory cortex, 
hippocampus (CA1 region), and dorsal striatum (Zeisel et al. 2015; Földy et 
al. 2016; Gokce et al. 2016; Muñoz-Manchado et al. 2018). 
On characterising the interneuron subpopulations, a high degree of overlap 
was detected in the interneuron subtype composition between the mouse 
hippocampus, dorsal striatum and somatosensory cortex (Zeisel et al. 2015; 
Földy et al. 2016; Gokce et al. 2016; Muñoz-Manchado et al. 2018). Although, 
the dorsal striatal interneuron subtype composition appeared to be the least 
diverse. In addition, the relative abundance of common subtypes was also 
region-dependent, for example fast spiking PVALB interneurons were more
abundant in the hippocampus CA1 region (Zeisel et al. 2015). Whereas, 
regular-spiking CGE-derived (serotonin receptor 3A, 5ht-r 3a expressing) 
interneuron subtypes were more abundant in somatosensory cortex (Földy et 
al. 2016). Moreover, each brain region had a unique region-specific set of 
interneuron subtypes (Zeisel et al. 2015; Földy et al. 2016; Gokce et al. 2016; 
Muñoz-Manchado et al. 2018). For example, VIP/CR interneurons (also co-
expressing Proenkephalin Penk, and corticotropin-releasing hormone Crh), 
and RELN interneurons (co-express Lhx6, GABA type A receptor delta subunit 
Gabrd) were restricted to somatosensory cortex and hippocampus 
respectively (Zeisel et al. 2015; Földy et al. 2016). The mouse dorsal striatum 
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had the largest number of unique region-specific subtypes including: 
parathyroid hormone like hormone (Pthlh)/Pvalb co-expressing interneurons 
(most abundant), cholinergic interneurons (Gad1 negative) and tyrosine 
hydroxylase (Tyh)/ Gad1 co-expressing interneurons (Muñoz-Manchado et al.
2018). Also of interest was the region-specific differences in expression of 
genes related to formation and maintenance of perineuronal nets and 
synaptic plasticity (Muñoz-Manchado et al. 2018). This led to the conclusion 
that interneurons within a particular region express a unique set of genes 
that complement their surroundings. However, whether the region-
appropriate gene expression pattern was already innately pre-programmed, 
or moulded within the region of destination remains unclear. 
1.5.5 Significance of extrinsic cues on lineage commitment   
Fate-mapping studies have been used to investigate the influence that 
region-specific cues have over determining the terminal fate of the 
interneurons (Bele et al. 1995; Rolando et al. 2010; Ishino et al. 2017; 
Quattrocolo et al. 2017). In brief, the experimental design centred around 
tracking the fate of interneuron precursors that originated from one region 
(donor region), but had been transplanted into an alternative region (host 
region). These so-called heterotopic transplanted grafts were compared to 
controls, which had been transplanted back into the donor region (homotopic 
transplant) (Ishino et al. 2017; Quattrocolo et al. 2017). For example, P0-2 
hippocampal and cortical tissue-derived interneuron precursors were isolated 
from Nkx2.1-driven reporter mouse line, and transplanted into wild-type mice 
of matched age. On 30 days post-transplantation, some interneuron subtypes 
specific to the donor region manifested in the grafts independent of the site 
of transplantation. This included the establishment of hippocampal-specific 
type II nitric oxide synthase 1 (nNOS) interneurons in hippocampal-derived 
grafts transplanted into the cortex and hippocampus (Quattrocolo et al.
2017). Whereas, the abundance of other interneuron subtypes (e.g. PVALB 
expressing Chandelier cells) appeared to be dependent on host region (Ishino 
et al. 2017; Quattrocolo et al. 2017). This could be due to several reasons.  
First, the subtype commitment of the interneuron precursors was subject to 
modifications by extrinsic cues, and by altering the region of destination the 
final lineage commitment of the interneuron was changed. The extrinsic 
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influences mainly refer to the shaping of interneuron fate by the 
inputs/outputs the interneuron precursor is subjected to within the region of 
destination (an activity-dependent mechanism)  (Wamsley & Fishell 2017). 
However, this theory is questioned due to independent studies finding an 
incomplete/absent conversion of interneuron fates to match the host region 
(Bele et al. 1995; Rolando et al. 2010). The second mechanism favours an 
intrinsically driven lineage commitment, with interneuron fate restricted early 
in development (in the region of origin). Therefore, to explain changes 
observed in interneuron subtype composition reported by Ishino et al. and 
Quattrocolo et al. an alternative theory has been proposed, namely the 
selective survival bias of interneuron precursors committed to subtypes that 
matched the host region (Southwell et al. 2012). To date, which explanation 
was correct or whether the mechanism is subtype-dependent remains 
unknown (Quattrocolo et al. 2017). Moreover, there is evidence to suggest 
that responsiveness to local environmental cues progressively decreases with 
developmental age of the interneuron precursors, adding additional 
complexities to untangling the mechanism (Grimaldi et al. 2005).
1.6 Lineage commitment models
Ultimately, these findings have led to the proposal of two alternative 
interneuron lineage commitment models illustrated in Figure 1.3.  Model one 
favours an intrinsically guided fate restriction, with the place and time of birth 
acting to preprogram the fate of the cell within the region of origin, and this 
remains largely independent of extrinsic cues in the region of destination 
(Bele et al. 1995; Rolando et al. 2010) (Figure 1.3). However, the conflicting 
evidence that indicates a more dominant extrinsic influence over dictating 
interneuron lineage has led to the proposal of the second model (Ishino et al.
2017; Quattrocolo et al. 2017). In this model interneuron precursors have a 
certain degree of flexibility in their lineage commitment, and differential 
extrinsic cues (synaptic inputs/outputs) determine the final fate. As a result, 
progenitors born with common intrinsic factors can diverge into different 
subtypes (Mukhopadhyay et al. 2009; Ishino et al. 2017; Quattrocolo et al.
2017; Wamsley & Fishell 2017) (Figure 1.3). 
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Figure 1.3 Two alternative interneuron lineage commitment models.
Interneurons are born within two neighbouring regions, the CGE and MGE. 
Interneurons are then dispersed across multiple region of destinations (e.g. the 
cerebral cortex, striatum, hippocampus) through tangential migration, and integrate 
to form neuronal circuits. Model 1 proposes that the subtype the MGE/CGE
progenitor will ultimately become is determined through specific intrinsic instructions, 
dictated by the location and time of birth within the region of origin. Therefore, within 
the MGE/CGE there are distinct progenitor pools with differential lineage 
commitments. Model 2 considers the influences that the region of destination has 
on interneuron fate. This second model proposes that interneuron precursors from 
the same progenitor pool maintain the potential to become one of many interneuron 
subtypes, depending on the final location of the precursor. In this model, the lineage 
commitment is moulded by the specific cues within the region of destination, such as 
the region-dependent extracellular matrices and inputs from region-specific principle 
cells (activity-dependent mechanism). Cartoon illustrations of neurons were adapted 
from figures taken from https://www.motifolio.com/neuroscience-all.html (Motifolio 
2018).
Somatostatin, SST. Parvalbumin, PV. Calretinin, CR. MGE, medial ganglionic 
eminence. CGE, caudal ganglionic eminence.
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1.7 Single-cell transcriptome analysis
1.7.1 Principle 
To better understand interneuron diversification a method is required that 
allows one to characterise the molecular heterogeneity of the population, and 
the transcriptome dynamics of the population over time. However, when 
using bulk-level analysis to explore heterogeneity in a population, there is the 
risk that some differences may be masked due to a similar proportion of the 
population upregulating and downregulating the same gene (Wills et al.
2013). Moreover, bulk-level transcriptomics prevents one from distinguishing 
between a transcript that is weakly detected due to low expression in a large 
subpopulation or high expression in a rare subpopulation (Ofengeim et al.
2017). Single-cell transcriptomics provides an ideal method to tease apart 
and define the molecular heterogeneity, by detecting between-cell differences 
in gene expression, and using this to assign cells with similar expression 
profiles to discrete subpopulations (Liu & Trapnell 2016). 
1.7.2 Methodology  
One of the major challenges overcome by single-cell methodologies was how 
to isolate viable single cells. Ideally, the method would be of high throughput, 
low labour, low cost and timely. Unfortunately, no single technique has been 
able to encompass all these points, and as a result, each methodology must 
compromise on one or more of the optimal properties (Moignard & Göttgens 
2016; Poulin et al. 2016).
One of the simplest approaches to isolate single cells is manual picking 
(Figure 1.4). Although this method is by far the most time consuming and 
low throughput of all the techniques, there are advantages to this approach 
(Poulin et al. 2016). Manual picking is of low cost, with no additional expense 
for specialised capture machinery. Moreover, as the cell capture is set by the 
experimenter, a selection criterion can be easily introduced. 
Higher throughput and less labour-intensive techniques include the 
microfluidic and microdroplet systems, Fluidigm C1 and Chromium 10x 
Genomics, respectively (Poulin et al. 2016) (Figure 1.4). The 10x Genomics
chip works by step-by-step mixing of the single-cell suspension, barcoded 
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micro-beads and oil to form single-cell tagged beads isolated within oil 
droplets (gel beads in emulsion, GEM) (Zheng et al. 2017). Due to the much 
higher ratio of gel beads loaded onto the chip relative to single cells, the 
system should tag a single cell per GEM, uniquely barcoding the cell for later 
processing (Zheng et al. 2017). However, this single cell capture per GEM 
cannot be visually checked, thus making optimisation difficult. Whereas, 
Fluidigm C1 microfluidic chip, termed the integrated fluidic circuit (IFC), 
contains isolated capture sites (butterflies) that can be viewed before and 
after cell loading (Pollen et al. 2014). The cells are directed into empty 
butterflies using a pressured valve system (smallest IFC, 96 butterflies to 
largest IFC, 800 butterflies). Thus, the chip design results in Fluidigm C1 
system having a lower throughput and higher cost per cell relative to other 
techniques (Poulin et al. 2016). Nevertheless, the ability to visually checked 
capture efficiency and state of the captured cells (e.g. viable, meets any 
selection criteria) before lysing is an important quality control check (Pollen 
et al. 2014). This manual check holds value, because first, this prevents any 
erroneous conclusions being made from poor quality/doublet cDNA, and 
second, reduces downstream costs as no further reagents are wasted on 
unusable/undesired samples (Poulin et al. 2016). 
Once the single-cells have been isolated there is then the choice of reaction 
chemistry, which includes (but not limited to): SMART-seq, CEL-seq and 
Tang-seq (Tang et al. 2009; Hashimshony et al. 2012; Ramsköld et al. 2012; 
Ziegenhain et al. 2017). Along with differences in cost, these reaction 
chemistries differ in the method of reverse transcription (template-switching 
or second-strand synthesis) and preamplification (in vitro transcription and 
polymerase chain reaction, PCR) (Tang et al. 2009; Hashimshony et al. 2012; 
Ramsköld et al. 2012). Ultimately this results in the reaction chemistries 
differing in the coverage of the mRNA, being full-length or 3’ end only, with 
full-length coverage providing greater sensitivity and higher read depth 
option (Poulin et al. 2016). Reaction chemistries performing full-length mRNA 
coverage (SMART-seq) are therefore particularly desirable for detecting low-
abundance transcripts (Ziegenhain et al. 2017). 
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Figure 1.4 Step-by-step guide to single-cell RNA sequencing 
methodology.
Although there are distinctions between single-cell RNA sequencing 
methodologies, this can mainly be distilled down to two main differences: 
capture method and reaction chemistry. Otherwise, the basic steps of single-
cell RNA sequencing are common across protocols. These steps required the 
generation of single-cell cDNA that is barcoded to allow the cDNA 
corresponding to each cell to be uniquely identified. The single-cell cDNA is 
then carried through certain quality control checks to determine whether the 
quality is high enough for single cell RNA sequencing. These steps include 
Bioanalyzer and Qubit quantification, along with single-cell QPCR analysis. On 
passing these quality control checks the cDNA can be carried forward for 
library preparation, and then sequencing of the pooled single-cell libraries on 
the Illumina platform. For more details see Chapter 2. The single-cell RNA 
sequencing data obtained provides an in-depth, unbiased characterisation of 
the genes expressed by each cell, which led to an understanding of the 
heterogeneity within/across populations and the genes responsible.  Figures 
adapted from Liu & Trapnell 2016. 
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1.7.3 Applications
Single-cell RNA sequencing analysis has provided valuable information 
concerning interneuron subtype diversity in the adult brain in both humans 
and mice (Darmanis et al. 2015; Lake et al. 2016; Boldog et al. 2018).  The 
cross-comparisons between species has revealed species-dependent 
differences in interneuron subtype number and identity (Darmanis et al.
2015; Bakken et al. 2016; Sousa et al. 2017). A classic example is the 
differences in the predominant interneuron subtype of a region, with cortical 
PVALB and CR interneurons being the most abundant subtype in mouse and 
human cortex respectively (Darmanis et al. 2015; Bakken et al. 2016; Sousa 
et al. 2017). Moreover, human-specific, novel interneuron subtypes have 
been detected using single-cell RNA sequencing of adult human tissue 
(Boldog et al. 2018). One of these subtypes included the irregular spiking 
cholecystokinin (CCK) subtype (co-expressing COUPTF II, complexin 3
CPLX3, SV2C), dubbed “rosehip” cortical interneurons. This specific subtype 
was rare in the human cortex (making up less than 6% of COUPTF II positive 
interneuron population) and restricted to layer I of the cerebral cortex, which 
is in agreement to previous work characterising COUPTF II positive 
interneuron population in human cortex (Varga et al. 2015; Boldog et al.
2018). 
Moreover, longitudinal single-cell transcriptome analysis of the mouse MGE 
and CGE has identified age-dependent differentially expressed genes, which 
has provided novel insight into the developmental trajectory of interneurons 
(Chen et al. 2017; Close et al. 2017; Mi et al. 2018). Of significance was the 
ability to detect novel candidate lineage determining transcription factors 
(Mayer et al. 2018; Mi et al. 2018). However, such analysis is still awaited in 
humans. 
Finally, single-cell transcriptomic analysis can identify co-expression patterns 
of genes that represent putative gene regulatory networks/nodes that could 
be responsible for a particular phenotype or directing progenitors along a 
specific lineage pathway (Nowakowski et al. 2017; Tripathy et al. 2017; Mi et 
al. 2018; Mayer et al. 2019). Such analysis can be useful in understanding 
disease mechanisms, by identifying disrupted gene regulatory networks and 
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thereby naming candidate therapeutic targets and biomarkers (Ofengeim et 
al. 2017; Zhang et al. 2019).  
1.8 The connectivity of neurons
The architecture of neuronal circuits is finely tuned in an activity-dependent 
manner. Therefore, the connectivity of a neuron, in terms of the identity and 
the number of synaptic partners, reflects the function of the neuron.  
However, mapping neuronal connectivity is a challenging feat. Since the 
1970s, neuronal tracing tools have been developed, becoming more 
sophisticated over time, both in terms of sensitivity and versatility (Lanciego 
& Wouterlood 2011).
1.8.1 How to measure neuronal connectivity 
Early neuronal tracers were chemicals or proteins capable of selectively 
marking neuronal circuits either directly (tracer with a fluorescent tag) or 
indirectly (immunohistochemistry staining for the tracer). These early tracers 
included Fluoro-Gold and proteins, such as cholera toxin subunit B and 
leucoagglutinin, which showed low toxicity, high stability and were selectively 
taken up by neurons (Lanciego & Wouterlood 2011). However, early tracers 
often suffered from weak signals, especially over long distance synaptic 
transmission, and lacked the ability to be re-defined to the experimenter’s 
requirements  (Lanciego & Wouterlood 2011; Ginger et al. 2013). This led to 
the generation of viral tracers, a highly versatile tool to measure neuronal 
connectivity (Wickersham et al. 2007; Osakada et al. 2011; Osakada & 
Callaway 2013). 
Over the last decade, viral tracers have been used to map neuronal 
connectivity both in vivo and in vitro (Wickersham et al. 2007; Ginger et al.
2013; Wall et al. 2013; Grealish et al. 2015; Wertz et al. 2015; Tian et al.
2016; Doerr et al. 2017; Tornero et al. 2017; Sarkar et al. 2018). The system 
exploits the ability of specific viruses to selectively infect neurons, and spread 
through their synaptic connections. A mechanism termed polysynaptic 
transmission (Ginger et al. 2013). The native wild-type rabies virus is an 
example of such a virus, which is transmitted through retrograde polysynaptic 
transmission (Osakada et al. 2011). In addition to inducing the expression of 
viral genes required for self-replication, the viral tracer enforces the 
expression of reporters (e.g. mCherry), and in some cases additional genes 
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to modify/monitor neuron function (e.g. calcium sensors or light-activated 
ion channels/proton pumps) (Wall et al. 2013; Grealish et al. 2015; Wertz et 
al. 2015; Tian et al. 2016; Doerr et al. 2017; Tornero et al. 2017; Sarkar et 
al. 2018).  As a result, synaptic partners can be identified as well as 
manipulated. 
1.8.2 Principles of the monosynaptic rabies viral tracing system
Refinements to the rabies viral tracing system have been made over time, 
leading to the generation of monosynaptic rabies viral tracers that provide a 
more discrete tracing system (Wickersham et al. 2007; Osakada & Callaway 
2013). This was achieved by generating a non-self replicating rabies viral 
tracer through the deletion of one of the five genes needed for rabies virus 
replication: the rabies glycoprotein (Wickersham et al. 2007; Osakada & 
Callaway 2013). The recombinant glycoprotein deficient (ΔG) rabies tracer 
must obtain the glycoprotein from an exogenous source, the host neuron, in 
order to make new viable ΔG rabies tracers, and amplify the tracer signal. 
This process has been named glycoprotein trans-complementation (Osakada 
& Callaway 2013). 
Moreover, the viral tracer uptake can be limited to the neuronal class of choice 
by changing the tropism of the viral tracer  (Osakada & Callaway 2013). This 
has been achieved through a step called pseudotyping (Osakada & Callaway 
2013). Natively the rabies virus has the ability to enter any mammalian 
neuron using an envelope protein that is complementary to proteins on the 
cell surface membrane of mammalian neurons. However, by changing the 
endogenous envelope protein to that of a non-mammalian targeting virus, 
such as EnvA of the avian sarcoma leukosis virus, the viral tracer can no 
longer enter mammalian cells (Osakada & Callaway 2013). The neuronal class 
of choice is then genetically modified to express the complementary protein 
to EnvA, the avian cell surface protein, TVA  (Osakada & Callaway 2013). This 
restricts uptake of the viral tracer to this TVA expressing neuronal class, thus 
limiting analysis to which synaptic connections are made on to this specific 
neuronal population.
In summary, by combining both the glycoprotein deficiency and pseudotyping 
of the viral tracer, to generate EnvA pseudotyped ΔG rabies tracer, the entry 
and amplification of the tracer can be restricted to TVA and rabies 
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glycoprotein expressing neurons, which are termed starter neurons (Figure 
1.5). To distinguish between starter neurons, rabies infected starter neurons 
and their presynaptic partners (termed traced neurons), the starter neurons 
are also modified to express a reporter distinct to the viral tracer signal (e.g. 
starter neuron, histone-green fluorescent protein (GFP) positive and traced 
neurons, mCherry positive, infected starter neuron, both GFP/mCherry 
positive) (Figure 1.5). Overall, the EnvA pseudotyped ΔG rabies tracer 
simplifies the analysis of neuronal connectivity down to which neurons have 
direct (monosynaptic) inputs on the starter neurons (Figure 1.5). Unlike 
polysynaptic tracers, this provides a connectivity pattern which is both easier 
and less labour intensive to interpret. 
1.8.3 Applications  
The mapping of neuronal connectivity is of value for a number of reasons. 
First, the influence a neuron has over signal integration/coding is determined 
by the number and type of synaptic partners (Tian et al. 2016). Interneurons 
are a classic example of a neuronal class which typically has a large number 
of synaptic outputs, to allow interneurons to regulate the firing pattern of 
multiple postsynaptic partners (e.g. cortical pyramidal neurons) in synchrony
(Hirano et al. 2008; Sohal et al. 2009). This is critical for creating rhythmic 
patterns of signalling in the brain (Hirano et al. 2008; Sohal et al. 2009). 
Second, evaluating connectivity in vivo has allowed identification of the native 
synaptic partners of neurons, with a prime example being the neuronal inputs 
onto the striatal projection neuron MSN (Wall et al. 2013). This study 
identified the synaptic inputs onto D1 and D2 MSN subtypes to understand 
the shared and differential connectivity of each subtype (Wall et al. 2013). 
This has provided clarity on circuit integration across brain regions, and in 
this case, gave a refined and enhanced understanding of the basal ganglia 
circuitry (Wall et al. 2013). Third, a cross-comparison of neuronal connectivity 
in control and disease models have implicated aberrant connectivity of 
neurons in many neurological disorders, including schizophrenia, intellectual 
disability and Rett syndrome (Brennand et al. 2011; Marín 2012; Sun et al.
2019). This has been supported by many of the known risk genes, for 
neuropsychiatric disorders, encoding for synaptic proteins, including cell-
adhesion molecules (neuroligins NLGN, neuregulin NRG, Erb-B2 receptor 
26
tyrosine kinase 4, ErbB4) and scaffold proteins (SH3 and multiple ankyrin 
repeat domains gene family SHANK, disrupted in schizophrenia 1 DISC1) 
(Südhof 2008). Together, this has enhanced our understanding of disease 
mechanism, and may enable novel, and more efficacious therapeutic targets 
to be generated. Finally, cell replacement therapy is a promising therapeutic 
approach, which relies on the successful and appropriate integration of the 
neuronal graft in atrophied brain regions to repair and replace the 
degenerated circuits (Aubry et al. 2008; Cunningham et al. 2014; Grealish et 
al. 2015). In rodent models, a measure of the outputs/inputs onto the 
neuronal graft would allow an accurate evaluation of the efficacy of the graft 
and could guide improvements necessary to progress the development of this 
therapeutic strategy (Grealish et al. 2015; Tornero et al. 2017). 
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Figure 1.5 Schematic of the retrograde monosynaptic viral tracer system: 
step-by-step guide.
EnvA pseudotyped ΔG rabies viral tracer acts to selectively map discrete neuronal 
circuits made up of the starter neuron and the monosynaptic presynaptic partners of 
this starter neuron. The viral tracer system exploits the innate and selective ability 
of the wild-type rabies virus to spread trans-synaptically from one neuron into the 
neurons connected presynaptically onto this starter neuron (retrograde 
transmission). By making the following complementary modifications to the rabies 
virus and the selected starter neuron population, the monosynaptic viral tracer 
system can be established. First, restrict entry of the viral tracer through 
pseudotyping the virus with non-mammalian envelope protein (e.g. EnvA) and 
enforce the expression of the complementary receptor (e.g. TVA) in starter neurons 
selectively. Second, restrict viral tracer replication, and therefore the transmission of 
the tracer signal, by deleting a critical rabies gene from the rabies tracer genetic 
material (e.g. the glycoprotein), and only provide starter neurons with the ability to 
express the missing rabies glycoprotein. Therefore, once the pseudotyped ΔG rabies 
viral tracer has been trans-synaptically transmitted, the tracer signal is terminated 
(as no glycoprotein provided to allow signal to be amplified). Finally, to allow 
independent identification of the starter neurons and traced neurons, have starter 
neurons innately expressing one reporter (e.g. histone-GFP) and the rabies tracer 
enforce the expression of a different reporter (e.g. mCherry). Any viral tracer infected 
starter neurons are therefore nuclear GFP and mCherry double positive. Whereas, 
neurons that are either post-synaptic to starter neuron or not monosynaptically 
connected to the starter neuron, do not take up EnvA pseudotyped ΔG rabies viral 
tracer (remain untraced, GPF and mCherry negative). Cartoon illustrations of neurons 
were adapted from figures taken from https://www.motifolio.com/neuroscience-
all.html (Motifolio 2018).
Glycoprotein-deficient, ΔG. GFP, green fluorescent protein. 
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1.9 Research models 
Rodent models have been a valuable resource in research, due to the ability 
to directly link genetics, output of defined neuronal circuits, and behaviour. 
However, the use of rodent models as a means to understand human 
interneuron development and function in the brain also raises many caveats. 
These limitations mainly relate to between-species differences in interneuron 
numbers, spectrum of subtype diversity and subtype composition in each 
brain region (Wu & Parent 2000; Bakken et al. 2016; Sousa et al. 2017; 
Boldog et al. 2018). The apparent inter-species differences have highlighted 
the importance of conducting experiments directly in humans. This work has 
included molecular and functional characterisation of primary human tissue, 
both post-mortem adult and foetal tissues (Mo et al. 2007; Moore et al. 2009; 
Boldog et al. 2018; Garas et al. 2018; Zhong et al. 2018). Unfortunately, 
primary human tissue use presents many challenges and restrictions, 
including, but not limited to: the scarcity of tissue, the inconsistency of tissue 
quality, and legal age restrictions of human foetal tissue usage. To overcome 
these limitations, several independent groups have established robust means 
to generate interneuron-like cells from human pluripotent stem cell (hPSC) 
models (Goulburn et al. 2011; Cambray et al. 2012; Maroof et al. 2013; 
Nicholas et al. 2013; Kim et al. 2014; Colasante et al. 2015; Noakes et al.
2019).
1.9.1 Principles of neuron differentiation of hPSC
Over the last decade, PSC-derived neurons have emerged as a promising tool 
in regenerative medicine and neuroscience research. The common aim of 
differentiation paradigms is to recapitulate the neuronal differentiation steps 
that occur natively during development in order to efficiently convert PSC into 
the neuronal lineage of choice. The earliest success stories were obtained 
from mESC, with hPSC-derived neuronal models subsequently following (Bain 
et al. 1995; Okabe et al. 1996;  Zhang et al. 2001; Chambers et al. 2009). 
Although the precise details of the differentiation paradigms differ, common 
principles are shared across neuronal differentiation paradigms (Figure 1.6). 
Broadly speaking in vitro neuronal differentiation paradigms have been 
categorised into two different methodologies depending on the approach 
taken to induce neuronal fate commitment: intrinsic or extrinsic cues. Further 
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variations within each method relate to differences in how the cells are 
cultured, either as 2D-monolayers adhered to the surface or free-floating 3D-
spheres/embryoid bodies (and then into organoids) (Figure 1.6). Although 
embryoid body and organoid cultures better mimic the native form of the 
brain,  these 3D-cultures are often confounded by issues of poor delivery of 
small molecule factors, nutrients and O2 to inner layer cells. This often results 
in greater inconsistencies in the efficiency of the paradigm, along with higher 
levels of atrophy and expression of stress markers in the surviving cells 
(Camp et al. 2015; Xiang et al. 2017).  
The basic principle of the extrinsic cue approach is to use small molecule 
factors to induce the expression of key transcription factors that will guide 
the PSC along the neuronal lineage of choice. Stage one involves directing 
PSC to take the first step towards a neural restricted lineage, in a process 
termed neural induction. A highly efficient and simple means to generate 
neuroepithelia was achieved using two chemical factors (SB-431542 and 
noggin/noggin analogue LDN-193189) in a process termed dual SMAD 
inhibition (Chambers et al. 2009; Maroof et al. 2013). The factors act to 
repress PSC taking alternative fates by inhibiting transforming growth factor-
beta (TGF-β) signalling pathway. Stage two uses a region of origin dependent 
set of small molecular factors to restrict the fate of the neuroepithelial cells 
to a lineage of choice by mimicking the native environment in the culture 
(Figure 1.6). Alternatively, the intrinsic cue approach enforces the expression 
of lineage determining transcription factors and neurogenic microRNAs in 
hPSC using lentiviral transduction (or less efficient, electroporation) to obtain 
neuron-like progenitors belonging to the desired lineage (Figure 1.6) 
(Colasante et al. 2015; Sun et al. 2016; Yang et al. 2017; Yuan et al. 2018). 
The final stage of the neuron differentiation paradigm is common across 
methodologies, and describes the transition of progenitors to a post-mitotic 
state that marks the terminal differentiation of the neuron-like cell (Figure 
1.6). This can be driven by neurotrophic/neurogenic factors (e.g. brain/glial 
derived neurotrophic factor BDNF/GDNF) (Maroof et al. 2013; Close et al.
2017; Noakes et al. 2019). Moreover, the application of retinol has been 
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Figure 1.6 Methodologies used to generate hPSC-derived neurons.
Although hPSC-derived neuronal differentiation paradigms have specific 
requirements to induce a certain neuronal lineage, there are common principles 
across paradigms. Broadly speaking there are two methods to direct hPSC to take on 
a particular neuronal fate. Method one, the use of extrinsic cues to mimic the cues 
in the native region were the neurons are born. In the case of interneurons, the 
MGE/CGE environmental cues are recapitulated in vitro to promote interneuron fate 
commitment using SHH signalling. Further variations exist within the extrinsically 
driven differentiation paradigms (summarised by approaches 1 to 3, top to bottom). 
Approach 1 describes monolayer differentiation protocols, where at all stages cells 
are adhered to a coated surface of the plate and grown as a 2D-monolayer. 
Approaches 2 and 3 both begin with generating embryoid bodies, with the culture 
dish spun to maintain the culture as free-floating 3D neuroepithelial spheres. On 
sphere formation (end of stage 1), approach 2 seeded the neuroepithelial cells and 
continued maturation as a 2D-monolayer. Whereas, approach 3 continued to expand 
the neuronal committed cells as a 3D-culture, which undergoes terminal 
differentiation to form an organoid. Method two, enforced expression of lineage 
determining transcription factors and neurogenic microRNAs known to be critical for 
directing hPSC towards the desired neuronal lineage. Classically, interneuron 
differentiation paradigms using intrinsic cues use lentiviral vectors to drive the 
expression of one or more of these genes: LHX6, MASH1, DLX5, miR-124 and miR-
9/9*. A final difference between extrinsic and intrinsic driven approaches, is the 
typically extended duration of differentiation paradigms using extrinsic cues (method 
one). 
hPSC, human pluripotent stem cells. LHX6, LIM Homeobox 6. MASH1, achaete-scute 
family BHLH transcription factor 1. DLX5, Distal-less homeobox 5. miR, microRNA.
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demonstrated to further promote neuronal maturation and survival in vitro 
(Cambray et al. 2012; Maroof et al. 2013; Noakes et al. 2019). Differentiation 
paradigms using intrinsic cues typically complete terminal differentiation over 
a shorter timeframe, and often have greater consistency between 
independently generated cultures (Colasante et al. 2015; Sun et al. 2016; 
Yang et al. 2017; Yuan et al. 2018). However, this method relies on well-
established knowledge of the genetics underpinning the neuronal lineage. 
Such knowledge is not always available for a neuronal class. Moreover, direct 
induction of the neuronal fate poorly recapitulates the native steps in 
neurodevelopment, arguably reducing the value as an in vitro 
neurodevelopmental model. 
1.9.2 Interneuron differentiation of hPSC
Differentiation paradigms to generate interneuron-like cells from PSC have 
been developed using both extrinsically and intrinsically driven 
methodologies. To efficiently generate MGE-like progenitors both SHH 
signalling agonists (SHH, smoothened agonist (SAG), purmorphamine) and 
WNT signalling inhibitors (XAV939) are used to ventralise the neuroepithelia 
(Maroof et al. 2013; Meganathan et al. 2017; Xiang et al. 2017; Noakes et 
al. 2019). As described in section 1.4.1, WNT inhibitors and SHH are critical 
for the spatial patterning of cells across the ventral telencephalon and have 
the strongest signalling within the MGE. Thus, PSC-derived differentiation 
paradigms with variations on the time and duration of SHH agonist 
application, and SHH agonist concentration exist for generating LGE, CGE and 
MGE-derived neurons in vitro (Danjo et al. 2011). Alternatively, activin 
signalling has been successfully used to generate both CGE-derived 
interneuron subtypes and LGE-derived MSN in vitro (Cambray et al. 2012; 
Arber et al. 2015). This paradigm relies on the activation of TGF-β signalling, 
and acts independently of SHH signalling (Arber et al. 2015). Whereas, 
regionalisation step in differentiation paradigms using intrinsic cues to induce 
MGE-fate requires ectopic expression of critical transcription factors (LHX6, 
achaete-scute family BHLH transcription factor 1 MASH1 and distal-less
homeobox DLX 2/5) and neurogenic microRNAs (miR-124 and miR-9/9*) 
(Colasante et al. 2015; Sun et al. 2016; Yang et al. 2017; Yuan et al. 2018).
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Irrespective of the protocol, the ability to consistently and efficiently generate 
defined interneuron subtypes from PSC is lacking. Moreover, generating 
interneuron-like cells of the same molecular and functional standard as their 
native counterparts remains a major challenge within the field. 
1.9.3 Application of hPSC-derived neuronal models  
Although human in vitro models are limited by the inability to directly test 
the link of molecular/circuit-level changes to behaviour, hPSC-derived 
neuronal models have many advantages and applications (Kelava & Lancaster 
2016). First, hPSC-derived neuronal models hold great promise as they are 
not confounded by species differences, a major drawback of rodent models, 
and are therefore arguably a more translatable model (Bakken et al. 2016; 
Garas et al. 2018). Second, hPSC models provide a simpler, cheaper and 
faster-turnover platform to investigate how specific pathways and neuronal 
classes can be affected by pharmacological and genetic manipulations (Anton 
et al. 2018; Shao et al. 2019). Hence, the malleable nature of hPSC-derived 
neurons has led to the wide application of in vitro models in 
neurodevelopment and disease modelling, and drug discovery (Kelava & 
Lancaster 2016). Third, hPSC-derived neuronal progenitors hold potential as 
a regenerative medicine strategy. This was marked by the first human clinical 
trials using hPSC-derived dopaminergic neuronal progenitors as the graft 
source in Parkinson’s disease launching in 2018 (Barker et al. 2017). The 
results are eagerly awaited.  Although previous findings in neurodegenerative 
rodent models would add caution, with limited and inconsistent success 
reported for the use of hPSC-derived neuronal progenitor grafts as a viable 
alternative to primary foetal tissue in cell replacement therapies (Delli Carri 
et al. 2013; Cunningham et al. 2014; Arber et al. 2015). These reports have 
demonstrated the need to optimise and validate in vitro models, to ensure 
that the neuron-like cultures closely resemble their authentic derivatives (in 
primary human tissue), both molecularly and functionally (Camp et al. 2015; 
Yao et al. 2016; Chen et al. 2017; Close et al. 2017; Xiang et al. 2017). 
1.10 General aims 
The series of experiments presented in this thesis aimed to evaluate an in 
vitro model of interneuron differentiation using several innovative 
approaches. Particular focus was given to determining how well the 
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differentiation of human embryonic stem cells (hESC), under an extrinsic cue 
based paradigm, could recapitulate the native steps of interneuron 
differentiation. With the limited understanding of interneuron subtype 
diversity that can be achieved in vitro, the culture was assessed in terms of 
the expression of molecular markers, physiology and neuronal connectivity. 
In order to investigate the heterogeneity within the culture, both the 
longitudinal molecular and functional characterisation was performed at 
single-cell resolution, using single-cell RNA sequencing and whole-cell patch 
clamp recordings respectively. Finally, a novel cross-comparison was 
performed between hESC-derived interneurons and human MGE to directly 
examine the authenticity of the neurodevelopmental model. 
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Chapter 2 - Material and Methods
2.1 Stem cell and tissue culture work 
2.1.1 General cell and primary tissue culture practice 
All cell/tissue culture work was carried out under sterile conditions (surfaces 
and equipment treated with Chemgene, STARLAB and 70% denatured 
ethanol, VWR), in a laminar flow hood (Maxisafe 2020, Thermo Scientific). 
For the majority of cultures, cultures were maintained in humidified 
incubators at 37˚C, 5% CO2 and 21% O2. The only exceptions were during 
viral transfection and transduction (altered settings: 35˚C, 3% CO2 and 21% 
O2). All viral and human tissue culture work was carried out in specified rooms 
isolated from other cell culture areas, with additional health and safety 
measures. These safety measures included: viral-suite specific lab coat, 
double-gloving, 24hr Chemgene soaking of any solid and liquid wastes, and 
autoclaving solid wastes within 24hrs of generation. 
2.1.2 Cell lines
hESC line used for interneuron differentiation was H7 (female) and included: 
H7 parent line and H7 LHX6::mCherry; PVALB::GFP (dual reporter line gifted 
by Maria Cruz, Li lab). Other human cell lines used were human embryonic 
kidney cells (HEK) 293T, and HEK 293T constitutively expressing TVA (HEK 
TVA). Additional cell lines included the baby hamster kidney (BHK) cells 
constitutively expressing EnvA (BHK-EnvA cells). Lastly, BHK cells 
constitutively expressing (under CMV promoter) T7 RNA polymerase, rabies 
glycoprotein, histone-GFP,  termed B7GG cells. The HEK and BHK derived cell 
lines were gifted from Parmar lab (Prof Malin Parmar, Lund University, 
Sweden). 
2.1.3 Cell maintenance for hESC lines
hESC were maintained on DMEM/F-12 diluted matrigel (matrigel, Corning and 
DMEM/F-12, Gibco) coated wells, and cultured in E8 basal media (Gibco). 
Once the confluency of the cells reached approximately 80%, the cells were 
detached from their original well using EDTA treatment (EDTA 0.02%, 
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Sigma). The EDTA treatment required initial washing of the cells with Ca2+ -
free, Mg2+ -free Dulbecco's phosphate-buffered saline (DPBS, Gibco) to 
remove debris, followed by approximately 2min incubation in EDTA at 37˚C. 
Immediately after this incubation, EDTA was removed and replaced with E8 
basal media, then the cells were manually scratched from the well surface 
(using 2ml stripette tip guided in a zig-zag pattern across the well). The 
detached cells were then gently resuspended in the appropriate volume of E8 
basal media. If the cells were still required, the resuspended hESC were 
seeded onto a freshly DPBS washed DMEM/F-12 diluted matrigel wells 
(typically at 1:3 split ratio, with the original well now being seeded into 3 
wells). The plate was gently shaken immediately after placing in the incubator 
to ensure even distribution of the cells within the well. This process, termed 
splitting, was repeated to maintain the hESC over time. 
2.1.4 Cell maintenance for HEK and BHK lines
HEK and HEK TVA cells were maintained in tissue culture flasks and cultured 
in “HEK media”. HEK media consisted of DMEM/F-12 media with 10% foetal 
bovine serum (FBS, Biosera), 1% non-essential amino acids (Gibco), 1% L-
glutamine (Gibco), 0.2% mycozap (Lonza). All BHK cells were also maintained 
in HEK media. Typically cells were seeded onto tissue culture flasks directly 
(no prior coating required). However, to reduce detachment during the 
transfection protocol (see Section 2.7.1), HEK cells were seeded onto 0.1% 
gelatin-DPBS coated flasks (gelatin solution, Sigma). To maintain HEK cell 
lines typical split ratio of 1:10 (1 flask worth of dissociated HEK cells sufficient 
to seed 10 flasks) was used every 2-3 days. Whereas, BHK cell lines were 
split at 1:15 ratio every 2-3 days. HEK and BHK cells were split using trypsin 
treatment (TrypLE Express, Life Technologies). The trypsin treatments began 
with HEK/BHK cells being washed with DPBS to remove any debris, twice. 
The HEK/BHK cells were then treated with diluted TrypLE (1:10 diluted in 
DPBS) for approximately 5min at 37˚C (until cells had begun to detach on 
tapping the flask). The detached cells were collected from the flask, and HEK 
media was added to terminate trypsinisation (diluting trypsin 1:3, e.g. 5ml 
TrypLE, add 10ml HEK media). The cell suspension was gently centrifuged 
(300g, 5min, room temp) to pellet the cells. The supernatant was removed, 
and cells resuspended in fresh HEK media. HEK and BHK cells grew best when 
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dissociated into single-cell/small clusters, so cells were thoroughly 
dissociated into the HEK media by trituration before seeding. The flask was 
also gently shaken once placed in incubator to ensure even distribution of 
cells. Lower split ratios (1:3 to 1:6) were used to obtain high confluency (80-
90%) within 24hrs, a step required for transfection protocols (refer to Section 
2.7.1).
2.1.5 Cell maintenance for human foetal tissue  
Human foetal tissue was donated as part of the South Wales initiative for 
transplantation (SWIFT) programme, in accordance with the Polkinghorne 
and department of health guidelines. The human foetal brain was dissected 
out to provide MGE, LGE and CGE (dissection carried out by Rachel Hills and 
Sophie Rowlands, Rosser lab). The crown-rump length (CRL) was measured 
on the day of dissection, and the conversion of CRL to gestational age was 
obtained from Loughna et al.,  and  Koornstra et al. for CRL larger than 80mm 
(Koornstra et al. 1990; Loughna et al. 2009). The dissected foetal tissue was 
kept at 4˚C in Hibernate E (Invitrogen) until collected within 24hrs. If the 
foetal tissue was to be maintained for a short period ex vivo (e.g. plated for 
immunohistochemistry), the foetal tissue was seeded onto poly-D-lycine 
(1:1000 diluted PDL, Sigma) coated plates, which had been repeatedly (3 
times) washed with sterile water, and air dried under UV light. The foetal 
tissue suspension was then seeded onto the dried plates in the following 
media: DMEM/F-12 with 1% FBS, 2% B27 with retinol (Invitrogen) and 0.2% 
mycozap. This media was referred to as “foetal tissue media”. The culture 
was then maintained for 2-3 days. After this period cells were fixed with 4% 
paraformaldehyde (PFA, paraformaldehyde powder dissolved in PBS, Sigma) 
ready to perform immunohistochemistry (see Section 2.2). 
The seeding of the foetal tissue required a single cell suspension to be made. 
To obtain a single-cell suspension of foetal tissue, TrypLE Select CTS (Life 
Technologies) treatment was used. The steps were as follows. First, Hibernate
E was removed from the foetal tissue, and replaced with prewarmed (37˚C) 
DMEM/F-12 and 20µl/ml Donase-α (also known as Pulmozyme), with the 
fresh media changed several times to remove debris. Second, DPBS was used 
to remove traces of DMEM/F-12/Donase-α before adding TrypLE Select CTS 
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with Donase-α (20µl/ml). The foetal tissue was incubated at 37˚C for 10min 
(the fresh tube gently tapped at the 5min interval) in TrypLE Select 
CTS/Donase-α mix. Once the incubation was complete, the trypsinisation was 
terminated by adding prewarmed foetal tissue media. The tissue was then 
manually dissociated into single cells through manual trituration in the foetal 
tissue media. The cell concentration (cells/ml) was calculated by manual cell 
counting of viable cells with Neubauer Chamber and Trypan Blue assay as a 
cell viability measure (Trypan Blue, Gibco). Tissues with viability of <80% 
were discarded. Approximately 50,000 cells were seeded into each well of a 
24-well plate in the form of a single drop of 30μl cell suspension. The well 
was then flooded with 500μl foetal tissue media between 4-6hrs after 
seeding. 
2.1.6 Interneuron differentiation of hESC 
Li lab has an established protocol to generate hPSC derived interneuron-like 
cells using extrinsic cues (Noakes et al. 2019, and Appendix folder 8). The 
differentiation paradigm consists of three main stages: neural induction, 
commitment to interneuron fate, and terminal differentiation. An illustration 
of these steps has been provided in Chapter 3 and 6 (without and with SCM1 
factors, respectively). 
Stage one began with seeding the hESC onto freshly DPBS washed DMEM/F-
12 diluted reduced growth factor matrigel plates (diluted 1:15, Corning). 
Once cell confluency reached >90% the E8 basal media was replaced with 
“neural induction media”, which consisted of a basal media and the following 
small molecule factors: SB431542 (10μM, Tocris), LDN193189 (100nM, 
StemGent) and WNT inhibitor XAV939 (2μM, Tocris). The basal media, 
termed N2B27 (retinol-free) media, consisted of: 75% DMEM/F-12, 25% 
Neurobasal (Gibco), 0.7% N2 supplement (Invitrogen), 0.7% B27 retinol free 
supplement (Invitrogen), 1% L-Glutamine (Gibco), 0.2% Mycozap and 0.1% 
β-mercaptoethanol (Gibco). This change in media marked day 0 of the 
differentiation protocol, and cells were maintained in neural induction media 
for approximately 9 days with half-volume media changes every 2 days. 
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Once stage one was completed, the ventralised neuroepithelial cells were split 
using EDTA treatment as described above (refer to Section 2.1.3), but with 
an additional step of having the cells exposed to 10μM ROCK inhibitor at least 
1hr before splitting. The cells were seeded to obtain 90% confluency onto 
freshly DPBS washed fibronectin (15 μg/ml, Millipore) coated wells. This 
marked the start of stage two of the interneuron differentiation paradigm, 
when SHH signalling is used to generate interneuron-like progenitors. The 
SHH treatment began on day 10 and typically lasted until day 20, and 
consisted of 200 ng/ml human recombinant SHH (SHH, R&D) and 1 μM Smo 
agonist purmorphamine (Calbiochem CAS 483367-10-8, Millipore) added to 
N2B27 (retinol-free) media. This is referred to as the “interneuron 
differentiation media”. 
Once the interneuron-like progenitors had become overly confluent, at 
approximately day 20, a second split was performed using accutase 
treatment onto PDL/laminin plates (laminin, Sigma). To gently detach the 
progenitors, cells were treated with accutase (Gibco) for a 10min incubation 
at 37˚C. To isolate the detached progenitors from the accutase, accutase-cell 
suspension was diluted (1:5) with N2B27 (retinol-free) media with 10μM 
ROCK inhibitor, and centrifuged (300g, 5min, room temp) to pellet the 
detached cells. The supernatant was then aspirated and the cells resuspended 
in N2B27 (retinol-free) media with 10μM ROCK inhibitor and 10ng/ml BDNF 
(PeproTech). Once the appropriate cell density was reached (typically 
300,000 cells/ml), 0.5ml of cell suspension media was seeded into each well 
of the 24-well plate. The plates were gently shaken on placing into the 
incubator to ensure even distribution. This marked the start of stage three, 
terminal differentiation, which lasted until day 65 day in vitro. Gradually, 
through half-volume media changes every 3-4 days, the N2B27 (retinol-free) 
media was replaced with N2B27 with retinol (substitution of B27 retinol free 
to B27 with retinol, Invitrogen), and BDNF (10ng/ml). This is described as 
the “neuronal maturation media”. To promote functional maturation of the 
interneuron-like progenitors (see Chapter 6), additional factors were added 
for approximately 5 to 7 days shortly after the second split (typically from 
day 22 to day 29). These factors were described as SCM1 factors, and 
included: BDNF (10ng/ml, PeproTech), DAPT (10uM, Sigma), ascorbic acid 
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(200 μM, Sigma), GABA (300 μM, Tocris), 0.5mM calcium chloride (Sigma), 
CHIR99021 (3 μM, Tocris), LM22A4 (1 μM, Tocris), Forskolin (10 μM, Tocris), 
PD0332991 (2 μM, Selleckchem) (Telezhkin et al. 2016). After the 5-7 day 
treatment with SCM1 factors, the added factors were reduced to BDNF 
(10ng/ml) and ascorbic acid (200 μM). In any experiments were SCM1 factors 
were used in the differentiation protocol, this has been clearly stated (see 
Chapter 6). 
2.1.7 Sequential serial expansion of hESC-derived interneuron 
progenitors 
A modified design of the differentiation paradigm was implemented when 
performing sequential serial expansions of hESC-derived interneuron 
progenitors (Chapter 3). Stage one (neural induction) and stage two 
(interneuron fate commitment) were completed as previously described in 
Section 2.1.6. On completing stage two (at approximately day 20) a 
proportion of the hESC-derived interneuron progenitors were carried forward 
into stage three, for terminal differentiation. The remaining day 20 
progenitors were re-seeded into stage two, under SHH treatment for another 
10 days (until day 30). The seeding was carried out to achieve high density 
(approximately 1.5 million cells per well on 12-well plate, 90% confluency), 
to encourage the maintenance of the proliferative progenitors, and the 
expansion of the progenitor population. This process was repeated 5 times to 
generate 6 sequentially derived cultures made from serial expansions, with 
the last culture seeded at day 70 (serial expansion 6, SE6). Although the final 
fix date was the same across sequentially generated cultures (day 110), the 
duration each culture had in the neuronal maturation media progressively 
decreased in each subsequent culture from 90 days in culture 1 (SE1 + 90 
days) to 40 days in culture 6 (SE6 + 40 days). Samples were collected for 
immunohistochemistry (Section 2.2), either 1 day after serial expansion (SE 
+ 1 days) onto fibronectin plates in SHH treatment (progenitor plate 
immunostaining) or at day 110 (terminally differentiated plate 
immunostaining). An illustration of the steps described above has been 
provided in Chapter 3. 
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2.2 Immunohistochemistry 
Immunohistochemistry was carried out on cells fixed using a PFA treatment. 
The following protocol was used to fix cells. First, cells adhered to the surface 
of a 24-well plate were washed twice with chilled (4 ˚C) DPBS. Second, cells 
were left in chilled 4% PFA for 15mins at room temperature. The PFA was 
then collected, and disposed of appropriately, and replaced with chilled DPBS, 
and stored at 4˚C. The fixed cells were stored for only a short period (no 
longer than 2 weeks) before immunostaining. To stain the cells for selected 
protein markers, the cells were washed with PBS (sterile water dissolved PBS 
tablets, Sigma), then treated with block solution. Block solution consisted of 
PBS, 0.02g/ml Bovine Serum Albumin (BSA, Sigma) and 5% donkey serum 
(Sigma). If nuclear markers needed to be identified, an additional methanol 
wash step, which involved sequential washes in methanol with dilutions 
gradually increasing in concentrations (to 100% methanol) and then 
gradually decreasing back to methanol-free wash, before the blocking step. 
Moreover, PBST (PBS with 0.1% Triton-X 100, Sigma) was used instead of 
PBS in wash steps. Once the blocking step was completed (approximately 1hr 
blocking, room temp, plate on shaker), primary antibodies diluted in block 
solution replaced the block solution (for list of primary antibodies see 
Appendix folder 1 table 1). Primary antibodies were left overnight, with the 
plate on a gentle shaker at 4˚C. The next day, primary antibody-block 
solution was removed and cells washed with PBS (or PBST) for 20min 
intervals, repeated 3 times (room temp). The secondary antibodies were 
prepared in PBS (or PBST) at 1:1000 dilution, and added to the cells for 
approximately 1hr at room temperature while on a gentle shaker (for list of 
secondary antibodies see Appendix folder 1 table 2). From this point onwards, 
the plates were kept in the dark using tin foil covering. Once incubation was 
completed, cells were exposed to nuclei marker DAPI (Molecular Probes) for 
5min (DAPI stock 1mg/ml, 1:3000 dilution in PBS). Three 10min washes in 
PBS then followed to remove unbound antibodies and reduce background 
staining. Finally, coverslips were placed over the stained cells using 
fluorescence mounting media (Dako) to mount the coverslip. If cells were 
cultured on coverslips (applicable for electrophysiology, Section 2.11), the 
coverslips were removed from the plate and moved onto a microscope glass 
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slide with coverslip facing cell side down, and adhered with Dako. Plates and 
glass slides remained at 4˚C, in tin foil, for preservation. 
2.3 Stages prior to quantitative polymerase chain reaction
Throughout all steps, benches and pipettes used were sprayed first with 70% 
ethanol and then RNase Zap (RNase Decontamination Solution, Invitrogen). 
Moreover, sterile filtered tips and RNase-free sterile tubes were used.
2.3.1 RNA extraction 
TRIzol method was used to extract RNA from tissue/cell cultures. Details of 
the protocol in full can be found in the manufacture’s guide: TRI Reagent 
Protocol (Sigma-Aldrich 2019). The samples were first washed twice with 
DPBS to remove any debris, then TRIzol (Invitrogen) was applied to generate 
a lysed, homogeneous TRIzoled sample. The TRIzoled samples were stored 
immediately at -80˚C. On the day of RNA extraction, the samples were 
removed from -80˚C stores and thawed on ice, and then left to reach room 
temp for approximately 5min. The appropriate volume of chloroform was 
added to the TRIzol samples, then mixed by vigorously shaking, and left to 
separate into three layers, which was then further promoted by centrifugation 
(12,000g, 15min, 4 ˚C). The colourless upper aqueous phase was collected 
into a fresh tube, and treated with the appropriate volume of isopropanol and 
shaken (isopropanol treatment 10min, room temp). The samples were 
centrifuged to pellet the RNA (RNA precipitation 12,000g, 10min, 4 ˚C). The 
supernatant was then removed, and the RNA was washed with freshly-made 
cold 75% absolute ethanol. All traces of ethanol was removed by centrifuging 
the sample at 12,000g, 5min, 4 ˚C. A second short spin (<10s) was then 
repeated once the ethanol supernatant had been removed to collect any 
remaining traces of ethanol. Once all traces of the ethanol was removed, RNA 
pellet was left to air dry for approximately 20min (until RNA pellet appeared 
matt). Finally, RNA pellet was resuspended in approximately 20-30μl PCR-
grade water. To help promote RNA resuspending in water, samples were held 
on a heat block at 65˚C for 15min. Using NanoDrop 2000 Spectrophotometer 
(Thermo Scientific), the A260/280 and concentration of the RNA samples 
were determined (pre-DNase treatment measure). 
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2.3.2 DNase treatment of RNA  
In order to remove traces of genomic DNA from the extracted RNA sample 
made in Section 2.3.1, DNase treatment was carried out (1 unit of DNase per 
μg of RNA). The DNase was added to the RNA samples for 30min incubation 
at 37 ˚C with DNase with MgCl2 and 10X reaction buffer mix. The RNA 
samples were gently mixed at the 15min interval. To terminate the DNase 
treatment 50mM EDTA was added (1:10 dilution) to the samples and 
incubated at 65˚C for 10min (gentle mixing of samples at 5min interval). 
Post-DNase treatment measure of the A260/280 and concentration of the 
RNA samples were performed on NanoDrop 2000 Spectrophotometer. RNA 
A260/280 should approximately be 2.0. Good quality RNA was stored at -80 
˚C for long term storage, the rest were discarded. Details of the protocol in 
full can be found in the manufacture’s guide: Product Information, DNase I, 
RNase free (ThermoScientific 2016).
2.3.3 Reverse transcription 
Once the RNA samples generated in through the steps described in Section 
2.3.1- 2.3.2 had been confirmed as good quality, 1μg of RNA from each 
sample was carried forward for 20μl reverse transcription (RT) reaction to 
convert RNA to cDNA. The RT reaction used reagents from the EvoScript 
Universal cDNA master kit (Roche Molecular Systems). The 20μl RT reaction 
mix consisted of: 4μl reaction buffer mix (consisting of magnesium acetate
Mg(OAc)2, random primers, anchored oligo(dT)18 and deoxynucleoside 
triphosphates) 2μl enzyme mix (with reverse transcriptase and protector 
RNase inhibitor), appropriate volume of RNA sample for 1 μg, and then PCR-
grade water to bring the total final volume to 20μl. For the reverse 
transcriptase free (-RT) negative controls, the 2μl enzyme mix was replaced 
with PCR-grade water. After gentle mixing, the 20μl RT reaction mix samples 
were taken through RT protocol on the thermocycler. The resulting cDNA 
samples were stored at -20˚C. Full instructions and reagent details can be 
found in the manufacture’s guide: EvoScript Universal cDNA Master, 
Instructions for Use (Roche Molecular Systems 2017).
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2.4 Quantitative polymerase chain reaction
Through the steps described in Section 2.3, good quality cDNA, and the 
corresponding -RT negative controls, have been generated ready for use in 
the quantitative polymerase chain reaction (QPCR) experiments. The QPCR 
reaction consisted of a 20μl final reaction volume made of 15μl master mix 
consisting of: 10μl  MESAgreen (Eurogentec), 1μl 10 μM forward and reverse 
primers, and 4μl PCR-grade water. The remaining 5μl came from diluted cDNA 
stock (1:12). Two controls were included in all QPCR runs, first -RT negative 
control (determine genomic DNA contamination) and cDNA negative control 
(5μl PCR-grade water, to determine primer dimerisation contamination). The 
QPCR reaction protocol was then carried out on Bio-Rad CFX real-time PCR 
detection system with Bio-Rad CFX manager 3.1 software. Stages of the 
QPCR reaction protocol were as follows. Initial incubation for 4 min, 94˚C, 
followed by the 45 times repeated cycle of 30s at 94˚C, 15s at 60˚C, 30s at 
72˚C. The final stage was the transition from 65 ˚C to 95 ˚C in 0.2 ˚C 
increments (over 0.01s). Note that the primers used were typically chosen 
from published scientific articles or designed through Primer-BLAST (National 
Center for Biotechnology Information 2019). For the full list of primers see 
Appendix folder 1 table 3.
Bio-Rad CFX manager 3.1 software provided the Ct value for each QPCR 
reaction corresponding to a particular gene, which was in turn used to 
calculate the delta Ct (relative to beta-actin). The relative gene expression of 
a gene (RE) was calculated as RE= 2-(double delta Ct) in reference to day 10 hESC-
derived interneuron samples (Chapter 3).
2.5 Molecular characterisation using single-cell RNA sequencing 
For full details of the individual reagents and volumes used please refer to 
SMART-Seq v4 Ultra Low Input RNA Kit for the Fluidigm C1 System, IFCs User 
Manual (Clontech Laboratories 2018).
2.5.1 Fluidigm C1 – single-cell capture and generation of single-cell 
cDNA
Single-cell transcriptome analysis, in the form of single-cell QPCR and RNA 
sequencing, was conducted on foetal tissue derived from human MGE, along 
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with hESC-derived interneurons (Chapter 4-6). The age of foetal tissue or 
time point along the interneuron differentiation protocol has been specified in 
any results presented (Chapter 4-6). Fluidigm C1 IFC was selected as the 
single-cell capture methodology. IFC size was medium (optimised to capture 
cells sized 10-17μm) to match the approximate size of neurons and neuronal 
progenitors. Each C1 run had the ability to capture up to 96 cells, with capture 
efficiency typically between 70-80%. The reaction chemistry was SMART-Seq 
v4 Ultra Low Input RNA kit chemistry (Clontech). RNA spikes were added to 
the reaction chemistry as a positive control. On completion of the C1 run, the 
single-cell pre-amplified cDNA was immediately harvested for quality control 
checks to generate the “Harvest Plate”.  
To achieve a high capture efficiency required the generation of a single-cell 
suspension at the appropriate concentration. The single-cell suspension was 
made through enzymic dissociation of the cells into small clumps, followed by 
manual dissociation into single cells. Accutase treatment was used for hESC-
derived interneuron (Section 2.1.6). Whereas, TrypLE Select CTS (Life 
Technologies) treatment was used to dissociate foetal tissue (Section 2.1.5). 
Once the single-cell suspension was ready, cold Suspension Reagent was 
added to the cell sample and gently mixed (1:1 ratio). The cell suspension 
mix was loaded onto the IFC. Once cell loading was completed, capture 
efficiency was determined by inspecting the IFC butterflies by eye under the 
inverted microscope. Any capture sites not meeting the criteria of a single 
viable cell were excluded from downstream applications. 
2.5.2 Quality control checks 
2.5.2.1 Bioanalyzer
Quality control checks began with a proportion of each single-cell cDNA 
sample being tested on the Bioanalyzer (Agilent Bioanalyzer with the Agilent 
High Sensitivity DNA Kit). The BioAnalyzer run generated electropherograms, 
and from these traces an approximation of quantity and average size of the 
cDNA fragments were determined for the raw single-cell sample (see 
Appendix folder 2 and 3 figures). The protocol can be found in full at: Agilent 
High Sensitivity DNA Kit Guide (Agilent Technologies 2017).
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2.5.2.2 Picogreen assay
For downstream use in library preparation steps (Section 2.5.3), all single-
cell cDNA samples obtained in Section 2.5.1 must meet the criterion of being 
between 0.1 – 0.3ng/μl. An accurate measure of single-cell cDNA 
concentration from the Harvest Plate was determined using the Picogreen 
assay. The Picogreen assay was run as a single 96 well microplate (flat 
bottom, charcoal black). The lambda standards were run in each independent 
assay as triplicates. As a back-ground reference, 1xTE buffer, Harvest 
reagent and C1 DNA dilution reagent were also run as triplicates on each 
plate. The rest of the plate had single-cell cDNA samples added directly from 
the Harvest Plate. The Picogreen master mix was added to each well. Once 
sufficiently mixed, the plate was run as part of the Picogreen programme on 
Tecan Infinite 200 Pro microplate fluorometer. The measured absorbance for 
each of the lambda standards was averaged across the replicates and used 
to generate the lambda standard concentration curve. From this standard 
curve, the concentration of each single cell sample was calculated. cDNA was 
then diluted with C1 DNA dilution reagent to achieve a final concentration 
within 0.1 – 0.3ng/μl range. Diluted cDNA samples were generated on a new 
96 well plate described as the “Dilution Plate”. Step-by-step instructions for 
Picogreen assay can be found at: Quant-iT PicoGreen double-stranded DNA 
Reagent and Kits (Invitrogen 2008).
2.5.2.3 Fluidigm Biomark - single-cell QPCR
Before any single-cell cDNA samples were carried forward for library 
preparation, a final quality control check was conducted. This involved using 
a proportion of the single-cell cDNA samples from the Dilution Plate (Section 
2.5.2.2) in single-cell QPCR. The QPCR reaction was run using the Fluidigm 
Biomark HD and the Biomark chip (96.96 IFC). For full details please refer to 
the protocol titled: gene expression with the 96.96 IFC using delta gene 
assays on preamplified samples (Fluidigm, 2015). In brief, 96 independent 
single-cell cDNA samples were carried forward for use in each single-cell 
QPCR run, and the relative expression of 31 different genes, along with RNA 
spikes were determined for each sample (please refer to Appendix folder 1 
table 3 for full list of primers). An assay mix was made for each primer set, 
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along with a sample mix for each single-cell sample. Each of the 96 sample 
mixes were placed into each inlet on one half of the Biomark 96.96 IFC. In 
the remaining 96 inlets, the assay mixes were loaded as triplets for each of 
the 31 sets of primers, with the remaining three inlets containing assay mixes 
against the RNA spikes (spikes 1, 4 and 7). For single-cell QPCR analysis 
steps see Section 2.12.3.
2.5.3 Library preparation 
2.5.3.1 Tagmentation and indexing
On successful completion of the quality control checks (Section 2.5.2), the 
final steps of single-cell RNA sequencing protocol were performed. The first 
stage began with tagmentation. A small proportion of each single-cell cDNA 
sample (1.25 μl) was transferred from the Dilution Plate into a fresh 96 well 
plate, and mixed with the tagmentation reaction chemistry. The new 96 well 
plate was named the “Library Prep Plate”. The Library Prep Plate was 
incubated at 55˚C for 10min, then cooled to 10˚C. Immediately on reaching
10˚C, NT buffer was added to each sample to neutralise the tagmentation 
reaction.  Once tagmentation was completed, each sample on the Library 
Prep Plate had Nextera PCR Master Mix added, along with an unique dual 
combination of indexes (N7xx and S5xx, Nextera XT DNA Library Prep Index 
Kit, Illumina). The indexed fragments for each cell were then amplified 
through PCR carried out on thermocycler. 
2.5.3.2 Bead clean up 
With each single-cell cDNA sample now uniquely tagged and amplified 
(Section 2.5.3.1), the indexed libraries for cells from the same foetal tissue 
source/time point along differentiation were pooled together (typically 60-70 
cells per pooled library). The pooled library was cleaned up using AMPure XP 
beads (Beckman Coulter) to remove any short fragments (likely dimerised 
indexes) or too long fragments (which would not sequence well on Illumina 
platform). The bead clean up involved first incubating the pooled library with 
AMPure XP beads to allow attachment (5min incubation, room temp). The 
1.5ml tubes containing bead-bound library were then placed on a magnetic 
separation device. As the beads were magnetic, this caused the bead-bound 
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library to become fixed to the tube surface instead of free-floating in the 
supernatant. The supernatant was then removed without disrupting the 
beads, and the bead-bound library was then washed with freshly-made 70% 
absolute ethanol to remove too long/short cDNA fragments, followed by air 
drying until the bead-bound library appeared matt (5-10min). The tubes were
removed from the magnetic stand, and the bead-bound library was eluted 
using C1 DNA dilution reagent. The bead clean up was repeated twice, and 
the final bead-purified library was eluted in 50μl C1 DNA dilution reagent.
2.5.3.3 Qubit assay
For the bead-purified library to be run on the Illumina platform the 
concentration of the library must be 4nM. In order to determine the 
concentration of the post-clean up pooled libraries, the following information 
was required: Qubit measure of bead-purified library concentration (given in 
ng/μl) and average library size (bp). The post-clean up average library size 
was determined by running the library in triplicates on Bioanalyzer (see 
Section 2.5.2.1). Qubit dsDNA HS Assay Kits (Invitrogen) was used to 
accurately determine the bead-purified library concentration in ng/μl, full 
instructions to complete the Qubit assay can be found within the Qubit 
double-stranded DNA HS assay kit protocol (Invitrogen 2015). In brief, Qubit 
dsDNA HS assay kits standards were used to calibrate the fluorometer before 
starting each assay set. These HS standards were diluted 10-fold in Qubit 
working solution. Each of the pooled libraries were diluted 100-fold in 200μl 
of Qubit working solution. Once the stock concentration and average library 
size were known, calculations were carried out to determine stock 
concentration of the pooled library in nM. Dilutions of stock pooled libraries 
were made to get the library to 4nM (within +/- 10%). All sequencing was 
carried out on HiSeq 4000 Illumina platform with the following parameters: 
paired-end reads, read length 2 x 75bp, and read depth of approximately 
1million reads per cell. The sequencing was carried out within the Wales Gene 
Park Genomic Facility (under Dr. Sarah Edkins and Dr Karen Reed). In 
Appendix folder 2 table 4 and folder 3 table 10, there is an overview of 
samples ran on Illumina HiSeq 4000.
For single-cell RNA sequencing analysis steps see Section 2.12.3.
50
2.6 Bacterial work leading to transfections 
The following steps were carried out using bacteria as a vehicle to amplify the 
DNA plasmids required for transfection. The plasmids were used to generate 
the two components of the monosynaptic viral tracer system (Chapter 6). 
First, the lentivirus to enforce the expression of  TVA, histone-GFP, rabies 
glycoprotein (under the human synapsin promoter) in hESC-derived 
interneurons, thereby generating the starter neuron population. Second, the 
monosynaptic rabies viral tracer. Details of all the plasmids used are provided 
in the Appendix folder 5 tables.
2.6.1 General practice in bacterial work 
Steps described below for bacterial work were all carried out within a sterile 
(Chemgene and 70% ethanol cleaned) horizontal laminar flow hood. The 
shaker (300rpm) and non-shaker incubators used for bacterial culture were 
at 37°C, and were reserved for bacterial work only. 
2.6.2 Bacterial transformation 
To amplify the quantity of DNA plasmid stocks, bacterial transformation was 
carried out. Bacterial transformation was induced using the heat-shock 
method. Tubes of 50μl NEB 5-alpha competent E. coli cells were thawed on 
ice, and to each tube 100ng DNA plasmid was added (mixed by the gentle 
flicking of the tube). The tubes were left on ice for 30min. The tubes were 
then placed in a water bath at exactly 42°C for precisely 30s. Once heated, 
the tube was immediately placed back on ice for 5min. SOC medium was 
added to each tube to bring the mixture to 1ml (950μl SOC medium added). 
The tubes were incubated in the shaker incubator for 1hr to allow bacterial 
growth. 
2.6.3 Colony selection
All plasmids, described in detail in Appendix folder 5 tables, conferred 
ampicillin resistance to the transformed E. coli bacteria, allowing colony 
selection based on this property. 1ml bacterial culture generated in Section 
2.6.2  was streaked onto at least 10 agar- ampicillin plates (ampicillin 
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100µg/ml, Gibco) and left to either grow (transformed) or die (lacking 
plasmid) overnight (14-16hr, non-shaker incubator). The agar-ampicillin 
plates were made by warming Luria Bertani (LB)-agar to liquid state. Once 
the LB-agar was fully in molten form, the required volume of LB-agar was 
collected and once cooled sufficiently (just cool enough to hold LB-agar 
bottle), ampicillin was added (final concentration 100µg/mL). The agar was 
then poured carefully into sterile 10-cm dishes (approximately 5ml agar-
ampicillin per dish). The agar was left to set within the dish for approximately 
30min at room temp within a horizontal laminar flow hood, and then used. 
Individual colonies were then picked, by scrapping off a single bacterial colony 
using a sterile pipette tip, and grown overnight in 3ml LB medium with 
ampicillin (100µg/mL) (shaker incubator 300rpm, 37˚C). All well-grown 
bacterial cultures were carried forward for DNA plasmid MINIprep (spin 
microcentrifuge method) for an initial determination of whether the bacterial 
colonies carried the appropriate plasmid. Only 1ml of the bacterial culture 
was required for MINIpreps. If the bacterial culture was confirmed to be 
carrying the appropriate plasmid (using restriction enzyme digestion and gel 
electrophoresis, Section 2.6.5 and Section 2.6.6 respectively), 1.5ml of the 
remaining bacterial culture was frozen down in L-glycerol aliquots (stored at 
-80˚C). The rest of the bacterial culture was added to 150ml LB medium with 
ampicillin (100µg/mL), and grown overnight (shaker incubator). The large 
flask of bacterial culture was then used in the QIAGEN MAXIprep protocol to 
obtain a high yield of the plasmid (0.5 to 1mg/ml). 
2.6.4 DNA plasmid extraction 
The well-grown flasks of 150ml bacterial culture, generated through the steps 
described in Section 2.6.3, were collected from the shaker incubator ready to 
be used in the MAXIprep protocol. The bacteria in each flask had been 
transformed with a different plasmid, therefore although MAXIpreps from 
different flasks may be performed in parallel, all tubes, stripettes and tips 
were kept separate to prevent contamination. The MAXIprep steps for a single 
150ml culture have been provided as an example. Full details of the QIAGEN 
protocol can be found at: QIAGEN plasmid purification handbook (QIAGEN 
2012).
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First, the 150ml bacterial culture was equally split between three 50ml sterile 
centrifuge tubes, and centrifuged gently to pellet the bacteria (6000g, 15min, 
4˚C). During this time P1 buffer was prepared by adding RNase A (3:1000). 
On collecting the tubes, the supernatant was removed and for one of the 
three tubes, the P1 buffer-RNase A mix was added. The resulting bacterial 
suspension was then added in turn to the remaining two tubes of pelleted 
bacteria. This led to all the bacteria from the same original flask being 
combined. The bacterial suspension was then transferred into a single high-
speed 50ml tube, which had pre-warmed P2 buffer (37 ˚ C) added. The mixed 
solution was then left to incubate for 5min at room temp. On exactly 5min, 
pre-chilled (4 ˚C) P3 buffer was added to the tube, and the tube inverted 
until cloudy white debris was seen. To help precipitation of the debris, the 
tube was incubated on ice for 30min. The debris was then pelleted by 
centrifuging the high-speed centrifuge tube at 15,000g for 30min at 4 ˚C. 
The supernatant was then transferred to a fresh 50ml sterile high-speed 
centrifuge tube, with care taken not to transfer any of the white debris. The 
clear supernatant was then passed through the pre-prepared QIAGEN-tip 
500, thus trapping the DNA plasmid within the QIAGEN-tip. To remove any 
remaining contaminants, 30 ml QC buffer wash was performed twice. To elute 
the plasmid DNA pre-warmed  (65˚C) QF buffer was passed through the 
QIAGEN-tip. To precipitate the DNA out of the QF buffer, 15ml isopropanol 
was added, and the tube was left at room temp for 15min. The plasmid DNA 
was pelleted by centrifugation (15,000g for 30min at 4 ˚C). The supernatant 
was then carefully removed, and pellet washed with chilled 70% absolute 
ethanol. To remove all traces of ethanol, the tube was spun again. Lastly, the 
pellet was left to air dry for 15-20min at room temp. The DNA plasmid was 
resuspended in 500μl PCR-grade water. The concentration and A260/280 of 
the DNA plasmid stock were determined using NanoDrop 2000 
Spectrophotometer. Good quality DNA should have A260/280 of 1.8. 
2.6.5 Restriction enzyme digestion
To ensure that the DNA obtained through MINIpreps or MAXIpreps (see 
Section 2.6.4) corresponded to the appropriate plasmid, restriction enzyme 
digestion of each plasmid was performed, followed by gel electrophoresis to 
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visualise the DNA plasmid and digestion products (Section 2.6.6). Plasmid 
maps obtained from Addgene were viewed using SnapGene DNA programme, 
which provided details of the restriction enzyme cut sites in the DNA plasmid, 
and the expected digestion product sizes (GSL Biotech 2019). For each 
plasmid the following reactions were carried out: control with no restriction 
enzyme added, single-cutter only digestion, and two independent single-
cutters (double digestion) or multi-cutters (2 or more products). Each 30μl 
restriction enzyme digestion reaction consisted of: 1μg of plasmid, 3μl of the 
appropriate NEB 10x buffer (either NEB 3.1 Buffer or NEB 2.1 Buffer or 
Cutsmart), 10 units of each restriction enzyme(s), and PCR-grade water 
added to bring the total volume to 30μl. If no restriction enzyme was added, 
the volume was replaced with PCR-grade water. The restriction enzyme 
digestion was carried out at 37˚C for 5-7hrs using a thermocycler. The 
digestion products are shown in Appendix folder 5 figures and tables. 
2.6.6 Gel electrophoresis  
Once incubation for the restriction enzyme digestion was completed (Section 
2.6.5), the samples were collected and ran on 1% agarose gel to determine 
the approximate size of DNA digestion products present. The 1% agarose gel 
was made by adding 2g of agarose powder (UltraPure Agarose, Invitrogen) 
to 200ml of 1x TAE buffer. The solution was warmed to dissolve the agarose 
fully. Once the molten agarose was just cool enough to hold, 20μl of Safeview 
(Safeview 1:10,000 dilution, NBS Biological Limited) was added, and 
thoroughly mixed. The agarose-Safeview liquid mix was poured into a gel 
tray and left to set for 30min at room temp with the 16-well comb (that forms 
the lanes) in place. During this time, the digestion samples (30μl) had 6x 
loading dye (NEB) added and mixed, and kept on ice until needed. Once set, 
the gel was removed from gel tray and placed within the gel electrophoresis 
box, and submerged in 1xTAE buffer. The digestion samples, with loading 
dye, were pipetted into each lane (30μl per lane). Typically 8μl of the DNA 
ladder (Hyperladder 1kb, Bioline or Smartladder 1kb, Eurogentec) was added 
into free lanes for each run (at least two lanes per run). The electrodes were 
connected to electrophoresis battery pack with the following settings: 90V, 
300mA, 2hr. The gel was checked after first 15min to check for the 
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appearance of DNA bands (ladder and samples) under ultraviolet (UV)-light 
using the UV Mini Transilluminator (Bio-Rad), and then left to run until the 
DNA ladder bands were clearly separated and samples had run approximately 
three-quarters of the gel length.  The DNA bands were imaged using 
Molecular Imager Gel Doc XR System (Bio-Rad). The approximate size of each 
digestion product was checked against the expected size determined from the 
plasmid map on SnapGene (see Appendix folder 5 figures and tables).
2.7 Lentiviral vector: pBOB-synP-HTB
2.7.1 Transfection of HEK cells and viral harvest
To generate the non-self replicating lentivirus carrying pBOB-synP-HTB 
(encodes for TVA receptor, rabies glycoprotein, histone-GFP under the human 
synapsin promoter), this plasmid along with those encoding for critical 
lentiviral structural proteins (packaging plasmid psPAX2, and envelop plasmid 
pMD2.G) were introduced into HEK cells using lipofectamine 3000 
transfection reagent (Thermo Fisher Scientific). Note that HEK cells had
passage <12 on transfection. On the day preceding transfection, HEK cells 
were split at a low split ratio (1:3) using trypsin treatment on to 0.1% gelatin-
coated plates (refer to Section 2.1.4). Only plates within the optimal 
confluency range (80-90%) were carried forward for lipofectamine based 
transfection. Between 2-4hr before transfection, the selected plates were 
washed with DPBS and given 10ml fresh HEK media. The Lipofectamine 3000 
reagent protocol provided in the manufacturer's guide (Invitrogen 2014) was 
used with a few adjustments. First, the following quantity of plasmids were 
used to transfect a single high confluency 10-cm plate: 14μg pBOB-HTB, 5μg 
pMD2.G and 9μg psPAX2. The appropriate volumes of each plasmid were 
added to the P3000 reagent, and OptiMEM reagent mix.  A second reagent 
mix of lipofectamine 3000 and OptiMEM was also generated. The two 
OptiMEM reagent mixes were added together (1:1) to generate the 
lipofectamine-DNA mix, and then left for 5min (at room temp). During this 
time, HEK media was removed from each plate and replaced with 6ml 
OptiMEM. The lipofectamine-DNA mix was added dropwise to each plate to 
bring the final volume for each 10-cm plate to 9ml. Plates were placed at 
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37˚C, 5% CO2 in viral suite incubator overnight. The media was replaced the 
following day (12-14hrs post-transfection) with 15ml fresh HEK media, and 
plates moved to 35˚C, 3% CO2 incubator until viral harvest. When the media 
began to turn orange, typically after 2-3 days, HEK media from each plate 
was collected, and replaced with fresh 10ml HEK media. The first collected 
viral harvest was centrifuged at 800g, 5min, 4 ˚C to pellet cell debris. The 
supernatant was then filtered through 0.45μm filter. The supernatant was 
then frozen down as crude viral harvest (stored at -80 °C) or concentrated 
through ultracentrifugation (Optima XPN 80 Ultracentrifuge, Thermofisher, 
with SW 32 Ti rotor, at 70,000g, 2hrs, 16˚C). On completing 
ultracentrifugation, the supernatant was carefully decanted from the tubes, 
and viral pellet was resuspended in ice-cold DPBS (150-200μl). To aid 
resuspension, the tubes were gently vortexed (short 5s vortex, 10 times) and 
left for 1hr on ice before aliquoting and storing at -80˚C. This process of viral 
harvest collection, centrifugation and filtering, and ultracentrifugation was 
repeated for the second viral harvest media.
2.7.2 Titering of lentivirus in hESC-derived interneurons  
The crude and concentrated lentivirus was titered in hESC-derived 
interneurons (see Chapter 6 and Appendix folder 5 figures). The lentivirus 
was added to the neuronal maturation media at a final concentration 1:250, 
1:500 or 1:750. The administration was either given as a single or a double 
hit (same concentration repeated 7 days apart). For all transductions, 
negative controls given viral-free media were used.  After 5 days post-
transduction, GFP positive cells were seen by eye using the fluorescent 
microscope. The GFP positive (transduced) population was quantified using 
flow cytometry (Section 2.10 and Appendix folder 5 figures) and 
immunostaining against GFP (Section 2.2).  In all future lentiviral 
transductions of hESC-derived interneurons, single hit 1:250 dilution was 
used. 
2.8 Pseudotyped ΔG ChR2-mCherry rabies viral tracer 
The full details of the protocol to obtain pseudotyped glycoprotein deficient 
(ΔG) channelrhodopsin 2 (ChR2)-mCherry rabies virus (the viral tracer) can 
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be found from Osakada & Callaway published protocol (Osakada & Callaway 
2013). 
2.8.1 Transfection of B7GG cells 
Lipofectamine 2000 transfection reagent was used to transfect the B7GG 
packaging cells, which in turn generated and enabled amplification of the ΔG 
ChR2-mCherry rabies virus (the viral tracer). Note that B7GG cells used were 
at passage <10 at transfection. The transfection steps were similar to those 
described for lipofectamine 3000 protocol in Section 2.7.1, but with the 
following differences specified below and in the manufacturer's guide
(Invitrogen 2013). The following quantity of each plasmid was used for each 
10-cm plate transfection: 5μg pcDNA-SADB19G, 7.5μg pcDNA-SADB19L, 
7.5μg pcDNA-SADB19P 15μg pcDNA-SADB19N, 30μg pSADdeltaG-ChR2-
mCherry.  The volume of OptiMEM media added to 10-cm plate of highly 
confluent B7GG cells was 5.5ml, and 2.5ml of DNA-lipofectamine 2000 mix 
was added dropwise to 10-cm plate. The B7GG cells were left for 6hr at 37 
˚C, 5% CO2 and then the media was replaced with 15ml fresh HEK media. 
The following day the B7GG plates were transferred to the incubator with the 
adjusted conditions of 35 ˚C, 3% CO2. Once the B7GG cells reached 
maximum confluency and media was orange, the B7GG cells were split (1:10)
onto new T75 flasks using trypsin treatment (Section 2.1.4), and maintained 
to amplify the viral harvest. 
2.8.2 Viral harvest of unpseudotyped ΔG ChR2-mCherry viral tracer
As transfected B7GG cells, generated in Section 2.8.1, have the ability to 
generate new ΔG ChR2-mCherry rabies virus, by providing the missing rabies 
glycoprotein, the transfected B7GG were maintained over a 2 week period to 
increase the concentration of the ΔG ChR2-mCherry rabies viral harvest. The 
mCherry positive cells were monitored by eye under the fluorescent 
microscope, and once a high proportion of high intensity mCherry positive 
cells were observed, the first viral harvest was collected (typically 1-2 weeks 
post-transfection). The viral harvest was performed in the same manner 
described in Section 2.7.1, except with Optima XPN 80 Ultracentrifuge, SW 
32 Ti rotor, set to 70,000g, 2hrs, 4˚C. Also, the majority of the ΔG ChR2-
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mCherry rabies viral harvest was kept as crude media, ready to be 
pseudotyped. 
2.8.3 Generating EnvA pseudotyped ΔG ChR2-mCherry viral tracer
Crude unpseudotyped viral harvest obtained from B7GG cells (Section 2.8.2) 
was pseudotyped using BHK-EnvA cells. BHK-EnvA cells were grown to 70% 
confluency in T75 flasks and transduced with the crude viral harvest media
(0.45μm filtered). Within 12hr, fresh HEK media was added (1:2 dilution). 
After a further 24hrs, BHK-EnvA cells were split using trypsin treatment 
(Section 2.1.4), and resuspended into fresh HEK media. BHK-EnvA cells were 
washed thoroughly, twice, with DPBS on splitting. On the day following 
splitting, the media was replaced with fresh HEK media. These wash steps 
and repeated change of HEK media ensured that any unpseudotyped ΔG 
ChR2-mCherry rabies virus was removed, thereby preventing contamination 
of the pseudotyped viral harvest media. The expression of mCherry by the 
BHK-EnvA cells was checked under the fluorescent microscope every day. The 
mCherry positive cell count, by eye, appeared at approximately day 5 post-
transduction, peak at day 7 and then plateau past day 7. At day 7-10 post-
transduction, the pseudotyped viral harvest media was collected and 
processed as described for the lentivirus in Section 2.8.2. 
2.8.4 Titering of pseudotyped and unpseudotyped ΔG ChR2-mCherry 
viral tracer
Titering of pseudotyped and unpseudotyped ΔG ChR2-mCherry rabies virus 
was conducted using HEK and HEK TVA cells (see Chapter 6 and Appendix 
folder 5 figures). Pseudotyping had been used to change the tropism of the 
ΔG ChR2-mCherry rabies virus, so that EnvA pseudotyped ΔG ChR2-mCherry 
rabies virus can only enter and infect TVA expressing cells. To determine if 
restricted entry had been achieved, transduction using the concentrated
pseudotyped and unpseudotyped ΔG ChR2-mCherry rabies viral stocks 
(Section 2.8.2 -2.8.3) were carried out in HEK and HEK TVA cells in parallel. 
The appropriate viral stock was added to the HEK media at a final 
concentration 1:100, 1:250, 1:500 or 1:750. This marked day 0 of 
transduction. For all transductions, negative controls given viral-free media 
were used.  After 5 days post-transduction, mCherry positive cells were seen 
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by eye using the fluorescent microscope (although not in all culture 
conditions). The mCherry positive (transduced) population was quantified 
using flow cytometry (Appendix folder 5 figures) and immunostaining against 
GFP (Section 2.2).  In all future EnvA pseudotyped ΔG ChR2-mCherry rabies 
viral transductions, 1:100 dilution was used.
2.9 Application of the completed viral tracing system
Lentiviral transductions were performed on day 30-35 hESC-derived 
interneurons at 1:250 final concentration. This led to the generation of 40-
50% starter neuron (GFP positive) population in the culture. At day 50, this 
culture was then infected with the EnvA pseudotyped ΔG ChR2-mCherry 
rabies tracer (final concentration 1:100). The culture was then left 7 days 
before downstream applications began. These applications included 
immunostaining for GFP and mCherry (Section 2.2), and electrophysiology 
and optogenetics (Section 2.11). The complete viral tracer system was used 
up to 14 days post-infection with rabies tracer. 
2.10 Flow cytometry 
To prepare cells for flow cytometry, a single well of 12-well plate was used 
for each viral dilution, along with the negative (non-viral treated) control.
Cells were washed twice with DPBS, and then detached from the well using 
enzymic treatment (trypsin for HEK293T/HEK TVA cells, accutase for hESC-
derived interneurons) (see Section 2.1.4 and 2.1.6, respectively). The cell
suspension was diluted 10-fold in DPBS and manually dissociated by 
trituration.  A repeated cycle of centrifuging the suspension (300g, 5min, 
4˚C) to pellet the cells, removing the supernatant, and then resuspending 
the pelleted cells in chilled DPBS was performed three times. The washed 
single-cell suspension in DPBS was then passed through a cell strainer (35µm 
nylon mesh). The strained single-cell suspension was used on the flow 
cytometer (BD LSR Fortessa cell analyser, BD Biosciences). Flow cytometer 
was used to detect hESC-derived interneurons expressing GFP (“FITC” 
excitation laser 488nm, excitation wavelength 493nm, emission max 525nm) 
and HEK/HEK TVA cells that were mCherry positive (“PE-Texas Red” 
excitation peaks 496nm and 565nm, excitation laser 488nm, emission max 
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613nm). The BD FACSDiva 8.0.1 software was used to generate the 
histograms and scatterplots (Appendix folder 5 figures). 
2.11 Functional characterisation of hESC-derived interneurons 
2.11.1 Electrophysiology solutions for whole-cell patch clamp  
External solution was prepared fresh weekly. The external solution consisted 
of fresh 1L sterile water with: sodium chloride (NaCl) 7.89g, potassium 
chloride (KCl) 0.373g, magnesium chloride (MgCl2) 0.244g, 2mM stock 
calcium chloride (CaCl2 ) 0.625ml, D-glucose 1.8g, HEPES 1.192g. Once the 
solution was thoroughly mixed, 1L bottle remained on the magnetic spinner 
and sodium hydroxide (NaOH) was added drop-wise to achieve a final pH of 
7.4 (measured using pH meter). The internal solution (also known as the 
pipette solution) was made in bulk and stored at -20˚C in 500µl aliquots. The 
internal solution used was potassium-gluconate based. The internal solution 
consisted of 1L sterile water with: 27.4g K-gluconate, 0.584g NaCl, 2.62g 
HEPES, 1.1g Na2-ATP, 1.05g Na-GTP, 0.306g Na2-phosphocreatine, 0.41g 
MgCl2, 2mM stock CaCl2 0.5ml, and 4.184g EGTA. In a similar manner 
described for the external solution, the pH of the internal solution was 
adjusted to pH 7.2 using KOH. 
2.11.2 Immediate steps prior to patch-clamp recordings
For all electrophysiology experiments, progenitors were seeded on UV-light 
sterilised PDL/laminin coated coverslips to allow removal of the cells and 
transfer to electrophysiology rig. On collection of the coverslip (on day of the 
experiment), cells were gradually exposed to the external solution. The 
internal solution aliquot was thawed and filtered through polypropylene 
centrifuge tube filter (0.22μm filter) using a short spin, to separate internal 
solution from any contaminants. The filtered internal solution was stored on 
ice until needed. Glass patch pipettes were prepared fresh each day using a 
programmable mechanical Puller (Flaming/Brown Sutter micropipette puller 
P1000). Glass capillaries (Sutter) were heated and pulled to generate a patch 
pipette with resistance between 4-8 MΩ.
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2.11.3 Whole-cell patch clamp
Electrophysiology was carried out on hESC-derived interneurons, the day in 
vitro that the culture was collected for whole-cell patch clamping has been 
specified in the data shown (Chapter 6). On immediately breaking into the 
neuron, the resting membrane potential was noted. To determine additional 
intrinsic and evoked parameters of the patched neuron, three distinct whole-
cell patch clamp paradigms (in current-clamp mode) were performed 
sequentially on the patched neuron (holding potential -60mV). For illustrative 
examples of each paradigm please see Appendix folder 6 figures.  In 
paradigm one (Appendix figure S) the patched neuron was exposed to a 
current injection drop of 10pA for 1s, repeated 10 times in succession. The 
input resistance and membrane time constant (tau) were determined from 
the averaged voltage deflection traces during the final 0.1s of -10pA current 
injection. The capacitance could then be calculated from these values 
(capacitance = tau/input resistance). In paradigm two (Appendix folder 6
figure T), the patched neuron was injected with current progressing from 
−70pA to maximum of +110 pA in 20pA steps (10 steps in total, each lasting 
1s). The ability of the neuron to generate an action potential or train of action 
potentials was then determined for each current step. In paradigm three 
(Appendix folder 6 figure U) an alternative strategy was used to evoke an 
action potential response, namely the short 5ms pulse of a very large current 
injected (+200pA). This pulse of current was repeated 5 times in succession. 
In paradigm two and three, an action potential was only counted as successful 
if the spike reached above 0mV. While holding the patched neuron at -60mV 
spontaneous activity (mini excitatory postsynaptic potentials and action 
potentials) were also recorded. Analysis of traces was carried out on Clampfit 
10.6 (Molecular Devices 2019).
2.11.4 Optogenetics
The complete monosynaptic viral tracer system described in Section 2.9 was 
analysed using whole-cell patch clamp recordings and optogenetics. The EnvA 
pseudotyped ΔG ChR2-mCherry rabies tracer enforces the expression of 
ChR2-mCherry fusion protein. ChR2 is a light-gated ion channel stimulated 
by blue light (490nm). To test this component of the viral tracer system, 
mCherry positive traced neurons were identified in the culture and patched. 
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The patched neurons were stimulated with both current injections (paradigms 
two and three described in Section 2.11.3) and blue light pulses (Chapter 6) 
to determine if ChR2 was efficiently expressed and functional. The 
photostimulation of the traced neuron ranged from 0.5ms exposure to up to 
10s exposure.
2.12 Data processing and statistics 
2.12.1 Figures
Illustrative figures were created in Powerpoint (Microsoft, 2016) and when 
required, edited using InkScape (Inkscape 0.92.4). Fluorescent images were 
then taken using Leica DMi 6000B inverted or Leica DM 6000B upright (for 
glass slides) microscopes at 20x magnification (within 2 weeks of staining, 
Section 2.2). Where indicated, deconvolution images were taken, which 
involved collecting a series of stacked images through the z plane, and then 
merging into a single image using post-imaging processing steps on Leica AF 
Hardware and ImageJ (Rasband 1997-2018). Cell counting was performed 
using ImageJ and Cell Profiler (Carpenter et al. 2006). Graphs were created 
using Graphpad Prism 5 (GraphPad Software 1995-2017).
2.12.2 Statistics 
Statistical tests were also conducted in Graphpad Prism 5, and included:
nonparametric, Mann-Whitney test, when comparing two groups, and 
Kruskal-Wallis test with Dunn’s multiple comparisons post-hoc test when 
comparing 3 or more groups. 
2.12.3 Single-cell transcriptome analysis 
Single-cell QPCR data, in the form of a matrix of Ct values for each sample-
assay reaction, obtained from the Biomark HD 96.96 IFC run was initially 
processed on the Fluidigm real-time PCR analysis software (Fluidigm 2018a). 
The data was processed to calculate delta Ct values (relative to house-
keeping gene, beta-actin). Any poor quality data (e.g. those that failed to 
express house-keeping genes) were identified and excluded from further 
analysis. The exported data sheet of delta Ct values was then ready for 
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analysis on R programme (R Core Team 2013). Single-cell RNA sequencing 
data was also pre-processed for use in the Fluidigm Singular analysis toolset
(Fluidigm 2018b). The initial pre-processing steps were performed by Dr 
Peter Giles (Cardiff institute of medical genetics), with the remaining analysis 
using the Singular analysis package performed by myself. The pre-processing 
steps began with trimming the reads to remove sequencing adapter and poor 
quality bases using Trim Galore.  Trimmed reads were then mapped against 
the GRCh38 no_alt_plus_hs38d1_analysis_set (GENCODE GRCh38.p10) 
using STAR aligner tool (version 2.5.0b) (Dobin et al. 2013). Finally, the 
expression counts were converted to transcripts per million ([number of reads 
mapped to a selected gene / total number of mapped reads of a sample]*106
) unit using RSEM. Quality control checks of the reads led to removal of low 
quality reads prior to analysis. Once in the correct format, the expression 
data set was exported as a matrix that could be uploaded into R programme 
for analysis. Singular analysis package was used to generate a list of 
differentially expressed genes between time points/ages/independent 
samples by performing ANOVA pair-wise analysis, with genes only included if 
the p-value <0.05 and the relative fold change >4 (in either direction). 
Moreover, the Singular analysis package was used to generate the gene 
expression heatmaps and tSNE plots (Chapter 4 and 5, and Appendix folders 
2-4). All analysis was conducted using data trimmed to the top 400 
differentially expressed genes. The script required to convert Ensembl gene 
IDs to gene names was created by Dr Daniel Cabezas de la Fuente (Li lab).
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Chapter 3 - Interneuron differentiation of hPSC
3.1 Introduction
As described in detail within the General Introduction (Chapter 1), inhibitory 
interneurons represent a classic example of lineage diversification, which to 
this date remains to be fully understood (Flames & Marín 2005; Kessaris et 
al. 2014). The use of hPSC-derived interneurons could, therefore, provide 
novel insight into interneuron lineage commitment and differentiation 
trajectories that are not easy obtained from the primary source, due to the 
scarcity and legal age restrictions of human foetal tissue usage. 
3.1.1 Extrinsic cue based interneuron differentiation paradigms 
Differentiation paradigms using extrinsic cues aim to recapitulate the native 
environment in vitro, and therefore provide a more authentic 
neurodevelopmental model. In general, knowledge of which extrinsic cues 
has been guided from rodent work (Backman et al. 2005; Xu et al. 2010). 
These in vivo studies have led to the understanding that critical morphogens 
regulate neuronal induction and spatial patterning within the brain (refer to
Chapter 1). A decade ago, a simple and highly efficient method to indirectly 
induce neural fate commitment in hPSC (by suppressing alternative fates) 
was described using two chemical factors that inhibit SMAD signalling 
pathways (dual SMAD inhibition) (Chambers et al. 2009). The introduction of 
additional morphogens to direct a specific neuronal lineage further enhanced 
the value of hPSC-derived neuronal models, by allowing enrichment of the 
neuronal class of interest. In the case of interneuron differentiation, SHH 
and/or SMO receptor agonists (SAG and purmorphamine) were applied
(Maroof et al. 2013; Nicholas et al. 2013; Anderson et al. 2016). 
3.1.2 Shortcomings of in vitro interneuronal models  
However, obtaining defined interneuron subtypes through in vitro interneuron 
differentiation paradigms remains a critical goal and challenge within the 
field. Due to the vulnerability of specific subtypes in different 
neuropathologies, the inability to fine-tune the in vitro interneuron subtype 
composition has limited the scope of PSC-derived interneurons as an in vitro 
neurodevelopmental and disease model. For example, there has been a 
common focus on generating MGE-derived cortical PVALB interneurons in 
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vitro, which stems from the implication of cortical PVALB interneurons in 
numerous neuropathologies (schizophrenia, ASD, epilepsies) (Powell et al.
2003; Kataoka et al. 2010; Marín 2012). However, current paradigms 
typically report either low abundance or absence of PVALB interneurons in 
the terminally differentiated culture (Liu et al. 2013; Nicholas et al. 2013; 
Kim et al. 2014; Sun et al. 2016; Yang et al. 2017; Noakes et al. 2019). 
Although when hPSC interneuron differentiation has been completed in vivo, 
in the rodent neocortex, a greater abundance of PVALB interneurons are 
generated from the graft (Chen et al. 2013; Nicholas et al. 2013). This has 
demonstrated that, provided the optimal environment has been provided, 
PVALB interneurons can be efficiently generated from hPSC-derived 
interneuron progenitors. This has encouraged research aiming to explore the 
full extent and potential of PSC-derived interneuron heterogeneity, and 
whether refinements to current differentiation paradigms could enrich the 
culture in desired subtypes (Tyson et al. 2015; Close et al. 2017; Xiang et al.
2017).  
3.1.3 Refining interneuron differentiation paradigms that use 
extrinsic cues 
3.1.3.1 Sonic hedgehog signalling   
Through attempts to improve the efficiency of interneuron differentiation 
protocols, both the effect of different timings and duration of SHH treatment 
on interneuron fate commitment have been investigated (Danjo et al. 2011; 
Maroof et al. 2013; Tyson et al. 2015). This led to an understanding that an 
optimal window exists during differentiation when SHH selectively and 
efficiently enhances interneuron fate commitment (Danjo et al. 2011; Maroof 
et al. 2013). Moreover, the differentiation of mESC-derived interneurons 
under high and low SHH signalling has been shown to change SST: PVALB 
commitment bias of mESC-derived interneurons after completion of 
differentiation in vivo (early postnatal mouse neocortex) (Tyson et al. 2015). 
This nicely mirrored work in rodent models that demonstrated a SHH 
signalling gradient across the MGE, which caused a SST and PVALB 
commitment bias of the dorsal and ventral progenitors, respectively (Flames 
et al. 2007; Tyson et al. 2015). However, the same result has not been 
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independently achieved by manipulation of SHH concentrations during 
interneuron differentiation of hPSC (Close et al. 2017; Xiang et al. 2017). If 
a change was reported, this was limited to a shift in the proportion of SST
and NPY expressing neurons (elevated in higher SHH treatment culture), but 
no change in PVALB expression between treatments (Xiang et al. 2017). This 
may be due to species differences and/or poor efficiency of interneuron 
differentiation paradigms in generating PVALB interneurons in vitro (Liu et al.
2013; Nicholas et al. 2013; Kim et al. 2014; Sun et al. 2016; Yang et al.
2017; Noakes et al. 2019). 
3.1.3.2 Temporal manipulation  
Furthermore, one of the major shortcoming of in vitro differentiation 
paradigms is the inability to recapitulate the generation of temporally distinct 
progenitor pools that occur over an extended period in native development 
(late first to second trimester in humans) within the ventricular zone of the 
MGE/CGE (Zecevic et al. 2011; Reinchisi et al. 2012; Onorati et al. 2014; Al-
Jaberi et al. 2015). Whether hPSC-derived interneuron progenitors could 
even be maintained in their highly proliferative, progenitor state through 
serial expansions, without loss of their differentiation potential, is currently 
unknown. If such an unlimited source of interneuron-like progenitors could 
be achieved from a single parent culture, this would greatly simplify and 
shorten the duration of any subsequent differentiation, thereby reducing 
costs and labour. However, evidence of temporal influence on interneuron 
lineage commitment would suggest that the sequential sister progenitor 
cultures may not have the same resulting subtype composition or functional 
maturity (Butt et al. 2005; Miyoshi et al. 2010; Inan et al. 2012; Tyson et al.
2015; Arendt et al. 2016; Bardy et al. 2016). Primarily, this evidence came 
from utero-transplantation fate-mapping studies in rodents (Butt et al. 2005; 
Inan et al. 2012). On transplanting reporter labelled mouse MGE/CGE of 
different ages (E13.5 vs E15.5) into wild-type embryos of matching age, the 
proportion and diversity of the reporter labelled interneuron subtypes 
identified in the adult mouse brain were found to be dependent on the age of 
graft at transplantation (Butt et al. 2005; Inan et al. 2012). But why? 
Molecular characterisation of MGE/CGE primary tissue over an extended 
period of development in mouse and human is limited, and often left as a 
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qualitative histology staining rather than a quantified measure (Butt et al.
2005; Zecevic et al. 2011; Hansen et al. 2013; Zechel et al. 2014). Therefore, 
markers differentially expressed between early and late-born progenitors of 
the same region of origin are unknown. Such knowledge would be fruitful for 
selectively enriching in vitro derived interneuron subtype populations for a 
specific subtype (e.g. PVALB interneurons). 
3.2 Aims 
To characterise the developmental trajectory of hPSC-derived interneurons 
from progenitor to post-mitotic stages of the differentiation paradigm.
To investigate whether sequential serial expansions of hPSC-derived 
interneuron progenitors can successfully maintain the progenitor population 
over an extended period. 
To determine whether the serial expansions mimic the generation of early 
and late-born progenitors with differential lineage commitments, as reported 
during native MGE/CGE development. 
3.3 Results 
As described in detail in Chapter 2, and illustrated in Figure 3.1A, hESC were 
differentiated as a monolayer culture under extrinsic cue paradigm to 
generate interneuron-like progenitors, which completed terminal 
differentiation in vitro to give rise to post-mitotic interneuron-like cells. 
During the first stage, hESC undergo forebrain neural induction (using dual 
SMAD and WNT inhibition), proceeded by treatment with interneuron 
differentiation media (SHH and purmorphamine) to mimic native conditions 
that promote MGE/CGE fate commitment in the brain (Figure 3.1A). The 
progenitors were driven to terminally differentiate under neuronal maturation 
media, supplemented with neurotrophic factor BDNF (Figure 3.1A). 
3.3.1 SHH treatment efficiently generated interneuron-like cells 
In order to evaluate the differentiation trajectory of the ventralised 
neuroepithelial cells, samples were collected at day 10, 20, 35, 50 and 65 for 
bulk-QPCR analysis (Figure 3.1B-3.1C). The day 10 marked the start of SHH 
treatment, and was used to determine the relative change induced by 
exogenous SHH signalling (Figure 3.1B-3.1C). To complement the RNA level 
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analysis, samples were also collected for immunohistochemistry staining at 
day 20, 35, 50 and 65 (Figure 3.1D-3.1G).
At RNA level, an early MGE marker, NKX2.1 level was found to be highest at 
the earliest time point, and then remain at a slightly reduced, but maintained 
expression level across the differentiation period (Figure 3.1B). The high 
expression of NKX2.1 from day 10 likely relates to the ventralising effects of 
WNT inhibitor XAV939 in the neural induction culture media. The maintained 
expression of NKX2.1 may indicate progenitor contamination of later cultures 
or a striatal (rather than cortical) interneuron identity of the post-mitotic 
interneuron-like cells. Whereas, late MGE markers LHX6 and LHX8 displayed 
mirrored temporal dynamics in expression levels, each peaking at day 35 and 
then downregulated in the later stages of differentiation (Figure 3.1B). This 
coincided with the peak of SST at RNA level at day 35 (approx. 45-fold 
increase relative to day 10 expression level) (Figure 3.1C).  This could 
indicate the insufficiencies of the neuronal maturation media to maintain 
these subpopulations of post-mitotic interneurons and/or promote high 
expression of these markers. A dorsal MGE and CGE marker, COUPTF II
expression was upregulated between day 10 and 20 (5-fold increase), then 
declined to a similar level of expression as at day 10 in the later time points 
(Figure 3.1B). Whereas, post-mitotic GABAergic interneuron markers GAD1 
and CR progressively increased over time, both of which reached maximal 
expression at day 65 (Figure 3.1C). Relative to day 10, PVALB expression 
showed a 8-fold increase in expression at day 20 and then continued to 
decline back to day 10 expression level (Figure 3.1C).  
3.3.2 The day 20 population was abundant in MGE-like progenitors 
Immunostaining of day 20 revealed that the population was highly abundant 
in cells expressing a pan-neuroepithelia marker Nestin, the forebrain 
transcription factor FOXG1 (60%) and NXK2.1 (80%) (Figure 3.1D-3.1E). In 
agreement with bulk-QPCR analysis, the proportion of NKX2.1 positive cells 
remained high in the later stages differentiation (30-50%) (Figure 3.1E). 
However, the day 20 cultures had low abundance of cells expressing a late 
MGE marker LHX6 (20%), which remained low in later cultures (Figure 3.1E). 
Immunostaining for COUPTF II, revealed a low and constant population of 
COUPTF II expressing cells over time (25%) (Figure 3.1E). To further 
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evaluate the dorsal-ventral and anterior-posterior identity of the day 20 
cultures, the proportion of cells expressing the dorsal telencephalon marker 
PAX6 and floor plate marker FOXA2 was examined (Figure 3.1D). Less than 
20% of the cells stained positive to these markers ,which likely accounted for 
the NKX2.1/FOXG1 negative population (Figure 3.1D).Together the QPCR and 
immunohistochemistry data would indicate that the day 20 cultures were 
mostly composed of MGE-like progenitors with a small proportion of CGE-like 
progenitors and nascent postmitotic interneurons. 
3.3.3 Terminal differentiation gave rise to diverse interneuron-like 
subtypes   
As the period within neuronal maturation media lengthened, the post-mitotic 
interneuron-like cells grew in abundance (Figure 3.1F-3.1G).  This was shown 
by the high proportion of cells staining positive for pan-neuronal marker TUJ1 
at day 65 (Figure 3.1F). At day 65, the culture was enriched in GABAergic 
neuronal marker GAD1 positive cells (55%), with a very small proportion of 
glutamatergic marker vGLUT1 positive cells (<1%) (Figure 3.1F). Hence, the 
interneuron-like progenitors generated by day 20 successfully differentiated 
into GABAergic neuron-like cells. In order to evaluate the subtype diversity 
of the interneuron-like cells, known MGE-derived and CGE-derived subtype 
markers were checked (Figure 3.1F-3.1G). At day 65, approximately 30% of 
the population stained positive for dorsal MGE and CGE-derived CR positive 
interneurons. This subpopulation of interneuron-like cells grew progressively 
in numbers, reaching and maintaining a peak of 25-30% abundance at day 
50 to 65 (Figure 3.1F). The CR interneurons may be derived from the CGE-
like progenitors (COUPTF II positive, NKX2.1 negative) at day 20 (Figure 
3.1D). Although the high abundance of CR relative to MGE-derived subtype 
markers SST (10%) and PVALB (<3%) may suggest that NXK2.1 
positive/COUPTF II negative progenitors may also give rise to CR 
interneurons (Figure 3.1F). In a similar manner to CR, the number of SST 
positive cells progressively increased with time, which did not reflect the 
sharp fold-change at day 35 reported in QPCR data (Figure 3.1C and 3.1F). 
Calbindin (CALB1) was also expressed by a large proportion (35%) of the day 
65 population, likely due to the post-mitotic interneuron marker not being a 
mutually exclusive subtype marker, but expressed by multiple interneuron 
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subtypes (e.g. CR, PVALB and SST) (Figure 3.1F).  Finally, a proportion of the 
GABAergic negative population was accounted for by ChAT interneuron-like 
cells, which made up approximately 20% of the total population at day 65 
(Figure 3.1F). ChAT interneurons are also MGE-derived, and most likely 
accounts for the LHX8 expressing interneurons precursors (Figure 3.1B and 
3.1F).
In summary, molecular characterisation of interneuron-like cells over the 
course of the differentiation paradigm using bulk QPCR and 
immunohistochemistry indicated that a predominantly early MGE-like 
progenitor population was efficiently generated by day 20. This led to an 
abundant interneuronal population, marked by the high proportion of GAD1, 
CALB1 and CR positive cells by day 65. Cholinergic interneuron-like cells also 
added to the heterogeneity of the culture. However, does this characterisation 
describe the full differentiation potential of the early MGE-like progenitor 
population? 
70
71
72
73
74
75
Figure 3.1 Longitudinal molecular characterisation of hESC-derived 
interneurons.
A) Schematic of the in vitro hPSC interneuron differentiation protocol utilised in this 
study, with real-time brightfield images of the in vitro culture at different time points. 
The paradigms has been simply divided into three different stages. Stage 1, neural 
induction (yellow). Stage 2, interneuron fate commitment (orange). Stage 3, terminal 
differentiation (green). For more information please refer to Chapter 2. 
B-C) Developmental trajectory of hESC-derived interneurons – at RNA level, day 20, 
35, 50 and 65 in vitro. The data has been presented in the form of relative gene 
expression, with the relative fold change made in reference to day 10 of the in vitro 
interneuron differentiation protocol (all day 10 fold changes =1). The initial delta Ct 
was calculated in reference to beta-actin as the standard housekeeping gene. The 
relative gene expression of a gene (RE) was calculated as RE= 2-(double delta Ct), 
along with +/- SEM. Biological replicates n=3. Technical replicates n=3. 
D) Molecular characterisation of hESC-derived interneuron-like progenitors – at 
protein level, day 20 in vitro. The data has been presented in the form of a panel of 
immunohistochemistry deconvoluted images, and percentage of marker expressing 
cells out of the total cell population (total cell count measured using DAPI count). The 
graph plotted shows the mean percentage of marker expressing cells for each time 
point, along with +/-SEM. Biological replicates n=4. Technical replicates n=12 per 
biological replicate. The average total number of cells counted per technical replicate 
can be found in Appendix folder 7. 
E) Longitudinal evaluation of the expression of lineage critical transcription factors –
at protein level, day 20, 35, 50 and 65 in vitro. The data has been presented in the 
form of percentage of marker expressing cells out of the total cell population (total 
cell count measured using DAPI count). The graph plotted shows the mean 
percentage of marker expressing cells for each time point, along with +/- SEM. 
Biological replicates n=3 . Technical replicates n=12 per biological replicate. The 
average total number of cells counted per technical replicate can be found in 
Appendix folder 7. 
F) Molecular characterisation of hESC-derived interneuron-like cells – at protein level, 
day 65 in vitro. The data has been presented in the form of a panel of 
immunohistochemistry deconvoluted images, and percentage of marker expressing 
cells out of the total cell population (total cell count measured using DAPI count). The 
graph plotted shows the mean percentage of marker expressing cells for each time 
point, along with +/- SEM. Biological replicates n=3. Technical replicates n=12 per 
biological replicate. The average total number of cells counted per technical replicate 
can be found in Appendix folder 7. 
G) Longitudinal evaluation of interneuron subtype markers– at protein level, day 20, 
35, 50 and 65 in vitro. The data has been presented in the form of percentage of 
marker expressing cells out of the total cell population (total cell count measured 
using DAPI count). The graph plotted shows the mean percentage of marker 
expressing cells for each time point, along with +/- SEM. Biological replicates n=3 . 
Technical replicates n=12 per biological replicate. The average total number of cells 
counted per technical replicate can be found in Appendix folder 7. 
SHH, Sonic Hedgehog. BDNF, Brain derived neurotrophic factor. NK2 Homeobox 1, 
NKX2.1. COUP transcription factor 2, COUPTF II. LHX6, LIM Homeobox 6. LHX8, LIM 
Homeobox 8. OLIG2, oligodendrocyte transcription factor 2.FOXG1, Forkhead Box 
G1. PAX6, Paired box protein 6. FOXA2, Forkhead Box A2. SST, somatostatin. PVALB, 
parvalbumin. CR, calretinin. GAD1, glutamate decarboxylase 1. TUJ1, β-Tubulin 3. 
ChAT, choline acetyltransferase. vGLUT1, vesicular glutamate transporter 1. Gamma-
aminobutyric acid-ergic, GABAergic. hESC, human embryonic stem cell. MGE, medial 
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ganglionic eminence. dMGE, dorsal medial ganglionic eminence. CGE, caudal 
ganglionic eminence. SEM, standard error of the mean.
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3.3.4 Serial expansions generated molecularly distinct interneuron-
like progenitor populations 
Sequential serial expansions of interneuron-like progenitor populations were 
performed to investigate two main questions. First, can the generation of 
newborn interneuron-like progenitors be extended by sequential serial 
expansions? Second, do progenitors derived from sequential serial 
expansions give rise to different interneuron subtypes, and is this reflected 
by changes in the molecular profile of the progenitors? 
The experimental design has been summarised in Figure 3.2A. In brief, hESC 
underwent the three stages of interneuron differentiation paradigm, as 
described in Figure 3.1A. At day 20, which marked the end of stage 2 
(MGE/CGE regionalisation with SHH), a proportion of the cells were allowed 
to undergo terminal differentiation in the neuronal maturation media until day 
110 in vitro (stage 3). In parallel, a proportion of sister progenitors were 
maintained under stage 2 (SHH treatment) condition for 10 days (Figure 
3.2A). This process was then repeated 5 more times to generate serial 
expansions of interneuron-like progenitors, each round generating a 
sequential culture to undergo terminal differentiation (named through 1 to 
6). The first culture was seeded for terminal differentiation at day 20 and 
maintained until day 110 (total of 90 days in neuronal maturation media) 
(Figure 3.2A). The final culture (culture 6) was seeded for terminal 
differentiation at day 70 and maintained until day 110 (total of 40 days in 
maturation media) (Figure 3.2A).
To characterise the interneuron-like progenitors generated in each round of 
serial expansion, a proportion of the cells replated into stage 2 (SHH 
treatment) condition were collected for immunohistochemistry staining 1 day 
post replating (serial expansion number X + 1 day) (Figure 3.2B-3.2E). 
Immunostaining for early MGE progenitor marker NKX2.1, and late MGE 
interneuron precursor marker LHX6 was performed as an indication of the 
proportion of earlier-born (LHX6 positive) and newborn (NKX2.1 positive) 
progenitors in the population (Figure 3.2B-3.2D). Over the first three serial 
expansion (cultures 1 to 3), the proportion of NKX2.1 and LHX6 positive cells 
remained unchanged (Figure 3.2C- 3.2D). The abundant NKX2.1 positive 
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population (70-80%), and absence of LHX6 positive cells in sequential 
cultures 1 to 3 would indicate that these first few serial expansions efficiently 
maintained proliferating interneuron-like progenitors, which gave rise to 
newborn progenitors (NKX2.1 positive). However, serial expansions of later 
derived cultures (cultures 4 to 6) led to the NKX2.1 positive population 
significantly decreasing to approximately 20% (***p<0.001, Figure 3.2C). 
Whereas, LHX6 positive population significantly increased, although to only 
8% (***p<0.001, Figure 3.2D). Together these findings would suggest that 
MGE-like progenitors were transitioning out of the cell cycle by the later serial 
expansions, thereby failing to give rise to newborn NKX2.1 positive 
progenitors. This was supported by visual observations of reduced 
proliferation in the culture (confluency did not increase over the 10 days in 
SHH treatment). As a result, later derived cultures replated into stage 2 
condition simply maintained interneuron precursors (NKX2.1 negative, LHX6 
positive) for longer and longer durations in SHH before seeding for 
maturation. However, as the proportion of LHX6 positive cells was low, and 
the proportion of other late ganglionic eminence markers OLIG2 and GSX2, 
did not significantly change, this explanation cannot account for the entire 
loss of NKX2.1 positive cells (Figure 3.2B). Alternatively, one could argue that 
prolonged expansions of interneuron-like progenitors had resulted in the 
downregulation of NKX2.1 expression and subsequent loss of MGE-like 
identity. Although, to what alternative lineage is unclear, but mid-brain 
dopaminergic neuronal lineage marker FOXA2 and CGE marker COUPTF II 
remained unchanged (Figure 3.2B).
Overall, molecular characterisation of the sequential serial expansions of 
hESC-derived progenitors using immunohistochemistry indicated that 
proliferative interneuron-like progenitors were only maintained over a 
restricted, and small number of serial expansions. 
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Figure 3.2 Effect of sequential serial expansions of hESC-derived 
interneuron progenitors on molecular profile of progenitors.
A) A schematic of the modifications made to hESC interneuron differentiation protocol 
in order to generate sequential hESC-derived interneuron cultures (1 to 6) through 
serial expansions into interneuron differentiation media (10 day SHH treatment). The 
passaging  of the interneuron progenitors was repeated every 10 days to generate 6 
temporally distinct cultures. Molecular characterisation of the progenitor plates was 
performed 1 day post serial expansion back into SHH treatment (SE + 1). The day 
immunohistochemistry staining was performed on terminally differentiated plates 
was day 110. 
B) Molecular characterisation of each of the 6 hESC-derived interneuron progenitor 
cultures–protein level, 1 day post each serial expansion. The immunohistochemistry 
data has been presented as a percentage of marker expressing cells out of the total 
cell population (total cell count measured using DAPI count). Average total cell count 
per technical replicate can be found in Appendix folder 7. The graph in figure 3.2 
shows the mean percentage of marker expressing cells for each sequentially derived 
culture (1 to 6), along with +/- SEM. The actual day in vitro each culture was sampled 
was day 21 culture 1, day 31 culture 2, day 41 culture 3, day 51 culture 4, day 61 
culture 5 and day 71 culture 6. Only data from the final 4 cultures (cultures 3 to 6) 
were available for COUPTF II and LHX6 markers due to antibody issues. Biological 
replicates n=1. Minimum technical replicates n=6. 
C-E) Molecular characterisation of each of the hESC-derived interneuron progenitor 
cultures–protein level, 1 day post each serial expansion. Only data from final 4 
cultures (culture 3 to 6) were available for LHX6 marker. The immunohistochemistry 
data has been presented in the form of a panel of immunohistochemistry,  
deconvoluted images taken from each sequential culture of NKX2.1 (3.2C), LHX6 
(3.2D) and FOXG1 (3.2E) expressing cells. The graph plotted shows the mean 
percentage of NKX2.1 (3.2C), LHX6 (3.2D) and FOXG1 (3.2E) expressing cells out of 
total cell population (total cell count measured using DAPI count, blue) for each time 
point, along with +/- SEM. ). Average total cell count per technical replicate can be 
found in Appendix folder 7. Biological replicates n=1. Minimum technical replicates 
n=6. 
Statistics performed to determine significant differences in percentage of marker 
expressing cells, for each marker individually over time relative to culture 1 (standard 
paradigm) using nonparametric, Kruskal-Wallis test and Dunn's Multiple Comparison 
Test (*p<0.05, **p<0.01, ***p<0.001). NK2 Homeobox 1, NKX2.1. FOXA2, 
Forkhead Box A2. FOXG1, Forkhead Box G1. COUP transcription factor 2, COUPTF II. 
LHX6, LIM Homeobox 6. OLIG2, oligodendrocyte transcription factor 2. GSX2, GS 
Homeobox 2. hESC, human embryonic stem cell. SHH, Sonic Hedgehog. SE, serial 
expansion. SEM, standard error of the mean.
85
3.3.5 Sequentially generated cultures showed progressively elevated 
SST: CR on terminal differentiation
The serial expansions into stage 2 (SHH treatment) were terminated after 
seeding culture 6 for terminal differentiation on day 70, due to the limited 
proliferation observed. The resulting 6 cultures generated by sequential serial 
expansions were then terminally differentiated until day 110 in vitro. 
Although all cultures had the same total duration in vitro, the time in stage 3 
(neuronal maturation media) progressively decreased for each sequential 
culture from a maximum of 90 days for culture 1 to a minimum of 40 days 
for culture 6 (Figure 3.2A). 
The proportion of post-mitotic interneuron markers,  GAD1, LHX6 and PVALB 
remained unchanged between sequentially generated cultures 1 to 6 (Figure 
3.3A). The high abundance of GAD1 positive cells (>75%) after terminal 
differentiation would suggest that serial expansion did not affect the efficiency 
of the progenitors to give rise to GABAergic neurons (Figure 3.3A). Although 
the later derived cultures did not show a bias towards PVALB lineage, with 
PVALB positive cells rare in all cultures (<5%), other subtype markers were 
significantly differentially expressed across cultures (Figure 3.3B-3.3E). 
Firstly, the proportion of post-mitotic interneuron marker CALB1 positive cells 
significantly declined in cultures generated from later serial expansions 
(culture 3 onwards) (Figure 3.3C). A similar reduction was observed for CR 
positive interneurons across later cultures, from 15% to 8% (***p<0.001 
Figure 3.3D). Whereas, SST positive interneurons significant increased in 
abundance, although only peaking at 7% in culture 6 population (***p<0.001 
Figure 3.3E). Although the rise in SST interneurons was not matched by an 
increase in LHX6 positive cells in the terminal differentiated cultures, the 
cultures with significantly higher proportion of SST expressing cells did have 
significantly greater LHX6 and lower NKX2.1 positive population when seeded 
for stage 3 (***p<0.001 Figure 3.2C-3.2D and 3.3E). This would support the 
conclusion that the progressively elevated SST:CR in the cultures was driven 
by changes in the lineage commitment of the progenitors from CR to SST 
fate. However, these experiments cannot rule out the effect of subtype-
selective survival bias, which could have been driven by the serial expansions 
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and/or differential time in neuronal maturation media (Figure 3.2A).  In either 
case, sequential serial expansions gave rise to a more defined population, 
enriched in SST interneurons. 
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Figure 3.3 Effect of sequential serial expansions of hESC-derived 
interneuron progenitors on molecular profile of the post-mitotic 
interneuronal population.
A) Molecular characterisation of each of the 6 hESC-derived interneuron cultures 
generated through serial sequential expansions of the progenitors–protein level, at 
total of 110 days in vitro. The immunohistochemistry data has been presented as 
percentage of marker expressing cells out of the total cell population (total cell count 
measured using DAPI count). The graph plotted shows the mean percentage of 
marker expressing cells for each time point, along with +/- SEM. Culture 5 (SE5 +50 
days) results are missing due to detachment of culture on fixing for all markers 
except LHX6. Average total cell count per technical replicate can be found in Appendix 
folder 7. Biological replicates n=1. Minimum technical replicates n=6. 
B-E) Molecular characterisation of each of the hESC-derived interneuron cultures–
protein level, at 110 days in vitro. Only LHX6 marker expression data is available for 
culture 5 (SE5 seeded for terminal differentiation on day 60). The 
immunohistochemistry data has been presented in the form of a panel of 
immunohistochemistry,  deconvoluted images taken from each sequential culture of 
GAD1 (3.3B), calbindin (3.3C), CR (3.3D) and SST (3.3E) expressing cells. The graph 
plotted shows the mean percentage of GAD1 (3.3B), Calbindin (3.3C), CR (3.3D) and 
SST (3.3E) expressing cells out of total cell population (total cell count measured 
using DAPI count, blue) for each time point, along with +/- SEM. All stainings were 
carried out on day 110 cultures. Average total cell count per technical replicate can 
be found in Appendix folder 7. Biological replicates n=1. Minimum technical replicates 
n=6. 
Statistics performed to determine significant differences in percentage of marker 
expressing cells, for each marker individually over time relative to culture 1 (standard 
paradigm) using nonparametric, Kruskal-Wallis test and Dunn's Multiple Comparison 
Test (*p<0.05, **p<0.01, ***p<0.001). LHX6, LIM Homeobox 6. SST, somatostatin. 
PVALB, parvalbumin. CR, calretinin. GAD1, glutamate decarboxylase 1. hESC, human 
embryonic stem cell. SEM, standard error of the mean.
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3.4 Discussion 
3.4.1 Cross-comparison of hPSC-interneuron differentiation 
paradigms
Through the series of experiments described in this chapter evidence of the 
efficient generation of interneuron-like cells has been provided, both at the 
RNA and protein level. Yet how does the quality of this hPSC-interneuron 
differentiation protocol fair to others? Within the literature, there are several 
independent reports that characterise interneuron-like cells derived from 
hPSC (Cambray et al. 2012;  Maroof et al. 2013; Colasante et al. 2015; 
Meganathan et al. 2017). These paradigms differ on multiple factors, 
including, but not limited to: cell line used, co-culture conditions, extrinsic or 
intrinsic cue methodology, and in vivo vs in vitro terminal differentiation 
(Cambray et al. 2012; Maroof et al. 2013; Colasante et al. 2015; Meganathan 
et al. 2017). In this study the interneuron differentiation used extrinsic cues 
to generate an abundant MGE-like progenitor population, with a small 
proportion of CGE-like progenitors (and even smaller proportion of alternative 
lineages). Whereas, others have used similar interneuron differentiation 
media, but selectively enriched the culture for MGE-like progenitors using 
MGE specific reporter cell lines (Maroof et al. 2013; Tyson et al. 2015; Xiang 
et al. 2017). This focus would account for a greater proportion of MGE-derived 
SST and PVALB interneurons reported in these studies, and why CGE-derived 
subtypes were left unreported (Maroof et al. 2013; Tyson et al. 2015; Xiang 
et al. 2017). Here a wider diversity of subtypes (ChAT, SST, PVALB and CR) 
were detected through bulk-QPCR and immunostaining. Two of the most 
abundant subtypes generated in vitro were CR and ChAT interneuron-like 
cells. Both subtypes are enriched in the human striatum, which would account 
for the proportion of NKX2.1 positive cells in the post-mitotic population 
(Marín et al. 2000; Wu & Parent 2000; Batista-Brito et al. 2008; Nóbrega-
Pereira et al. 2008). The maintained NKX2.1 expression marks MGE-derived 
interneuron precursors for striatal rather than cortical destination in vivo 
(Marín et al. 2000; Wu & Parent 2000; Batista-Brito et al. 2008; Nóbrega-
Pereira et al. 2008). Moreover, the bias towards CR and ChAT lineage 
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commitment was, in part, supported by the molecular profile of the early and 
late interneuron precursors, which had high expression of LHX8 and COUPT 
II, and low expression of SST/PVALB interneuron precursor marker LHX6
(Tyson et al. 2015; Hu et al. 2017a; Elbert et al. 2019). Whereas, others 
have achieved higher LHX6 expression which has been followed by higher 
abundance in SST interneuron-like cells in the post-mitotic culture (Maroof et 
al. 2013; Close et al. 2017; Yuan et al. 2018). In fact, paradigms combining 
the use of SHH signalling and overexpression of LHX6 selectively enhanced 
the efficiency of generating SST interneurons in vitro (5% using extrinsic cues 
to 12% with LHX6 overexpression and extrinsic cues) (Yuan et al. 2018). 
Therefore, the failure of the extrinsic cues to induce LHX6 expression likely 
accounts for the low abundance of PVALB and SST interneurons in the culture. 
3.4.2 The differentiation trajectory of interneuron-like cells
The longitudinal molecular characterisation of interneuron-like cells across 
differentiation revealed the temporal dynamics in key transcription factors, 
as well as subtype markers (SST, CR, PVALB). Together these findings would 
indicate that although early MGE-like progenitors were efficiently generated, 
the differentiation paradigm failed to maintain and enhance the expression of 
the late MGE markers (LHX6 and LHX8). Therefore, although a high 
proportion of interneuron-like cells were generated using this paradigm, one 
would question the full authenticity of the cells compared to their native 
counterparts. This is likely due to exogenous SHH signalling alone not being 
sufficient to recapitulate all extrinsic cues interneurons are subject to across 
their differentiation trajectory. Therefore, introducing additional extrinsic 
cues (such as BMP and fibroblast growth factor, FGF signalling) may help 
drive and maintain the expression of these later markers, by reproducing 
some of the signals received during migration to the region of destination 
(Mukhopadhyay et al. 2009; Danjo et al. 2011). Moreover, the use of 
additional neurogenic and neurotrophic factors during terminal differentiation 
may help selectively promote neuronal survival and maturation, and 
potentially shorten the duration of the terminal differentiation stage 
(Telezhkin et al. 2016).
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3.4.3 Extended production of interneuron-like progenitors 
During development temporally distinct waves of progenitors are born within 
the ventricular zone of the MGE/CGE. The ventricular zone is maintained over 
an extended period of development, only beginning to significantly shrink 
from 14WPC onwards (Hansen et al. 2013). However, the extrinsic cues 
required to maintain proliferating interneuron progenitors remains unclear. 
In attempt to extend production of proliferating hESC-derived interneuron 
progenitors in vitro, sequential serial expansions of cultures maintained in 
SHH treatment was performed. Although this strategy successfully generated 
newborn interneuron-like progenitors, this success was restricted to the first 
three serial expansions. The maintenance of proliferating progenitors 
(although short-lived) reflects the mitogen activity of SHH, which acts to 
increase the expression of cell cycle regulatory proteins (including cyclin D1 
CCND1, E2F Transcription Factor E2F1/2) and inhibit differentiation (Fuccillo 
et al. 2006; Elkabetz et al. 2008; Cambray et al. 2012). However, SHH 
signalling alone was not sufficient to maintain proliferating interneuron-like 
progenitors over extended periods. This would encourage investigating 
whether additional mitogens, potentially FGF-2 and Notch signalling, could 
work synergistically with SHH to lengthen the duration in vitro that the 
progenitors could be maintained (Okabe et al. 1996; Elkabetz et al. 2008).
3.4.4 Early vs late-born interneuron-like progenitors 
The depletion of proliferating progenitors in the later cultures altered the goal 
of the serial expansion paradigm. Instead of generating newborn progenitors, 
earlier-born MGE-like progenitors transitioning to post-mitotic state (LHX6 
positive, NKX2.1 negative) were maintained under SHH signalling before 
seeding for in vitro maturation. With each expansion the proportion of earlier-
born (LHX6 positive) interneuron precursors progressively increased, as did 
the duration the interneuron precursors were cultured in SHH before terminal 
differentiation. Although unintended this had generated a situation similar to 
the one reported by Tyson et al. (Tyson et al. 2015). However, Tyson et al.
directly isolated these populations using a dual MGE specific reporter mESC 
line  (Nkx2.1::mCherry, Lhx6::GFP) and transplanted each enriched 
population into early postnatal mouse cortex (Tyson et al. 2015). After 
completing terminal differentiation in vivo, earlier-born (Lhx6::GFP positive) 
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MGE-like progenitor-derived grafts preferentially generated SST interneuron 
subtypes compared to late-born (Nkx2.1::mCherry) MGE-like progenitors 
(Tyson et al. 2015). These findings by Tyson et al. were, in part, in agreement 
to the significantly higher abundance of SST interneurons within later derived
cultures, which increased in a graded manner with serial expansions (Tyson 
et al. 2015; Xiang et al. 2017). However, no change was observed in PVALB 
interneuron abundance, which was low across all cultures. The difficulty in 
modifying PVALB subtype abundance during interneuron differentiation of 
hPSC through SHH manipulation has been reported previously, and may be 
due to the low efficiency that interneuron differentiation paradigms have in 
generating PVALB interneurons in vitro (Close et al. 2017; Xiang et al. 2017). 
Instead, only the loss of CR and CALB1 interneuron-like cells was detected. 
3.4.5 Mechanisms underpinning the elevated SST: CR interneuron
The elevated SST:CR in the terminally differentiated later derived cultures 
could be explained by alternative mechanisms. First, the serial expansion of 
the culture and extended duration under exogenous SHH signalling changed 
the lineage commitment of interneuron precursors from CR to SST. However, 
this would require interneuron fate commitment of interneurons derived from 
the same ancestor (part of the same clonal lineage) to be unrestricted. With 
conflicting evidence concerning the flexibility of interneuron lineage 
commitments within the literature, this mechanism remains under scrutiny 
(Rolando et al. 2010; Ishino et al. 2017; Quattrocolo et al. 2017). Moreover, 
the shift towards SST lineage in later cultures would not have been expected 
from mouse CGE and MGE fate-mapping studies (Butt et al. 2005; Inan et al.
2012). Mouse CGE and MGE grafts obtained at E13.5 and E15.5 showed a 
differential bias towards CR and PVALB interneuron (in particular PVALB 
Chandelier subtype) commitment in the older grafts (Butt et al. 2005; Inan 
et al. 2012). The inability to reproduce this result in hPSC-derived 
interneuronal model may be due to between-species differences, or due to 
terminal differentiation of sequentially generated cultures failing to 
recapitulate the temporally induced change in lineage commitment of the 
progenitors. Instead, the serial expansion and shorter duration in the 
neuronal maturation media, may have resulted in the selective survival bias 
in favour of SST interneuron precursors, and against CR interneuron 
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precursors. This theory is, in part, supported by an independent study, using 
a similar hPSC interneuron differentiation paradigm, which has shown that 
extended durations in the neuronal maturation media (up to 100 days) 
significantly depleted the culture of GAD1 and SST positive cells (Close et al.
2017). Nevertheless, no change was reported for the proportion of CR 
positive cells (Close et al. 2017). Therefore, the extended duration in 
neuronal maturation media (e.g. 90 days for culture 1) alone cannot account 
for the higher proportion of CR interneuron-like cells in these cultures. 
3.4.6 Conclusions  
Overall, serial expansion of interneuron-like progenitors holds promise as a 
means to simulate the endogenous generation of temporally distinct 
progenitor pools, and thereby expanding the spectrum of interneuron 
subtypes derived from a single original parent culture. However, certain 
optimisations to the design would be required to enhance proliferation, and 
to enable these populations to be monitored in real-time to better guide 
manipulation of early vs late-born progenitor ratio (e.g. dual reporter cell 
line) (Tyson et al. 2017). However, previous work within the literature has 
indicated a potential negative impact of repeated passaging of neuronal 
progenitors on the quality of neurons generated on terminal differentiation 
(Bardy et al. 2016). With each serial expansion, the neuronal cultures derived 
were progressively less active and displayed more immature spike patterns 
(Bardy et al. 2016). Therefore, conducting electrophysiology on each 
temporally distinct culture would determine whether repeated passaging is a 
feasible and advantageous approach to take to generate interneuron-like cells 
that are both a realist molecular and functional model of their authentic 
counterparts. 
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Chapter 4 - Single-cell transcriptome analysis of hESC-derived 
interneurons 
4.1 Introduction
Single-cell transcriptomics remains a hot topic within science due to the broad 
utility of this innovative technique, which has started to untangle the puzzling 
threads of research within multiple fields of study (Drissen et al. 2016; Poulin 
et al. 2016; Close et al. 2017; Azizi et al. 2018). Over the years following the 
publication of the first single-cell transcriptomic protocol, further refinements 
have been reported, providing users with an array of choices on reaction 
chemistry and single-cell capture technique to enhance both the sensitivity 
and throughput respectively (Tang et al. 2009; Hashimshony et al. 2012; 
Ramsköld et al. 2012; Poulin et al. 2016). 
4.1.1 Single-cell transcriptomics – applications 
Single-cell transcriptomics has been an invaluable tool to researchers due to 
the ability to uncover data previously hidden in bulk-level analysis of 
heterogeneous samples (Wills et al. 2013; Liu & Trapnell 2016; Ofengeim et 
al. 2017). In particular, single-cell RNA sequencing analysis describes the 
entire (within detection limits) expression profile of each cell, from which 
valuable information can be gained. First, one can identify the cell types 
within the population, and potentially detect novel cell types and/or novel 
genes associated with the lineage (Liu & Trapnell 2016; Boldog et al. 2018). 
Second, one can tease apart the molecular heterogeneity within and across 
samples, thereby identifying the differentially expressed genes responsible 
for this heterogeneity (Liu & Trapnell 2016). This has been particularly useful 
when characterising the differentiation trajectories of cells during 
development, and has led to candidate lineage determining transcription 
factors being named (Close et al. 2017; Xiang et al. 2017; Mayer et al. 2018; 
Mi et al. 2018).  Finally, one can detect gene expression patterns that may 
represent putative gene regulatory networks/nodes (Camp et al. 2015; Liu & 
Trapnell 2016).
4.1.2 Single-cell transcriptomics – interneurons 
Overall these applications of single-cell transcriptomics makes the tool ideally 
suited to teasing apart the genetic heterogeneity of interneurons (Darmanis 
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et al. 2015; Lake et al. 2016; Boldog et al. 2018). The in-depth profiling 
capable with single-cell RNA sequencing has expanded the molecular 
characterisation of interneurons in the brain, leading to novel species-
dependent subtypes being detected, along with novel interneuron markers 
(e.g. prepronociceptin Pnoc)  (Zeisel et al. 2015; Lake et al. 2016; Boldog et 
al. 2018). Moreover, between-region analysis has enabled region-specific 
subtypes to be determined, including the mouse striatal, hippocampal (CA1 
region) and cortical (primary somatosensory cortex) restricted interneuron 
subtypes: PVALB (Pthlh, Pvalb co-expressing), RELN (Reln, Gabrd, Lhx6 co-
expressing) and VIP/CR (Vip, Cr, Penk, Crh co-expressing), respectively 
(Zeisel et al. 2015). Finally, single-cell RNA sequencing analysis performed 
on primary mouse cortical tissue has detected genes that are selectively 
expressed by interneurons in particular cortical layers, so-called layer 
markers (Darmanis et al. 2015; Lake et al. 2016; Frazer et al. 2017; 
Nowakowski et al. 2017). These markers include tachykinin 3 (TAC3) and 
SV2C (upper layer markers), and MEIS homeobox 2 (MEIS2) (deep layer and 
white matter marker) (Darmanis et al. 2015; Lake et al. 2016; Frazer et al.
2017; Nowakowski et al. 2017).  This has provided evidence of an intrinsic 
regulation of cortical interneuron lamination, which likely interplays with 
contact-dependent extrinsic cues from the principal cells of the cortex 
(Nowakowski et al. 2017; Wester et al. 2019). 
Moreover, longitudinal single-cell transcriptomics has the potential to 
decipher the genetic basis of interneuron lineage divergence (Darmanis et al.
2015; Lake et al. 2016; Chen et al. 2017; Boldog et al. 2018; Mayer et al.
2018; Mi et al. 2018). Through independent single-cell RNA sequencing study 
on mouse MGE and CGE, MAF BZIP transcription factor (Maf) and myocyte 
enhancer factor 2C (Mef2c) have been named as SST and PVALB interneuron 
lineage determining transcription factors respectively (Mayer et al. 2018; Mi 
et al. 2018). Although these findings in mice are promising, issues concerning 
between-species differences in interneuron development may impair the 
translation of these finding to humans (Wu & Parent 2000; Bakken et al.
2016; Lake et al. 2016; Sousa et al. 2017; Boldog et al. 2018).
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4.1.3 Single-cell transcriptomics – hPSC-derived interneurons 
However, due to the scarcity and legal age restrictions on primary human 
foetal tissue usage, obtaining an unrestricted outlook of interneuron 
differentiation trajectory from human primary tissue has not been possible. 
This has promoted single-cell RNA sequencing to be performed on hPSC 
models of interneuron differentiation (Close et al. 2017; Xiang et al. 2017). 
However, our understanding of interneuron progenitor and subtype diversity 
generated using hPSC interneuron differentiation paradigms is incomplete. At 
present, hPSC-derived interneurons have only been independently profiled, 
at single-cell resolution, by two studies (Close et al. 2017; Xiang et al. 2017). 
These reports have been valuable as a guide in the work presented here, 
encouraging an expanded number of time points to be sampled throughout 
the differentiation protocol, to gain a more detailed understanding of the 
interneuron-like cell differentiation trajectory. Currently, lineage determining 
transcription factors have not been named from longitudinal single-cell 
transcriptomics conducted on hPSC-derived interneurons, although 
successful findings from primary mouse MGE and CGE would encourage 
persistence in the search (Close et al. 2017; Xiang et al. 2017; Mayer et al.
2018; Mi et al. 2018). 
4.2 Aims 
To characterise the differentiation trajectory of hPSC-derived interneurons 
using longitudinal single-cell RNA sequencing.
To analyse the list of differentially expressed genes to identify any 
transcription factors that may be responsible for the diversification of 
interneuron-like cells into different subtypes.
To detect genes potentially uniquely co-expressed by SST, PVALB or CR 
interneuron-like cells or their precursors, and therefore may underlie the 
unique phenotype of these subtypes. 
4.3 Results 
Single-cell RNA sequencing was carried out on hESC-derived interneurons at 
multiple time points along the differentiation protocol to give a longitudinal 
description of gene expression profiles. The differentiation paradigm and time 
points used matched those in Chapter 3 to allow cross-technique comparison 
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(RNA and protein level). As described in detail in Chapter 2, Fluidigm C1 IFC 
was the selected platform to both isolate single cells and perform reaction 
chemistry (lysis, reverse transcription, preamplification). Full-length mRNA 
coverage and high sensitivity reaction chemistry SMART-seq was selected to 
allow low expressed, rare and potentially novel transcripts to be detected. 
4.3.1 hESC-derived interneuron subtypes resembled those 
originating from dorsal MGE and CGE
From the longitudinal characterisation of hESC-derived interneurons 
presented in Chapter 3, initial analysis of single-cell RNA sequencing data 
began with a description of the NKX2.1 expressing MGE-like progenitor 
population at day 20 (Figure 4.1A). In agreement with the immunostaining 
conducted in Chapter 3, the day 20 cultures were abundant in NKX2.1
expressing cells (90%) (Figure 4.1E). The co-expression patterns of the 
NKX2.1 expressing cells revealed a high co-expression with forebrain marker 
FOXG1, and low co-expression with late MGE markers (LHX6/8 and DLX1/5) 
(Figure 4.1A). This would indicate that the day 20 hESC-derived progenitors 
were abundant in early MGE-like progenitors. Moreover, 40% of NKX2.1
expressing cells co-expressed COUPTF II. The NKX2.1/COUPTF II population 
is natively restricted to dorsal MGE, suggesting a good representation of the 
dorsal MGE-like progenitors in the day 20 cultures. By day 65, hESC-derived 
interneuron culture was abundant in MAP2 expressing cells, which expressed 
a diverse range of interneuron subtype markers, the most abundant including 
CALB1, SST, CR, and RELN (Figure 4.1B). Although rare within the day 65 
hESC-derived interneurons (<2%), additional subtype marker expressing 
cells were also detected, such as CGE-derived interneuron markers VIP, nNOS
and 5HT-R-3A, and MGE-derived interneuron markers SST/CR, PVALB and 
PVALB/CR (Figure 4.1B). However, CCK, NPY and PVALB/SST expressing 
neurons were absent from the culture (Figure 4.1B). Overall, the subtype 
composition most closely resembled one obtained natively from the dorsal 
MGE and CGE. 
4.3.2 hESC-derived interneurons showed subtype-dependent 
expression patterns 
To further explore the differences in the molecular profile of CR, SST and 
PVALB expressing interneuron-like cells, genes uniquely co-expressed by 
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each of the subtypes were determined from single-cell RNA sequencing data 
(Appendix folder 2, tables). Many of these genes included transcription 
coactivators (SS18 like 2, PVALB specific), cyclin proteins (cyclin I, SST 
specific), chaperons (heat shock protein 90 alpha family class A member 1, 
SST specific) and intracellular signalling proteins (G protein nucleolar 2, 
PVALB specific and GNAS complex locus, CR specific) (see Appendix folder 2). 
Although transcription factors previously named in mouse CGE/MGE single-
cell RNA sequencing analysis (MAF and MEF2C) were found not to be uniquely 
associated with a single lineage in this search, genes regulating transcription 
and protein activity have been identified, and therefore may have an 
important role in shaping the fate and phenotype of these subtypes. 
Moreover, the subtype-dependent expression pattern likely accounted for (at 
least in part) the heterogeneity in the population, as seen in the tSNE plots 
at each time point (Figure 4.1C). 
4.3.3 Known interneuron markers showed temporal dynamics in 
expression profile
tSNE plots act to visually present the heterogeneity within population, 
clustering cells with higher degree of similarity in expression profile closer 
together. An example of any genes highly expressed by a specific cluster has 
been displayed on each tSNE plot, with the full list of differentially expressed 
genes between clusters provided in Appendix 2 table 5 (Figure 4.1C). Of 
potential significance were the differentially expressed transcription factors 
(cellular retinoic acid binding protein 1 CRABP1, high mobility group box 2
HMGB2) and signalling factors (secreted protein acidic and cysteine rich, 
SPARC, delta like non-canonical Notch ligand 1 DLK1), which may be driving 
the divergence into subpopulations (Figure 4.1C). When looking across tSNE 
plots for each time point, more discretely segregated clusters of cells are 
present in the day 50 culture (Figure 4.1C). Therefore, although the tSNE 
plots showed heterogeneity in the population at each time point, the diversity 
in expression profile appeared to sharply increase between day 20 and 35, 
and peak at day 50 (Figure 4.1C). By studying the expression trajectory of 
known interneuron markers in the population, one can begin to understand 
the dynamics in gene expression within and across populations that may be 
responsible for this heterogeneity (Figure 4.1D).
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The tSNE plot for day 20 showed the least distinct between clusters (Figure 
4.1C). This dispersal pattern likely reflects the homogeneity of expression 
pattern at day 20, with 90% of the population displaying an early MGE-like 
co-expression pattern (NKX2.1/FOXG1 positive, LHX6/LHX8  negative) 
(Figure 4.1C-4.1D). However, over time the abundance of NKX2.1 expressing 
cells decreases to 20%, along with the NKX2.1 expression level in these cells,
as shown by the population average transcripts per million (TPM) value 
progressively decreasing at each time point (Figure 4.1D). However, late MGE 
markers LHX8 only showed a transient increase in abundance and expression 
level (at day 35, in agreement to bulk QPCR data, Chapter 3), but otherwise 
remained low across differentiation. Similarly, LHX6 expressing cells were 
rare in the culture at all time points (<5%) and was only weakly expressed 
(average TPM value <5 at each time point) (Figure 4.1D). Whereas, the 
number of cells expressing COUPTF II progressively increased in the 
population until day 50, and then plateaued at 80-90%. This high proportion 
of COUPTF II expressing cells was inconsistent with findings at protein level, 
which reported a steady proportion of COUPTF II positive cells across day 20 
to day 65 (25-30% Chapter 3). This discrepancy may underlie the additional 
regulatory steps between transcription and translation, and demonstrates the 
importance of performing analysis at both RNA and protein level. 
Nonetheless, these findings would suggest that the MGE-like progenitors 
failed to go on to express late MGE markers, and instead took on a more 
CGE/dorsal MGE expression pattern. 
In addition to the abundant MGE-like progenitor population at day 20, there 
were also nascent post-mitotic neurons  (MAP2 expressing) present, which 
may account for the smaller, more discrete clusters on tSNE plot (Figure 
4.1C). Within this post-mitotic neuronal populations, at day 20, were both 
PVALB and CR expressing cells (Figure 4.1E). Moreover, longitudinal analysis 
of the PVALB expressing population indicated that day 20 had the highest 
abundance of PVALB expressing cells (7%), with <2% PVALB expressing 
neurons detected in later time points (Figure 4.1E). However, PVALB 
interneurons remained undetected at protein level at day 20 (Chapter 3). This 
may be due to PVALB expression level being low (66 TMP average for day 20 
population) (Figure 4.1E). Nonetheless, the co-expression pattern of PVALB 
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expressing neurons would lend support for these cells at day 20 being true 
PVALB interneuron-like cells (all co-expressed ER81, CCND1/2, DLX5, GAD1, 
data not shown). Whereas, in agreement to the immunostaining for SST and 
CR, the proportion of SST and CR expressing cells gradually increased over 
the course of in vitro differentiation (SST 12% out of MAP2, CR 15% out of 
MAP2 Figure 4.1E). The higher expression levels of SST and CR, compared to
PVALB, may have enabled these markers to be detected in immunostaining 
(Chapter 3). However, the abundance of CR expressing cells suggested at 
RNA level mismatched immunostaining for CR (underestimated proportion of 
CR at RNA level), which could be due to the RNA analysis being restricted to 
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CR/MAP2 co-expressing subpopulation (while some CR interneuron-like cells 
may have only been TUJ1 expressing) (Figure 4.1E and Chapter 3). 
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Figure 4.1 Single-cell RNA sequencing analysis of hESC-derived 
interneurons.
A) Molecular characterisation of hESC-derived interneurons – at single-cell RNA level, 
day 20. The graph plotted shows the proportion of cells expressing each named 
marker. The marker positive cells have been counted if the cells are also co-
expressing NKX2.1 to restrict analysis to MGE progenitors. Biological replicates 
(independent differentiations) n=2. Total number of cells per time point can be found 
in Appendix folder 2 table 4. Total NKX2.1 expressing cells at day 20 = 128 cells.
B) Molecular characterisation of hESC-derived interneurons – at single-cell RNA level, 
day 65. The graph plotted shows the proportion of cells expressing each named 
marker. The marker positive cells have been counted if the cells also co-expressing 
MAP2 to restrict analysis to post-mitotic neurons. Biological replicates (independent 
differentiations) n=2. Total number of cells per time point can be found in Appendix 
folder 2 table 4. Total MAP2 expressing cells at day 65 = 129 cells.
C) tSNE plot of the relative similarity in single-cell profiles of hESC-derived 
interneurons at days 20, 35, 50 and 65. Each symbol on tSNE plot represents a 
single-cell and the unique gene expression profile of the cell (based on single-cell 
RNA sequencing data available, trimmed to top 400 genes). Clusters of symbols on 
tSNE plot represent cells with higher similarity in gene expression profile, with each 
cluster uniquely labelled with cluster number (e.g. C1) and an example of a highly 
expressed gene unique to this cluster (where an example exists). For full list of 
differentially expressed genes between cluster see Appendix folder 2 table 5.
Biological replicates (independent differentiations) n=2. Total number of cells per 
time point can be found in Appendix folder 2 table 4. 
D) Trajectory of hESC-derived interneurons expression of MGE/CGE markers– at RNA 
level, days 20, 35, 50 and 65 in vitro. Two graphs have been presented. One graph 
plotted shows the sample TPM value for each marker, with each symbol plotted 
representing the expression value of that marker for a single cell in the sample. The 
line graph plotted shows the proportion of cells expressing each named marker over 
time. Biological replicates (independent differentiations) n=2. Total number of cells 
per time point can be found in Appendix folder 2 table 4. 
E) Trajectory of hESC-derived interneurons expression of subtype markers– at RNA 
level, day 20, 35, 50 and 65 in vitro. Two graphs have been presented. One graph 
plotted shows the sample TPM value for each marker, with each symbol plotted 
representing the expression value of that marker for a single cell in the sample. The 
line graph plotted shows the proportion of cells expressing each named marker over 
time. The marker positive cells have been counted if the cells also co-expressing 
MAP2, to restrict analysis to post-mitotic neurons. Biological replicates (independent 
differentiations) n=2. Total number of cells per time point can be found in Appendix 
folder 2 table 4. Total MAP2 expressing cells at day 20=132 cells, day 35=177, day 
50=124 cells and day 65 = 129 cells.
TPM, transcripts per million. NK2 Homeobox 1, NKX2.1. COUP transcription factor 2, 
COUPTF II. LHX6, LIM Homeobox 6. FOXG1, Forkhead Box G1. SST, somatostatin. 
PVALB, parvalbumin. CR, calretinin. LHX8, LIM Homeobox 8. DLX5, Distal-less 
homeobox 5. DLX1, distal-less homeobox 1. MAP2, microtubule-associated protein 
2. Serotonin receptor 3A, 5HT-R 3A. Vasoactive intestinal peptide, VIP. Reelin, RELN. 
Neuropeptide Y, NPY. Neuronal nitric oxide synthase, nNOS. hESC, human embryonic 
stem cell. Delta like non-canonical Notch ligand 1, DLK1. Cellular retinoic acid binding 
protein 1, CRABP1. High mobility group box 2, HMGB2. S100 calcium binding protein 
A11, S100A11. Secreted protein acidic and cysteine rich, SPARC. Tetraspanin 7, 
TSPAN7. Stathmin 2, STMN2. Cyclin D1, CCND1. Phospholipid transfer protein, PLTP. 
Interferon induced transmembrane protein 2, IFITM2
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4.3.4 Differentiation trajectory of hPSC-derived interneurons was 
underpinned by the differential expression of specific transcription 
factors   
Finally, the heterogeneity between samples was explored by performing 
ANOVA pair-wise analysis (Figure 4.2B-4.2C). On observing all the single-cell 
profiles presented together on a single tSNE plot, day 20 population would be 
predicted to have the most unique expression profile relative to other time 
points (Figure 4.2A). This was indicated by nearly the entire day 20 sample, 
those corresponding to the early MGE-like progenitors, all clustering together 
into a single subpopulation (top right cluster, Figure 4.2A). Whereas, the day 
35 to day 65 cultures appeared to have many overlapping subpopulations, 
which could be further divided into three distinct clusters (Figure 4.2A). 
Furthermore, the ANOVA pair-wise analysis detected the greatest number of 
significantly differentially expressed genes in the day 20 cross-comparisons 
(highest being 29 genes for day 20 vs 65 comparisons, Appendix folder 2 
table 6 has full list). These significantly differentially expressed genes have 
been shown in Figure 4.2B and 4.2C, with genes that were more highly 
expressed at the later time point (e.g. day 35 in a day 20 vs day 35 
comparison) assigned a positive fold change value (Figure 4.2B). Whereas, 
any genes higher expressed at the earlier time point (e.g. day 20 in a day 20 
vs day 35 comparison) were assigned a negative fold change value (Figure 
4.2B).
To fully evaluate the differentiation trajectory of interneuron-like cells, 
relative fold changes in differentially expressed genes were determined for all 
the day 20 cross-comparisons (Figure 4.2B). As seen in Figure 4.2B, certain 
genes were only differentially expressed relative to day 20 at a single time 
point, and therefore showed only a transient change in expression over 
interneuron differentiation. This included DLX1/5 and fatty acid binding 
protein 3 (FABP3), which were both higher expressed at day 35, but showed 
no significant change in expression at day 50/65 (Figure 4.2B). This was
further reiterated in the day 35 cross-comparisons, which showed that the 
expression of DLX genes (DLX1, DLX2, DLX5, DLX6 antisense) peaked at day 
35 and then had been downregulated by later time points (Figure 4.2C). In 
addition, early MGE markers maternally expressed 3 (MEG3) and hes family 
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bHLH transcription factor 4/5 (HES4/5) were found to be higher expressed at 
day 20 (Figure 4.2B). Whereas, POU class 3 homeobox 4 (POU3F4) was 
higher expressed at day 50 compared to day 20 and day 35 (Figure 4.2B-
4.2C). Also of note was the gene with the highest relative fold-change 
observed, 220-fold upregulation of nuclear factor I/B (NFI B) at day 65 (day 
20 vs 65 comparison). NFI B was also significantly higher expressed at day 
65 in both day 20 and day 35 pairwise comparisons (Figure 4.2B-4.2C). 
Finally, chemokine C-C motif ligand 2 (CCL2) was found to be higher 
expressed at day 65 relative to day 20 (Figure 4.2B).
The interneuron differentiation of hPSC was also marked by genes 
consistently up or downregulated between the progenitor (day 20) and post-
mitotic stages (day 35 to 65). These genes were detected as significantly 
differentially expressed genes in all day 20 pairwise cross-comparisons 
(Figure 4.2B). This included the following genes consistently higher expressed 
at later time points (upregulated): annexin A1, RNA binding motif single 
stranded interacting protein 1 (RBMS1) and Na+ voltage-gated ion channel 
subunit SCN2A (Figure 4.2B). Overall, the temporal changes in expression 
pattern reflected the transition of progenitors, with high expression of early 
transcription factors (MEG3, HES4/5) to migratory interneuron-like cells 
expressing guidance cues (chemokines), ion channels (SCN2A) and late MGE 
markers (DLX1/5). 
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Figure 4.2 Differentially expressed genes marking the developmental 
trajectory of hESC-derived interneurons.
A) tSNE plot of the relative similarity in single cell profiles of hESC-derived 
interneurons at days 20, 35, 50 and 65. Each symbol on tSNE plot represents a single 
cell and the unique gene expression profile of the cell (based on single-cell RNA 
sequencing data available, trimmed to top 400 genes). Clusters of symbols on tSNE
plot represent cells with higher similarity in gene expression profile. Subpopulations 
within each time point are indicated by spatially isolated clusters. Cells from the same 
time point along differentiation paradigm share the same symbol (e.g. all day 20 cells 
are represented by red open circle). Biological replicates (independent 
differentiations) n=2.
B) Relative fold change in expression of genes significantly differentially expressed 
between day 20 relative to day 35/50/65. DEGs were determined through ANOVA 
pairwise analysis, and were included if p<0.05 and fold change (either up or 
downregulated) >4. In this plot, any genes upregulated were relatively higher 
expressed at the later time point (e.g. day 50 in day 20 vs 50 comparison) and were 
shown as a positive fold change. Any downregulated genes were higher expressed at 
the earlier time point (day 20 in all cases), and were shown as a negative fold change. 
See Appendix folder 2 tables for total cell per sample and DEG list. Biological 
replicates (independent differentiations) n=2.
C) Relative fold change in expression of genes significantly differentially expressed 
between day 35 relative to day 50/65, and day 50 relative to day 65. DEGs were 
determined through ANOVA pairwise analysis, and were included if p<0.05 and fold 
change (either up or downregulated) >4. In this plot, any genes upregulated were 
relatively higher expressed at the later time point (e.g. day 50 in day 35 vs 50 
comparison) and were shown as a positive fold change. Any downregulated genes 
were higher expressed at the earlier time point (e.g. day 35 in day 35 vs 50 
comparison), and were shown as a negative fold change. See Appendix folder 2 tables 
for total cell per sample and DEG list. Biological replicates (independent 
differentiations) n=2.
Total number of cells per time point can be found in Appendix folder 2 table 4. CDH6, 
Cadherin 6 .CAMK2B, Calcium/Calmodulin Dependent Protein Kinase II Beta. Ch1 
open reading frame 61, Chromosome open reading frame 61. Ch14 open reading 
frame 23, Chromosome open reading frame 23. DLEU1, Long Intergenic Non-Protein 
Coding RNA 21. GADD45G, Growth Arrest And DNA Damage Inducible Gamma. 
IGFBP3, Insulin Like Growth Factor Binding Protein 3. LPPR1, Phospholipid 
Phosphatase Related 1. LINC 478, Long intergenic non-protein coding RNA 478. 
NDC80 complex, NDC80 Kinetochore Complex Component. RBMS1, RNA Binding 
Motif Single Stranded Interacting Protein 1. SFRP2, Secreted frizzled related protein 
2.  NK2 Homeobox 1, NKX2.1. COUP transcription factor 2, COUPTF II. LHX6, LIM 
Homeobox 6. FOXG1, Forkhead Box G1. SST, somatostatin. PVALB, parvalbumin. CR, 
calretinin. LHX8, LIM Homeobox 8. DLX5, Distal-less homeobox 5. DLX1, distal-less 
homeobox 1. MAP2, microtubule-associated protein 2. Serotonin receptor 3A, 5HT-R 
3A. Vasoactive intestinal peptide, VIP. Reelin, RELN. Neuropeptide Y, NPY. Neuronal 
nitric oxide synthase, nNOS. DLX1, distal-less homeobox 1. DLX2, distal-less 
homeobox 2. LINC01158, long intergenic non-protein coding RNA 1158. MEIS2, meis 
homeobox 2. NFIB, nuclear factor I/B. S100B, S100 calcium binding protein B. hESC, 
human embryonic stem cell. Differentially expressed genes, DEGs.
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4.3.5 Single-cell RNA sequencing data was validated by quality 
control checks 
Before using the single-cell cDNA samples collected from Fludigm C1 IFC for 
library preparation, several quality control checks were performed to ensure 
that the single-cell cDNA was of high enough quality for sequencing (Figure 
4.3A-4.3D, Appendix folder 2 figures). The reaction chemistry used generated 
a high enough concentration of single-cell cDNA to allow both single-cell QPCR 
and RNA sequencing to be performed on the same samples (Figure 4.3A-
4.3D). 
In agreement to single-cell RNA sequencing data presented above, single-cell 
QPCR analysis at day 20 detected the high abundance of cells expressing 
known early MGE and CGE markers, such as FOXG1, NKX2.1 and COUPTF II,
and the absence of markers of alternative fates (CTIP2, FOXP1, PAX6) (Figure 
4.3A and Appendix folder 2 figures). However, single-cell QPCR analysis 
would also suggest a higher abundance in NKX2.1 and COUPTF II co-
expressing cells (90% NKX2.1/COUPTF II, Figure 4.3A). However, this finding 
was not replicated in single-cell RNA sequencing analysis performed on the 
same cDNA samples, nor in immunohistochemistry of day 20 progenitors 
shown in Chapter 3, which all found between 25-40% COUPTF II positive 
population at day 20 (Figure 4.1A and 4.3A). 
Another discrepancy reported from single-cell QPCR data was the relatively 
similar proportion of MAP2 expressing cells that co-expressed SST and CR at 
day 65 (approx. 20% for each subtype marker, Figure 4.3B). This finding was 
slightly mismatched to the single-cell RNA sequencing, which reported higher 
CR subtype abundance relative to SST (Figure 4.1B and 4.3B). Moreover, the 
longitudinal expression trajectory of CR and SST was inconsistent with single-
cell RNA sequencing findings (Figure 4.1E and 4.3D). The reported abundance 
of SST expressing cells was much higher in the single-cell QPCR analysis 
(peaking at 45% vs 13% at day 50, Figure 4.1D and 4.3D). This may be due 
to primer efficiency issues causing overestimation of SST levels in single-cell 
QPCR. Alternatively, single-cell RNA sequencing may be underestimating the 
abundance of SST expressing neurons, due to the lower sensitivity of the 
technique, which may have prevented cells with low SST transcript values 
being detected (Figure 4.3C). These neurons with low expression of SST
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(delta Ct >14) were of high abundance at day 50, the time point with the 
greatest discrepancy between the two methodologies (Figure 4.3C).   
However, what was encouraging was the detection of the rare PVALB 
interneurons, and SST/CR and PVALB/CR co-expressing cells within the 
culture using both single-cell QPCR and RNA sequencing methodologies of 
transcriptome analysis (Figure 4.1B and 4.3A). Furthermore, even though 
only a limited number of selected genes were used for single-cell QPCR 
analysis (30 genes tested), heterogeneity in expression of these genes 
between cells was still detected, thereby revealing some of the molecular 
heterogeneity that was fully described in single-cell RNA sequencing analysis 
(Appendix folder 2 figures).
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Figure 4.3 Single-cell QPCR analysis: quality control check data.
A) Molecular characterisation of hESC-derived interneurons – at single-cell RNA level, 
day 20. The graph plotted shows the proportion of cells expressing each named 
marker. The marker positive cells have been counted if the cells are also co-
expressing NKX2.1 to restrict analysis to MGE progenitors. Biological replicates 
(independent differentiations)= 2. Technical replicates =3. Total NKX2.1 expressing 
cells at day 20= 93 cells.
B) Molecular characterisation of hESC-derived interneurons – at single-cell RNA level, 
day 65. The graph plotted shows the proportion of cells expressing each named 
marker. The marker positive cells have been counted if the cells are also co-
expressing MAP2 to restrict analysis to post-mitotic neurons. Biological replicates 
(independent differentiations)= 2. Technical replicates =3. Total MAP2 expressing 
cells at day 65 = 46 cells. 
C) Trajectory of hESC-derived interneurons subtypes– at RNA level, days 35, 50 and 
65 in vitro. The data has been presented in the form of relative gene expression, with 
delta Ct calculated in reference to beta-actin. Each cell positive for the subtype 
marker, at each time point, has been individually displayed by a symbol on the graph. 
The marker positive cells have been counted if the cells also co-expressing MAP2, to 
restrict analysis to post-mitotic neurons. Biological replicates (independent 
differentiations)= 2. Technical replicates =3. Total MAP2 expressing cells per time 
point = 54 cells at day 35, 51 cells at day 50 and 46 cells at day 65.
D) Trajectory of hESC-derived interneurons subtypes– at RNA level, days 35, 50 and 
65 in vitro. The graph plotted shows the proportion of cells expressing each named 
marker. The marker positive cells have been counted if the cells also co-expressing 
MAP2, to restrict analysis to post-mitotic neurons. Biological replicates (independent 
differentiations)= 2. Technical replicates =3. Total MAP2 expressing cells per time 
point = 54 cells at day 35, 51 cells at day 50 and 46 cells at day 65.
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NK2 Homeobox 1, NKX2.1. COUP transcription factor 2, COUPTF II. LHX6, LIM 
Homeobox 6. FOXG1, Forkhead Box G1. SST, somatostatin. PVALB, parvalbumin. CR, 
calretinin. LHX8, LIM Homeobox 8. DLX5, Distal-less homeobox 5. DLX1, distal-less 
homeobox 1. MAP2, microtubule-associated protein 2. hESC, human embryonic stem 
cell. 
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4.4 Discussion 
The longitudinal single-cell RNA sequencing analysis of hPSC-derived 
interneurons presented here has expanded upon the molecular 
characterisation presented in Chapter 3. With this data, a novel description 
of interneuron differentiation of hPSC has been provided. 
4.4.1 Examining the subtype diversity within hPSC-derived 
interneurons
An unbiased and longitudinal evaluation of the hPSC-derived interneuron 
subtype composition revealed the full extent of subtype diversity achieved 
using this paradigm. Although the culture was enriched in early MGE-like 
progenitors, on terminal differentiation a population abundant in RELN, SST
and CR expressing interneuron-like cells was generated. These subtypes are 
typically derived from the dorsal MGE and CGE (Xu et al. 2004; Butt et al.
2005; Flames et al. 2007; Wonders et al. 2008; Miyoshi et al. 2010). On 
examining the differentiation trajectory of the early progenitors, the data 
revealed a low abundance/absence of late MGE marker (LHX6, LHX8, DLX5) 
expressing cells. Instead the population progressively became more caudal 
in molecular profile, with the rising expression of CGE enriched transcription 
factors COUPTF II and NFI B, with the latter being the most highly 
upregulated gene from day 50 onwards (Hu et al. 2017a; Mayer et al. 2018). 
This expression pattern may explain why the day 65 hESC-derived 
interneuron population had an absence or low abundance of certain MGE-
derived subtypes (NPY and PVALB respectively) (Vogt et al. 2014; Hu et al.
201a7; Mayer et al. 2018). A similar finding has been reported independently 
for mESC interneuron differentiation protocol, with SHH signalling alone 
inefficiently generating cells expressing Lhx6 and MGE-derived subtype 
markers Pvab, Npy, and Sst, which were typically co-expressed with Lhx6
(Danjo et al. 2011; Chen et al. 2017). This expression pattern has been linked 
to the absence of other critical spatial patterning cues, such as FGF8 and 
BMP4, which when added have selectively enhanced commitment to these 
lineages (Mukhopadhyay et al. 2009; Danjo et al. 2011; Chen et al. 2013). 
In addition, the longitudinal single-cell RNA sequencing analysis provided an 
understanding of when certain subtype dictated subpopulations emerge, and 
the dynamics of these subpopulations. In general, subtype marker expressing 
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cells grow in abundance over the course of the hPSC interneuron 
differentiation paradigm (Close et al. 2017; Xiang et al. 2017). This trend was 
true for most of the interneuron-like subtypes detected here, including CR, 
SST and RELN. However, the longitudinal analysis presented some novel and 
non-intuitive findings in relation to the emergence of PVALB interneuron-like 
cells. At day 20 the hESC-derived interneuron culture had a small proportion 
of nascent post-mitotic interneuron-like cells, which were identified as CR, 
PVALB and CR/PVALB co-expressing. However, the abundance of PVALB
expressing neurons peaked at day 20 and declined over the remainder of the 
differentiation paradigm.  This trend in PVALB expression was a novel finding 
and was in contrast to the expected trend. Nonetheless, the co-expression 
pattern of PVALB interneuron-like cells, and the independently reported 
existence of PVALB/CR co-expressing interneurons endogenously 
(hippocampal Chandelier cells), added weight to these cells being genuine 
PVALB interneuron-like cells (Ishino et al. 2017). This led to the conclusion 
that the neuronal maturation media was insufficient to maintain the PVALB 
interneuron-like cells. A similar report has also been made independently for 
the loss of SST interneuron-like cells generated in a similar hPSC 
differentiation paradigm, although at a much later time point (day 50 
onwards) (Close et al. 2017). Together these findings would indicate a 
missing component in the differentiation paradigm that would appear to be 
essential for maintaining certain interneuron subtypes. A strong candidate 
would be the absence of native synaptic partners. Endogenously the signals 
received as part of a neuronal circuit is necessary to promote the survival and 
maturation of neurons. Moreover, there is evidence of activity-dependent 
signalling promoting the terminal differentiation of interneuron, as well as 
fine-tuning the final subtype commitment (Ishino et al. 2017; Quattrocolo et 
al. 2017; Wamsley & Fishell 2017). Therefore, one strategy to explore that 
may help maintain (and potentially enhance) PVALB interneuron-like cells in 
vitro would be to co-culture hESC-derived interneurons with their native 
synaptic partners (such as primary tissue or hPSC-derived glutamatergic 
neurons) (Mukhopadhyay et al. 2009; Colasante et al. 2015; Meganathan et 
al. 2017). 
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4.4.2 The diversification of hPSC-derived interneurons  
By tracking the differential gene expression over time an in-depth 
characterisation of genes marking the differentiation trajectory of hESC-
derived interneurons was obtained. Many of these findings were in agreement 
to previous reports from other PSC models and mouse MGE/CGE, including 
the expression of specific transcription factors (HES4/5, MEG3, DLK1, NFI B) 
by the interneuron-like progenitors (Chen et al. 2017; Close et al. 2017; 
Mayer et al. 2018). Moreover, the upregulation in expression of migratory 
cues and ion channel subunits as the population progressed towards terminal 
differentiation would indicate a close recapitulation of later stages of native 
interneuron development (Mukhopadhyay et al. 2009; Hansen et al. 2013). 
In addition, novel candidate markers of interneuron differentiation trajectory 
have also been named, including kinases (calmodulin-dependent protein 
kinase II beta, CAMK2B) and cytoskeleton regulatory proteins (PDZ and LIM 
domain 3). Furthermore, in contrast to previous reports that detected a 
gradual increase in the heterogeneity of the hPSC-derived interneuron 
population over time, this study reported a sharp increase in the 
heterogeneity between day 20 and day 35  (Xiang et al. 2017). This sharp 
transition has been proposed as the emergence of subtype dictated 
interneuron-like cells in the culture, and the depletion of MGE-like 
progenitors. The subtypes detected at day 35 were maintain over time, but 
grew in abundance between day 35 and 65. This would encourage additional 
sampling between day 20 and day 35 to fully characterise the gene 
expression changes occurring in this critical period. 
In addition to which genes are expressed, single-cell transcriptomics also 
provides information concerning the between-cell differences in the 
expression level of each gene. However, what factors caused the number of 
transcripts generated in each cell to differ, and whether this has any 
consequences on function/phenotype is uncertain, and is likely gene-
dependent. Previous reports in mouse have demonstrated the ability to 
predict particular physiology parameters of a neuron from the expression 
level of specific genes (Dehorter et al. 2015; Fuzik et al. 2015; Bardy et al.
2016). For example, the firing pattern of mouse cortical PVALB interneurons 
(either non-delayed or delayed spiking) was dependent on the protein level 
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of ER81 (Dehorter et al. 2015). This highlights the importance of not just 
which genes are expressed, but also by how much. Therefore, methods that 
allow direct manipulation over the levels of selected transcripts or proteins, 
using RNA inference or small molecule-assisted shut-off (SMASh) platforms 
respectively, may be an advantageous means to generate a more defined 
interneuron subtype composition (Chung et al. 2015; Anton et al. 2018).
4.4.3 Candidate lineage determining genes  
Finally, in-depth evaluation of genes co-expressed with PVALB, SST and CR
using single-cell RNA sequencing allowed novel candidate genes that may 
contribute to the unique phenotype and fate commitment of these 
interneuron subtypes to be named. This has included subtype-specific 
association of cyclin I with SST interneuron-like cells. Previous rodent studies 
had reported the importance of cyclins, cell cycle regulatory proteins, in 
maintaining the appropriate balance of SST and PVALB subtypes during 
development (Glickstein et al. 2007; Gilani et al. 2014). Moreover, the role 
of cyclin I as a cyclin-dependent kinase 5 (CDK5) specific activator, has 
indicated a function beyond the cell cycle. The activated CDK5 is responsible 
for regulating cytoskeleton dynamics in neuronal migration and 
synaptogenesis, as well as promoting neuronal survival (Brinkkoetter et al.
2010; Rakić et al. 2015; Shah & Lahiri 2017). Moreover, deficits in CDK5 
activity in mice has been shown to cause depletion in SST and PVALB 
interneuron subtypes, and in humans has been associated with 
neurodevelopmental disorders, including schizophrenia and intellectual 
disability (Rakić et al. 2015; Shah & Lahiri 2017). Overall, this evidence would 
support the role of cyclin I in SST (and possibly PVALB) lineage commitment. 
Another gene of interest was the transcription co-activator uniquely 
expressed by PVALB interneuron-like cells, SS18 like 2. Little research has 
been performed on SS18 like 2, with the function inferred from the role of 
the gene homologue SS18 (de Bruijn et al. 2001). Nonetheless, the predicted 
function of SS18 like 2 has been linked to chromatin remodelling, and 
therefore SS18 like 2 holds the potential to regulate the expression of a large 
number of genes, with which genes depending on the accessory proteins 
present in the cell (de Bruijn et al. 2001).
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4.4.4 Conclusions  
In summary, the series of experiments described in this Chapter have 
demonstrated the multifaceted analysis possible with single-cell 
transcriptomics. Future experiments performing enforced expression of 
named candidate lineage determining genes (cyclin I and SS18-like 2), along 
with the underrepresented (LHX6 and DLX5) genes, in hPSC-derived 
interneurons may help to refine the interneuron subtype 
composition/abundance. 
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Chapter 5 - Single-cell transcriptome analysis of primary human
foetal MGE 
5.1 Introduction
PSC-derived models of interneuronal development aim to recapitulate the 
diversification of interneurons into the spectrum of subtypes present in the 
adult brain. Such a remarkable feat has been challenging to reproduce in vitro 
(Cambray et al. 2012; Liu et al. 2013; Maroof et al. 2013; Nicholas et al.
2013; Kim et al. 2014; Sun et al. 2016). This largely stems from the lack of 
clarity concerning the when, where and how of native interneuron 
differentiation (Kessaris et al. 2014; Hu et al. 2017b; Wamsley & Fishell 
2017). As described in detail in the General Introduction (Chapter 1), there 
are several alternative models of interneuron lineage commitment that 
propose different answers to the following questions (Hu et al. 2017b; 
Wamsley & Fishell 2017). First, when do interneurons diverge into lineage 
dictated subtypes (at birth or later)? Second, where is the final fate 
determined, in the region of origin or the region of destination? Third, how 
are interneurons directed to commit to a specific lineage in favour of another?
Depending on the selected model, to answer these questions and identify the 
Holy Grail in interneuron research (lineage determining transcription factors), 
molecular characterisation of interneurons in the region of origin and 
destination at single-cell resolution has been performed (Chen et al. 2017; 
Mayer et al. 2018; Mi et al. 2018; Zhong et al. 2018; Loo et al. 2019; Mayer 
et al. 2019). 
5.1.1 Single-cell transcriptomics 
As illustrated in Chapter 4, longitudinal single-cell transcriptomics is the ideal 
tool to detect the emergence of distinct, lineage committed subpopulations 
across development (Chen et al. 2017; Mayer et al. 2018; Mi et al. 2018). 
The precise and unbiased nature of single-cell RNA sequencing allows the 
genes uniquely shared by each subpopulation to be identified, with any 
transcription factors named as candidate genes for driving lineage 
commitment (Mayer et al. 2018; Mi et al. 2018). Although several longitudinal 
single-cell transcriptomics studies have been conducted on mouse and human 
foetal derived interneurons, the ability to name candidate lineage determining 
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transcription factors has been inconsistent between studies, and only 
obtained from studies in the region of origin (Chen et al. 2017; Mayer et al.
2018; Mi et al. 2018; Zhong et al. 2018; Loo et al. 2019; Mayer et al. 2019). 
To date, single-cell profiling of the region of origin (MGE/CGE) has only been 
performed in mouse (Chen et al. 2017; Mayer et al. 2018; Mi et al. 2018).  
5.1.2 Molecular characterisation of primary mouse MGE and CGE 
Native interneuron development in mouse MGE and CGE can be monitored 
over a shorter timeframe compared to humans (a matter of weeks relative to 
months). Thus, making longitudinal analysis encompassing the full 
development of the MGE/CGE a more achievable task in rodent models (Chen 
et al. 2017; Mayer et al. 2018; Mi et al. 2018). As a result, a large body of 
research concerning interneuron development has been obtained from rodent 
models (Marín et al. 2000; Kessaris et al. 2014).
A comparative assessment of the primary mouse CGE and (dorsal and 
ventral) MGE profiles during embryonic development revealed region-specific 
markers, some novel markers and some previously reported from 
immunostaining and bulk-QPCR (Butt et al. 2005; Wonders et al. 2008; 
Miyoshi et al. 2010; Miyoshi et al. 2015; Mayer et al. 2018; Mi et al. 2018). 
Mouse CGE-derived population abundantly expressed forkhead box P2 
(Foxp2), prospero homeobox 1 (Prox1), Meis2, 5ht-r 3a, and Nfi b (Mayer et 
al. 2018; Mi et al. 2018). Whereas, mouse MGE had an enrichment of Nkx2.1, 
Lhx6, Hes5, Mef2c, Patched (Ptch1) and Lhx8 (Mayer et al. 2018; Mi et al.
2018). These named markers were either absent or at low abundance in the 
alternative region (Mayer et al. 2018; Mi et al. 2018). Although there were 
distinctions in the expression profile of the MGE and CGE-derived populations, 
some similarities were observed. Of significance was the overlap in gene 
expression profile between the dorsal subdomain of the MGE and CGE, 
especially in terms of shared Couptf II and Sst expression (Mayer et al. 2018; 
Mi et al. 2018).
Furthermore, evidence of the biased commitment of progenitors born in CGE 
and MGE was detected in the single-cell RNA sequencing analysis. Firstly, in 
the detection of different variety and abundance of subtype marker 
expressing cells in the MGE and CGE, which included Sst and Npy (more 
abundant in MGE), and Vip and Reln (more abundant in CGE) (Mayer et al.
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2018). Secondly, transcription factors selectively associated with committed 
PVALB and SST interneurons were identified and named as candidate lineage 
determining transcription factors (Maf for SST lineage and Mef2c for PVALB
lineage) (Mayer et al. 2018; Mi et al. 2018).
5.1.3 Age-dependent changes in primary mouse MGE and CGE  
Although there was a clear origin-dependent distinction in single-cell 
expression profiles,  age-dependent changes were well conserved between 
the CGE and MGE. Over time, the primary mouse MGE and CGE populations 
transitioned towards a more heterogeneous, post-mitotic neuronal rich 
population (Chen et al. 2017; Mayer et al. 2018; Mi et al. 2018). At each 
developmental age the MGE/CGE neuronal population included neuronal 
committed cells, from highly proliferative progenitors to migratory immature 
interneurons (Chen et al. 2017; Mayer et al. 2018; Mi et al. 2018). The 
emergence of additional and distinct immature interneuron subpopulations 
over time led to the greater heterogeneity observed in the older MGE/CGE 
populations (Chen et al. 2017; Mayer et al. 2018; Mi et al. 2018). 
Moreover, fate mapping studies characterising the grafts obtained from 
temporally distinct MGE/CGE tissues (E13.5 and E15.5) have demonstrated 
the differential lineage commitments of MGE/CGE progenitors born at 
different ages of development (Butt et al. 2005; Inan et al. 2012). This has 
extended the view on age-dependent changes in the MGE/CGE beyond 
maturation to also reflect the temporal dynamics in the differentiation 
potential of MGE and CGE progenitors  (Chen et al. 2017). Therefore, 
longitudinal single-cell characterisation of the MGE and CGE over 
development could tease apart the differences between early and late-born 
progenitors, and lead to the identification of lineage determining transcription 
factors for additional subtypes. For example, this could be particularly 
relevant to determining the genes underpinning the divergence of progenitors 
into SST or PVALB committed cells in the MGE, which in mouse have shown 
to have an age-dependent regulation (early-born, SST bias, late-born PVALB 
bias) (Inan et al. 2012; Bandler et al. 2017). 
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5.1.4 Species differences and importance of primary human tissue 
studies
The studies described above in rodents have provided invaluable information 
concerning native MGE and CGE development, and helped fill the unknown 
gaps of human neurodevelopment, which (due to the legal restriction) cannot 
be monitored in the same complete manner (Chen et al. 2017; Mayer et al.
2018; Mi et al. 2018). With promising findings from the mouse work, 
longitudinal single-cell RNA sequencing analysis of human MGE and CGE is 
eagerly awaited. The importance of carrying out the parallel analysis in 
human foetal tissue has been demonstrated by between-species differences 
in interneuron abundance and diversity (Wu & Parent 2000; Bakken et al.
2016; Lake et al. 2016; Boldog et al. 2018). Therefore, rodent models may 
only provide an incomplete picture of interneuron development in human. 
This has encouraged, for the first time, the characterisation of human MGE 
using single-cell RNA sequencing in this study. Previous studies characterising 
human ganglionic eminence have guided a timeframe of 10WPC to 15WPC for 
the analysis (Zecevic et al. 2011; Reinchisi et al. 2012; Hansen et al. 2013; 
Onorati et al. 2014; Al-Jaberi et al. 2015).
5.2 Aims
To characterise native interneuron development by performing longitudinal 
single-cell RNA sequencing analysis on human MGE (10WPC to 15WPC).
To identify potential temporal and subtype-dependent gene expression 
signatures in the MGE population.
To evaluate the authenticity of the hPSC model of interneuron differentiation 
by performing a cross-comparison between the human MGE and hESC-
derived interneuron single-cell RNA sequencing data. 
5.3 Results 
Single-cell RNA sequencing analysis was conducted on human primary MGE 
tissue aged from 10WPC to 15WPC. The same single-cell capture 
methodology (Fluidigm C1) and reaction chemistry (SMART-seq) were used 
as the single-cell work described previously for hESC-derived interneurons 
(Chapter 4), thereby making tissue source the only changed factor. 
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5.3.1 The human MGE samples had consistently low contamination by 
neighbouring CGE and LGE regions 
Before performing single-cell transcriptome analysis on human primary foetal 
tissue, pilot data was generated to determine whether the MGE was being 
consistently and accurately dissected from neighbouring CGE and LGE 
regions. This analysis was performed at both the RNA and protein level. 
Additionally, the collection of primary tissue samples aged between 9WPC 
and 15WPC (≥3 foetuses per age) for QPCR analysis enabled a bulk-level 
evaluation of the age-dependent changes in expression trajectory of known 
MGE, CGE and LGE markers (in Appendix folder 3 figures). 
Bulk-QPCR analysis on human MGE, CGE and LGE from the same foetal tissue 
source was performed across 10WPC to 15WPC period (Figure 5.1A and
Appendix folder 3 figures). As examples, only data from the 15WPC MGE 
samples have been provided (Figure 5.1A). From this data set the appropriate 
expression pattern of both transcription factors and post-mitotic markers 
across regions was demonstrated (Figure 5.1A). For example, MGE-specific 
transcription factors, NKX2.1, LHX8 and LHX6, were consistently higher 
expressed (relatively lower average delta Ct value) in MGE than the other 
regions (Figure 5.1A). This trend was also true for MGE-derived subtype 
marker PVALB, although SST expression level was similar between CGE and 
MGE (Figure 5.1A). In addition, COUPTF II expression level in 15WPC MGE 
matched the level of expression in the CGE (average delta Ct of 4.5, Figure 
5.1A). Although the MGE contains COUPTF II expressing cells (typically 
restricted to the dorsal subdomain), the high level of COUPT II would suggest 
a possible CGE contamination of the MGE (Figure 5.1A). The low levels of 
contamination reported here, and seen in other cases (LHX6 and SOX6 levels, 
Figure 5.1A) may be assigned to the migratory interneuron precusors, which 
were migrating through neighbouring region at time of collection. 
Independent analysis was conducted at protein level by performing 
immunohistochemistry, using a single foetal tissue per age at 10WPC and 
15WPC (Figure 5.1B-5.1C and Appendix folder 3 figures). As examples, only 
data from the 15WPC MGE samples have been provided in Figure 5.1B-5.1C. 
In a similar manner to the bulk-QPCR data, the seeded 15WPC MGE, CGE and 
LGE samples were checked for the abundance of region-specific markers in 
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the population, along with common pan-ganglionic markers (Figure 5.1B-
5.1C). The predicted expression patterns were seen in the immunostainings, 
with 15WPC MGE population relatively sparse in LGE-markers (<5% FOXP1 
and DARPP32) relative to LGE (20% FOXP1, 5% DARPP32, Figure 5.1C). 
Moreover, the MGE exhibited a higher abundance of NKX2.1, SST and ChAT 
positive cells than CGE or LGE (Figure 5.1C). The similar abundance of CR 
positive cells (25%) in MGE and CGE samples may be due to migratory CGE-
derived CR interneuron precursors being located in the MGE at age of 
collection, although CR interneurons are derived from both regions (Figure 
5.1C).
By using two complementary approaches, the expression patterns in the 
MGE, CGE and LGE were consistent with the known expression profile of these 
regions, which indicated accurate dissection of each region. However, due to 
the migratory nature of interneuron precursors, low level of contamination 
from CGE should be expected and taken into account when analysing the
single-cell RNA sequencing data. 
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Figure 5.1 Primary human foetal tissue characterisation of MGE, CGE and 
LGE: pilot data.
A) Molecular characterisation of primary human MGE, CGE and LGE – at RNA level, 
at 15WPC. The data has been presented in the form of expression level provided as 
an average delta Ct, along with +/- SEM. The delta Ct was calculated in reference to 
beta-actin as the standard housekeeping gene. Minimum biological replicates 
(independent foetal tissue) n=3. Technical replicates n=3. 
B) Molecular characterisation of primary human MGE, CGE and LGE cultures– at 
protein level, at 15WPC. The isolated tissues were seeded and maintained for 2-3 
days in vitro before fixing. The data has been presented in the form of a panel of 
deconvoluted images for the immunostaining against CR (green) and COUPTF II 
(purple). The CGE, MGE and LGE were obtained from the same source. Biological 
replicates (independent foetal tissue) n=1. Minimum technical replicates n=6. The 
total number of cells counted per technical replicate can be found in Appendix folder 
7. 
C) Molecular characterisation of primary human MGE, CGE and LGE cultures– at 
protein level, at 15WPC. The isolated tissues were seeded and maintained for 2-3 
days in vitro before fixing. The graph shows the mean percentage of marker 
expressing cells out of the total cell population (total cell count measured using DAPI 
count), along with +/- SEM. The CGE, MGE and LGE were obtained from the same 
source. Biological replicates (independent foetal tissue) n=1. Minimum technical 
replicates n=6. The total number of cells counted per technical replicate can be found 
in Appendix folder 7. 
CGE, caudal ganglionic eminence. MGE, medial ganglionic eminence. LGE, lateral 
ganglionic eminence. WPC, weeks post-conception. NeuN, neuronal nuclei. SST, 
somatostatin. PVALB, parvalbumin. CR, calretinin. NK2 Homeobox 1, NKX2.1. COUP 
transcription factor 2, COUPTF II. ChAT, choline acetyltransferase. GAD1, glutamate 
decarboxylase 1. MAP2, microtubule-associated protein 2. DARPP32, dopamine- and
cAMP-regulated neuronal phosphoprotein. FOXP1, Forkhead Box P1. FOXG1, 
Forkhead Box G1. LHX6, LIM Homeobox 6. LHX8, LIM Homeobox 8. DLX5, Distal-less 
homeobox 5. COUP-TF-Interacting Protein 2, CTIP2. SRY-Box 6, SOX6. Gamma-
aminobutyric acid-ergic, GABAergic. SEM, standard error of the mean. 
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5.3.2 A discrete set of interneuron subtypes emerged within the 
human MGE
Initial inspection of the single-cell RNA sequencing data began with each of 
the MGE samples being checked for the expression of known MGE and CGE 
markers (Figure 5.2A-5.2B).  The proportion of marker expressing cells was 
then averaged for the entire data set (MGE samples of all ages) to provide a 
principal characterisation of the human MGE (Figure 5.2A-5.2B).  The human 
MGE (10WPC to 15WPC) had a large population of NKX2.1 expressing cells, 
which equated to an average of 60% across samples (Figure 5.2E). Out of 
these NKX2.1 expressing cells there was high co-expression within known 
late MGE markers, including DLX1/5 and LHX6 (Figure 5.2A). This would 
indicate that the MGE had a larger proportion of transitioning progenitors and 
interneuron precursors (LHX6, DLX5 expressing), then early proliferating 
progenitors (NKX2.1 expressing) during this developmental period. 
Furthermore, the detection of NKX2.1/LHX6 and NKX2.1/COUPTF II co-
expressing subpopulations likely corresponded to ventrally and dorsally 
located MGE progenitors respectively, with a good representation of both in 
the samples (Figure 5.2A). On characterising the post-mitotic neuronal 
population obtained from all MGE samples, NPY was the most abundant 
subtype marker (60%), followed by SST (30%) and CR (10%) (Figure 5.2B). 
In addition to NPY neurons, co-expression of NPY with SST and CR were also 
detected in the population, although these subpopulations were rarer than 
the NPY expressing interneurons without a secondary subtype marker (Figure 
5.2B). SST/CR co-expressing neurons were also detected in the population 
(5%), and were likely derived from the dorsal MGE NKX2.1/COUPTF II co-
expressing subpopulation described above (Figure 5.2B). Whereas, the 
proportion of CGE-derived interneuron subtype markers, VIP, CCK, RELN and 
nNOS, and late MGE-derived interneuron subtype marker PVALB were at low 
abundance (<5%) or absent across samples (Figure 5.2B). Moreover, no
MAP2 positive cells were found to express the CGE restricted marker 5HT-R 
3A (Figure 5.2B). The favoured expression of NPY and SST would indicate a 
high proportion of MGE-derived interneurons in each sample, with little 
contamination from the CGE (which was in agreement to pilot data presented 
above, Figure 5.1A-C).  
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To further explore the molecular profile of interneuron subtypes in the MGE 
sample, the three most abundant subtypes detected, SST, NPY and CR, were 
compared to identify genes uniquely expressed by each one (Appendix folder 
3). These genes included transcription factors that may have directed the 
lineage, for example S-phase kinase associated protein 1 (SKP1) was 
uniquely expressed by NPY interneurons (Appendix folder 3). Many of the 
genes uniquely co-expressed with SST or CR interneurons were also identified 
in hESC-derived interneuron analysis (Chapter 4), and included intracellular 
signalling proteins (GNAS complex locus, small EDRK-rich factor 2 , casein 
kinase 1 epsilon), chaperons (heat shock protein 90 alpha family class B 
member 1)  and cytoskeletal motor proteins (dynein light chain LC8-type 1) 
(Appendix folder 3). This would provide an initial favourable comparison 
between the in vitro and in vivo derived interneurons. 
5.3.3 The human MGE was composed of a diverse population 
The molecular heterogeneity within the human MGE for each developmental 
age sampled has been represented in a series of tSNE plots (Figure 5.2C). 
Within each time point there appeared to be two or three distinct clusters 
(labelled C1, C2 or C3, Figure 5.2C). Each cluster represented a molecularly 
distinct subpopulation in the MGE, with the cluster size and degree of 
segregation of each subpopulation variable (Figure 5.2C). This would indicate 
that some single-cell expression profiles were rarer, and showed greater 
differences to others. The full list of differentially expressed genes between 
clusters for each age can be found in Appendix folder 3, with a single example 
of highly differentially expressed genes shown in Figure 5.2C. To explore 
heterogeneity based on between-subject variability, tSNE plot was generated 
for the two independently sourced 12WPC MGE samples A and B (Figure 
5.2C). The tSNE plot showed a general clustering pattern based on foetal 
tissue source (A or B), indicating a molecular heterogeneity largely driven by 
between-subject variability (Figure 5.2C). This would encourage a greater 
number of independent samples to be used in future experiments to limit the 
effects of between-subject variability clouding the outcome of the data 
analysis. 
Finally, when all the MGE single-cell samples from 10WPC to 15WPC were 
analysed together to generate a single tSNE plot, the samples were found to 
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be broadly overlapping in gene expression profiles (Figure 5.2D). As seen in 
Figure 5.2D, single-cell samples from each time point distributed themselves 
into a least two visible clusters, with samples from each time point present in 
both subpopulations, although with a slight age-dependent bias. This may 
represent a division according to the maturity of the MGE cells, because 
samples from earlier developmental ages (10WPC and 12WPC derived MGE) 
were more abundant in one cluster (bottom right cluster) and 14WPC-15WPC
derived MGE single-cells were more abundant in the other (top left cluster) 
(Figure 5.2D). This would suggest that there were differences in gene 
expression profiles based on the age of the sample. 
5.3.4 Subtype dictated subpopulations become more abundant over 
time, adding to the age-dependent heterogeneity 
At each time point there was a mix of single-cell profiles belonging to neuronal 
and non-neuronal (glial precursors) lineages. For example, single-cell 
subpopulations were found to be segregated according to the differential 
expression of meteorin, a glial cell differentiation regulator (Appendix folder 
3 table 11 for full list of genes). 
Single-cell RNA sequencing data detected variability between cells, at each 
time point and across samples, in terms of the expression level of MGE-
specific markers and the proportion of cells expressing these markers in the 
population (Figure 5.2E-F). In particular, the proportion of COUPTF II
expressing cells decreased in older samples, which may reflect a slight ventral 
bias in the dissection of the older MGE samples (especially 14WPC) (Figure 
5.2E-F). LHX8 average TPM values and abundance of LHX8 expressing cells 
showed a progressive decline over developmental age (Figure 5.2E). The 
depletion of MGE-derived subpopulation expressing LHX8 from 12WPC 
onwards may represent a temporal shift in the lineage commitment of 
progenitors over this period, as LHX8 is strongly associated with ChAT 
interneuron lineage (which were not abundantly detected in these samples). 
LHX6 and NKX2.1 showed a mirrored change in abundance over the 
developmental period, which would support previous reports demonstrating  
NKX2.1-driven upregulation of LHX6 expression in MGE progenitors (Figure 
5.2E). 
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Further variability was detected in the expression of interneuron subtype 
markers, NPY, CR and SST (Figure 5.2F). CR expressing cells (out of MAP2) 
progressively increased in abundance between 13WPC to 15WPC (from 
approx. 10% to 35%, Figure 5.2F). The increase in CR positive population 
was also accompanied by CR average transcript level increasing (Figure 5.2F). 
A similar trajectory was reported for NPY, which was the most abundant 
subtype present at each time point (peaking at 85% at 15WPC), and 
progressively increased in abundance over time (Figure 5.2F). Furthermore, 
the transcript levels of NPY were, in general, the highest at each time point 
relative to CR and SST (Figure 5.2F). Whereas, between 10WPC to 15WPC 
samples, SST abundance and average transcript levels typically remained 
consistent at approximately 30-40% abundance and 100 TPM expression 
level, with only a large deviation from this range at 13WPC (Figure 5.2F). This 
may be due to between-subject variability, as only a single independent foetal 
tissue sample was used for this time point.
In conclusion, although each sample had a full spectrum of cells along 
interneuron development, from highly proliferative early MGE progenitors 
(SOX2, NKX2.1, FOXG1 positive), to immature interneurons (NPY, SST, CR
expressing), older MGE samples had a greater abundance of the latter (Figure 
5.2E-5.2F).
5.3.5 The developmental trajectory of the MGE could be distilled 
down to a shortlist of differentially expressed genes 
To identify the genes significantly differentially expressed across the 
developmental period, a series of pairwise ANOVAs were carried out between 
samples (Figure 5.2G). Only pairwise comparisons made relative to 10WPC 
have been presented here, although the full list for all pairwise comparisons 
can be found in Appendix folder 3 (Figure 5.2G). Any genes shown as a 
positive fold change (upregulated over time) were relatively higher expressed 
at later developmental ages (e.g. 15WPC in 10WPC vs 15WPC comparison). 
The reciprocal is true for genes assigned a negative fold change value 
(downregulated over time), which were relatively higher expressed at 10WPC 
(Figure 5.2G). In general, only a small number of genes (<6) were found to 
be significantly differentially expressed between 10WPC MGE population and 
older samples, with the exception being for the 10WPC and 15WPC 
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comparison (Figure 5.2G). This would suggest that only a small temporally-
induced change had occurred in MGE profile over 10WPC to 14WPC period. 
Whereas, a relatively greater age-dependent transition had occurred by 
15WPC in the MGE, with 14 genes detected as significantly differentially 
expressed between 10WPC and 15WPC sample (Figure 5.2G). A small 
proportion of these genes presented in Figure 5.2G had also been detected 
as differentially expressed in other pairwise comparisons, including X inactive 
specific transcript (XIST, highest upregulated gene at 13WPC, 14WPC and 
15WPC) and cyclin D1 (CCND1, the highest downregulated gene at 13WPC, 
14WPC and 15WPC) (Figure 5.2G). Many of the uniquely differentially 
expressed genes between 10WPC and 15WPC MGE samples encoded for 
transcription factors, which were downregulated at 15WPC (relative to
10WPC) (Figure 5.2G). Theses transcription factors included, CAMP 
responsive element binding protein 5 (CREB5) and nuclear receptor subfamily 
2 group E member 1 (NR2E1), and may be linked to the temporal dynamics 
of gene expression in MGE ventricular zone responsible for generating 
progenitors committed to different lineages (Figure 5.2G). Therefore, these 
identified transcription factors add to the list of candidate lineage determining 
transcription factors, although which lineage was undetermined. 
Additional genes identified as differentially expressed relative to 10WPC 
sample were associated with specific signalling pathways, including insulin-
like growth factor binding protein 2 (IGFBP2), neuroendocrine signalling 
protein secretogranin V, and activin and BMP4 signalling inhibitor, follistatin 
like 1 (Figure 5.2G). These signalling pathways may act indirectly to alter 
gene expression, and could potentially have a critical role in directing 
interneuron fate.
Moreover, many of the downregulated genes (relative to 10WPC) were 
related to RNA and protein synthesis (Figure 5.2G). These genes included the 
enzyme responsible for the conversion of deoxyribonucleotides from 
ribonucleotides, ribonucleotide reductase regulatory subunit M2 (RRM2), 
membrane trafficking protein Yip1 interacting factor homolog B (YIF1B) and 
adaptor related protein complex 1 subunit sigma 2 (AP1S2) responsible for 
protein sorting in trans-Golgi/endosomes (Figure 5.2G). The relatively higher 
expression of these genes at 10WPC would indicate the transition from a 
140
population abundant in proliferating progenitors at 10WPC, to a population 
with a greater proportion of immature interneurons (which have a reduced 
rate of both transcription and translation) by 15WPC.
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Figure 5.2 Single-cell RNA sequencing analysis of primary human foetal 
MGE.
A-B) Molecular characterisation of primary human MGE– at single-cell RNA level, total 
for all MGE samples (10WPC -15WPC). The graph plotted shows the proportion of 
cells expressing each named marker. The marker positive cells have been counted if 
the cells also co-expressing 5.2A) NKX2.1 or 5.2B) MAP2, to restrict analysis to MGE 
progenitors and post-mitotic neurons respectively. Minimum biological replicates 
(independent foetal tissue per age) n=1. 5.2A) Total number of cells expressing 
NKX2.1 =253. 5.2B) Total number of cells expressing MAP2 = 403 cells. 
C-D) tSNE plot of the relative similarity in single cell profiles of primary human MGE 
at 10WPC, 12WPC, 13WPC, 14WPC, 15WPC. Each symbol on tSNE plot represents a 
single cell and the unique gene expression profile of the cell (based on single-cell 
RNA sequencing data available, trimmed to top 400 genes). 5.2C) Each cluster
uniquely labelled with cluster number (e.g. C1) and an example of a highly expressed
gene unique to this cluster (where an example exists). For full list of differentially 
expressed genes between cluster see Appendix folder 3 table 11. 5.2D) All samples 
presented on a single tSNE plot. Cells from the same MGE sample share the same 
symbol (e.g. all 12WPC MGE from sample A cells are represented by red open circle). 
Minimum biological replicates (independent foetal tissue per age) n=1. Total number 
of cells per age can be found in Appendix folder 3 table 10. 
E) Trajectory of primary human MGE/CGE markers – at RNA level, at 10WPC, 12WPC, 
13WPC, 14WPC, 15WPC. The data has been presented as a quantification of the 
expression level of selected markers (TPM) and the proportion of cells expressing 
each named marker. On the graph displaying the TPM values, each symbol plotted 
represents the expression value of that marker for a single cell. Minimum biological 
replicates (independent foetal tissue per age) n=1. Total number of cells per age can 
be found in Appendix folder 3 table 10. 
F) Trajectory of primary human MGE derived interneurons subtypes – at RNA level, 
at 10WPC, 12WPC, 13WPC, 14WPC, 15WPC. The data has been presented as a 
quantification of the expression level of selected markers (TPM) and the proportion 
of cells expressing each subtype marker. On the graph displaying the TPM values, 
each symbol plotted represents the expression value of that marker for a single cell. 
The marker positive cells have been counted if the cells also co-expressed MAP2, to 
restrict analysis to post-mitotic neurons. Minimum biological replicates (independent 
foetal tissue per age) n=1. Total number of MAP2 expressing cells per age: 81 cells 
10WPC, 125 cells 12WPC, 75 cells 13WPC, 64 cells 14WPC and 59 cells 15WPC.
G) Relative fold change in expression of genes significantly differentially expressed 
between 10WPC and 12/13/14/15 WPC. Differentially expressed genes were 
determined through ANOVA pairwise analysis, and were included if p<0.05 and fold 
change (either up or downregulated) >4. In this plot, any genes upregulated had a 
relatively higher expression at the later age (e.g. 15WPC in 10WPC vs 15WPC 
comparison) and were shown as a positive fold change. Any downregulated genes 
were higher expressed at 10WPC (relative to the later age in the pair) and were 
shown as a negative fold change. See Appendix folder 3 tables for list. Minimum 
biological replicates (independent foetal tissue per age) n=1. Total number of cells 
per age can be found in Appendix folder 3 table 10. 
Single independent source of tissue for each age of primary human MGE, except for 
12WPC which had two independent tissues (labelled A and B). TPM, transcripts per 
million. WPC, weeks post-conception. NK2 Homeobox 1, NKX2.1. COUP transcription 
factor 2, COUPTF II. LHX6, LIM Homeobox 6. FOXG1, Forkhead Box G1. SST, 
somatostatin. PVALB, parvalbumin. CR, calretinin. LHX8, LIM Homeobox 8. DLX5, 
Distal-less homeobox 5. DLX1, distal-less homeobox 1. MAP2, microtubule-
associated protein 2. Serotonin receptor 3A, 5HT-R 3A. Vasoactive intestinal peptide, 
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VIP. Reelin, RELN. Neuropeptide Y, NPY. Neuronal nitric oxide synthase, nNOS. MGE, 
medial ganglionic eminence. Adaptor related protein complex 1 subunit sigma 2, 
AP1S2. CAMP responsive element binding protein 5, CREB5. Coiled-coil domain 
containing 25, CCDC25. Insulin like growth factor binding protein 2, IGFBP. Interferon 
induced transmembrane protein 3, IFITM3. Microsomal glutathione S-transferase 1, 
MGST1. Ribonucleotide reductase regulatory subunit M2, RRM2. X inactive specific 
transcript, XIST. Yip1 interacting factor homolog B, membrane trafficking protein, 
YIF1B. GABA type A receptor-associated protein, GABARAP. Calmodulin 3, CALM3.
H2A.Z variant histone 1, H2AFZ. Small integral membrane protein 26, SMIM26. Small 
nuclear ribonucleoprotein D2 polypeptide, SNRPD2. CDC28 protein kinase regulatory 
subunit 2, CKS2. Distal-less homeobox 6 antisense 1, DLX6-AS1. High mobility group 
box 2, HMGB2. Stathmin 2, STMN2.
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5.3.6 The MGE derived single-cell cDNA passed quality control checks
Prior to using the single-cell cDNA in library preparation for RNA sequencing, 
multiple quality control measures were performed to ensure the material for 
sequencing was of high standards (Figure 5.3A-5.3D and in the Appendix 
folder 3 figures). A large body of this work involved performing single-cell 
QPCR on the human MGE derived samples. This data was primarily used as a 
means to determine the quality of the single-cell cDNA, to prevent poor 
quality samples being used in single-cell libraries for RNA sequencing.  
Moreover, the data has provided a means to detect any inconsistencies 
between the two single-cell transcriptomic approaches, as the same samples 
were used in both methodologies. Overall, the findings were consistent 
between single-cell QPCR and RNA sequencing data, with a similar co-
expression pattern trend described for each marker (Figure 5.2A and 5.3A). 
Furthermore, a hint to the heterogeneity fully explored in single-cell RNA 
sequencing analysis was also observed in the single-cell QPCR data, in terms 
of the mix of immature neurons and progenitors, and the between-cell 
differences in expression levels (delta Ct values) of specific markers (Figure 
5.3A-5.3D and Appendix folder 3 figures). 
However, there were also several differences to note. Firstly, although the 
trend may be consistent between the two methodologies, the actual reported 
proportion of marker expressing cells did not match between the two single-
cell transcriptomic data sets. For example, single-cell RNA sequencing data 
reported almost 100% co-expression of NKX2.1, FOXG1 and DLX1/5 (Figure 
5.2A). Whereas, single-cell QPCR reported only 60% of NKX2.1 expressing 
cells co-expressed FOXG1 and DLX5 (Figure 5.3A). Moreover, there was a 
higher proportion of NKX2.1/COUPTF II co-expressing cells detected by 
single-cell RNA sequencing analysis (40% vs 17%, Figure 5.2A and 5.3A). 
These discrepancies may be due to primer issues in the Biomark QPCR 
reaction causing lower efficiency in the QPCR amplification of the transcripts, 
thus impairing the detection. 
A final inconsistency of significance concerns the proportion of PVALB
expressing cells. The single-cell QPCR analysis detected PVALB expressing 
cells (including PVALB/CR and PVALB/SST co-expressing cells) in the human 
MGE samples from 12WPC onwards, although at low abundance (<10% out 
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of MAP2 positive cells) and low expression levels (>12 delta Ct) (Figure 5.3C-
5.3D). However, no PVALB expressing cells were detected at RNA level using 
single-cell RNA sequencing (Figure 5.2F). The discrepancy may have been 
caused by the lower sensitivity of single-cell RNA sequencing paradigm, 
leading to PVALB transcripts being left undetected. This leaves the question 
over whether  PVALB expressing cells were detected in the human MGE over 
this period under doubt. 
Nonetheless, the single-cell QPCR analysis confirmed the high quality of the 
single-cell cDNA samples generated, and the overall abundance of MGE-
derived cells in the sample. This conclusion enabled the samples to be carried 
forward for single-cell RNA sequencing analysis. 
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Figure 5.3 Single-cell QPCR analysis: quality control check data.
A-B) Molecular characterisation of primary human MGE– at single-cell RNA level, 
average across all MGE samples (10WPC -15WPC). The graph plotted shows the 
proportion of cells expressing each named marker. The marker positive cells have 
been counted if the cells also co-expressing 5.3A) NKX2.1 or 5.3B) MAP2, to restrict 
analysis to MGE progenitors and post-mitotic neurons respectively. Total number of 
cells expressing NKX2.1 =116 cells. Total number of cells expressing MAP2 =163 
cells. Minimum biological replicates (independent foetal tissue per age) n=1. 
C) Trajectory of primary human MGE derived interneurons subtypes – at RNA level, 
at 10WPC, 12WPC, 13WPC, 14WPC, 15WPC. The data has been presented as a 
quantification of the expression level of selected marker (delta Ct). On the graph, 
each symbol plotted represents the expression value of that marker for a single cell. 
The marker positive cells have been counted if the cells also co-expressed MAP2, to 
restrict analysis to post-mitotic neurons. Total number of cells expressing MAP2 at 
each age = 48 cells 10WPC, 48 cells 12WPC, 35 cells 13WPC,13 14WPC and 19 cells 
15WPC.  Minimum biological replicates (independent foetal tissue per age) n=1. 
D) Trajectory of primary human MGE derived interneurons subtypes – at RNA level, 
at 10WPC, 12WPC, 13WPC, 14WPC, 15WPC. The data has been presented as the 
proportion of cells expressing each subtype marker. The marker positive cells have 
been counted if the cells also co-expressed MAP2, to restrict analysis to post-mitotic 
neurons. Total number of cells expressing MAP2 at each age = 48 cells 10WPC, 48 
cells 12WPC, 35 cells 13WPC,13 14WPC and 19 cells 15WPC. Minimum biological 
replicates (independent foetal tissue per age) n=1. 
Single independent source of tissue for each age of primary human MGE, except for 
12WPC which had two independent tissues (samples A and B) and have been 
averaged. NK2 Homeobox 1, NKX2.1. COUP transcription factor 2, COUPTF II. LHX6, 
LIM Homeobox 6. FOXG1, Forkhead Box G1. SST, somatostatin. PVALB, parvalbumin. 
CR, calretinin. LHX8, LIM Homeobox 8. DLX5, Distal-less homeobox 5. DLX1, distal-
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less homeobox 1. MAP2, microtubule-associated protein 2. MGE, medial ganglionic 
eminence. WPC, weeks post-conception. 
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5.3.7 Cross-comparison to hESC-derived interneurons revealed a 
large source-dependent difference in expression profiles   
The single-cell RNA sequencing data described in Chapter 4 for hESC-derived 
interneurons (day 20-day 65) and this Chapter were combined to allow a 
comparative assessment of the native human MGE molecular profile to one 
obtained in vitro (Figure 5.4A-5.4C). Analysis began by a comparison of all 
single-cell samples, in a single tSNE plot, to visualise the degree of similarity 
in single-cell expression profiles from the human MGE and hESC-derived 
interneuron cultures over time (Figure 5.4A).  As seen in Figure 5.4A, all 
single-cells derived from the same source (human foetal MGE or hESC) 
shared a greater similarity in gene expression profiles, which led to the 
segregation of all MGE derived samples (bottom right) from all hESC-derived 
interneurons derived samples (top left). However, the hESC-derived 
interneuron cluster was more disperse, forming three divisions within (Figure 
5.4A).   The wider clustering pattern on the tSNE plot would imply a greater 
molecular heterogeneity in the gene expression profile of hESC-derived 
interneurons between day 20 to day 65, relative to the differences in the 
molecular profile of MGE-derived populations between 10WPC to 15WPC 
(Figure 5.4A).   This is not surprising as the in vitro cultures showed a much 
sharper transition over the sample period, from one abundant in MGE-like 
proliferating progenitors at day 20, to an abundant post-mitotic interneuron-
like population by day 35 onwards (see Chapters 3 and 4). Whereas, the 
single-cell expression profiles of the human MGE would suggest a greater 
consistency in the progenitor vs neuron population ratio, with a gradual rise 
in the neuronal population over time (Figure 5.2F). 
Ultimately the clustering pattern on the tSNE plot was underpinned by a large 
number of differentially expressed genes (>150) between MGE and hESC-
derived interneuron samples (Figure 5.2B-5.2C). These genes were identified 
through a series of pairwise ANOVAs between human MGE samples and hESC-
derived interneuron samples, which named between 150-200 significantly 
differentially expressed genes (Appendix folder 4 tables). This number of 
differentially expressed genes was much greater than any other pairwise 
comparisons made between samples from the same source (<40 genes). 
Hence, the differences between the two sources outweighed the expression 
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profile changes observed in relation to age of MGE/time along the 
differentiation protocol. 
5.3.8 Post-mitotic interneuron-like cells showed the greatest 
resemblance to 15WPC MGE 
To investigate whether any particular subpopulation of hESC-derived 
interneurons, generated across the differentiation paradigm, showed greater 
resemblance to a particular age of MGE, the two most molecularly distinct 
MGE ages (10WPC and 15WPC) were compared in turn to all hESC-derived 
samples (Figure 5.4B-5.4E and Appendix folder 4 tables). The comparison 
involved performing pairwise ANOVAs. As predicted from the source-
dependent clustering pattern on the tSNE plot of hESC-derived interneurons 
and 10WPC MGE, a large number of genes were identified as differentially 
expressed between 10WPC and in vitro samples (>150 genes) (Figure 5.4B-
5.4C). Due to the large number of genes, only the differentially expressed 
genes within the top 5 highest fold changes (in both directions) relative to 
10WPC MGE have been shown as examples in Figure 5.4C (full list in Appendix 
folder 4 tables). All genes assigned a positive fold change value were 
significantly higher expressed in hESC-derived interneuron sample (in vitro) 
relative to 10WPC MGE (Figure 5.4C). Many of the genes with relatively higher 
expression in vitro were repeatedly detected across pairwise comparisons, 
and included calcyon neuron specific vesicular protein (CALY), developmental 
pluripotency associated 4 (DPPA4) and interferon induced transmembrane 
protein 2 (IFITM2) (Figure 5.4C). This would indicate a similar mis-match in 
the single-cell expression profiles of 10WPC MGE to each hESC-derived 
interneuron sample (independent of time along differentiation). The genes 
that showed a negative fold change in expression (relatively higher expressed 
in 10WPC MGE), in general encoded for transcription factors, such as NFI B, 
maternally expressed gene 3 (MEG3, maternally imprinted gene), DLX5, 
HES5, and POU Class 3 Homeobox 4 (POU3F4) (Figure 5.4C). The failure to 
induce as high expression of these transcription factors in vitro may link to 
the inability to achieve the wide-diversity of MGE-derived interneuron 
subtypes in the culture (especially NPY expressing neurons). 
On the other hand,  15WPC MGE single-cell gene expression profiles showed 
a higher resemblance to hESC-derived interneurons, in particular, a 
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subpopulation abundant in day 35 and day 65 cultures (Figure 5.4B and 
5.4D). Although there were still a large number of differentially expressed 
genes between 15WPC MGE and hESC-derived interneuron samples (approx. 
150 genes), the smallest number was detected between day 65 samples and 
15WPC MGE (Appendix folder 4, table 16). This was reflected in the closer 
clustering of these two samples on the tSNE plot (Figure 5.4D).  Certain genes 
were consistently found to be relatively higher or lower expressed in all hESC-
derived interneuron samples relative to 15WPC MGE, and these were distinct
from those described for 10WPC MGE comparisons (Figure 5.4C and 5.4E). 
The genes relatively higher expressed in vitro included, calcium/calmodulin-
dependent protein kinase II beta (CAMK2B), neurotrophic factor serpin family 
F member 1 (SERPINF1), FGF2 signalling inhibitor sprouty RTK signalling 
antagonist 2 (SPRY2), calcium signalling proteins S100 beta (S100B) and 
S100 A13 (S100A13) (Figure 5.4C). 
As previously reported for 10WPC MGE pairwise comparisons (Figure 5.4C), 
a large number of the genes identified as relatively higher expressed in 
15WPC MGE were transcription factors (MEG3, DLX5, NFI B, POU3F4) (Figure 
5.4E). As these transcription factors were repeatedly named in both 10WPC 
and 15WPC comparisons, this finding would emphasise the importance of 
these transcription factors in native human MGE development (Figure 5.4C 
and 5.4E). Similarly, a gene consistently detected across all MGE vs hESC-
derived interneuron comparisons, and found to be under-represented in vitro, 
encoded for the paternally imprinted gene, neuronatin, which encoded for a 
neuronally expressed proteolipid (Figure 5.4C and 5.4E). The relatively lower 
expression of neuronatin (up to 1000-fold) in vitro may reflect the inability to 
generate this particular native MGE subpopulation (restricted to lateral MGE 
border) in the hESC-derived interneuron culture (Figure 5.4C and 5.4E).  
In summary, encouraging similarities were found between 15WPC human 
MGE and post-mitotic interneurons-like cells generated in the in vitro model, 
at the molecular level (Figure 5.4D). Although, neither 10WPC or 15WPC MGE 
sample shared many similarities in expression profile with the day 20 MGE-
like progenitors enriched culture, likely due to the limited capability of the in 
vitro differentiation paradigm to induce the expression of certain transcription 
factors (MEG3, DLX5, POU3F4, NFI B) as potently as in the MGE.  
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Figure 5.4 Cross-comparison to hESC-derived interneuron single-cell RNA 
sequencing data.
A) tSNE plot of the relative similarity in single cell profiles of hESC-derived 
interneurons and human foetal MGE – all time points and samples combined. Each 
symbol on tSNE plot represents a single cell and the unique gene expression profile 
of the cell. Cells from the same time point along differentiation paradigm/ foetal 
tissue sample share the same symbol (e.g. all day 20 cells are represented by red 
open circle). Clusters of symbols on tSNE plot represent cells with higher similarity 
in gene expression profile. Minimum biological replicates for MGE, n=1. Biological 
replicates for in vitro differentiations n=2. Total number of cells per time point/age 
can be found in Appendix folder 2 table 4 and 3 table 10. 
B) tSNE plot of the relative similarity in single cell profiles of hESC-derived 
interneurons and human foetal MGE 10WPC. Cells from the same time point along 
differentiation paradigm or from 10WPC foetal tissue sample share the same symbol 
(e.g. all day 20 cells are represented by red open circle). Clusters of symbols on tSNE 
plot represent cells with higher similarity in gene expression profile. Biological 
replicates for 10WPC MGE, n=1. Biological replicates for in vitro differentiations n=2. 
Total number of cells per time point/age can be found in Appendix folder 2 table 4 
and 3 table 10. 
C) Relative fold change in expression of genes significantly differentially expressed 
between primary foetal MGE at 10WPC and hESC-derived interneurons. DEGs were 
determined through ANOVA pairwise analysis, and were included if p<0.05 and fold 
change (in either direction) >4. In the graphs only the top 5 DEGs in both directions 
(higher in vitro or in vivo) have been shown as examples (due to the large number 
of DEGs). The full list can be found in the Appendix folder 4. Genes with a relatively 
higher expression in hESC-derived interneuron sample (compared to 10WPC MGE) 
were shown as a positive fold change. Any genes with a relatively higher expression 
in 10WPC MGE (compared to hESC-derived interneuron sample) were shown as a 
negative fold change. Biological replicates for 10WPC MGE, n=1. Biological replicates 
for in vitro differentiations n=2. 
D) tSNE plot of the relative similarity in single cell profiles of hESC derived 
interneurons and human foetal MGE 15WPC. Cells from the same time point along 
differentiation paradigm or from 15WPC foetal tissue sample share the same symbol 
(e.g. all day 20 cells are represented by red open circle). Clusters of symbols on tSNE 
plot represent cells with higher similarity in gene expression profile. Biological 
replicates for 15WPC MGE, n=1. Biological replicates for in vitro differentiations n=2. 
Total number of cells per time point/age can be found in Appendix folder 2 table 4 
and 3 table 10. 
E) Relative fold change in expression of genes significantly differentially expressed 
between primary foetal MGE at 15WPC and hESC-derived interneurons. DEGs were 
determined through ANOVA pairwise analysis, and were included if p<0.05 and fold 
change (in either direction) >4. In the graphs only the top 5 DEGs in both directions 
(higher in vitro or in vivo) have been shown as examples (due to the large number 
of DEGs). The full list can be found in the Appendix folder 4. Genes with a relatively 
higher expression in hESC-derived interneuron sample (compared to 15WPC MGE) 
were shown as a positive fold change. Any genes with a relatively higher expression 
in 15WPC MGE (compared to hESC-derived interneuron sample) were shown as a 
negative fold change. Biological replicates for 15WPC MGE, n=1. Biological replicates 
for in vitro differentiations n=2.
DEG, differentially expressed gene. MGE, medial ganglionic eminence. hESC, human 
embryonic stem cell. Calcyon neuron specific vesicular protein, CALY. CAMK2B, 
calcium/calmodulin dependent protein kinase II beta. CDKN2C, Cyclin dependent 
kinase inhibitor 2C. Chromosome (Ch) 1 open reading frame 61. Chromosome (Ch) 
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11 open reading frame 96. Developmental pluripotency associated 4, DPPA4. DLX5, 
Distal-less homeobox 5. HES5, Hes family bHLH transcription factor 5. Interferon 
induced transmembrane protein 2, IFITM2. ISLR2, Immunoglobulin superfamily 
containing leucine rich repeat 2. LINC01833, Long intergenic non-protein coding RNA 
1833. Maternally expressed 3, MEG3. Neuronatin, NNAT. Nuclear factor I B, NFI B. 
Nuclear paraspeckle assembly transcript 1, NEAT1. Olfactomedin 2, OLFM2. PANTR1, 
POU3F3 adjacent non-coding transcript 1. POU3F4, POU class 3 homeobox 4. RBMS1, 
RNA binding motif single stranded interacting protein 1. S100A13, S100 calcium 
binding protein A13. S100B, S100 calcium binding protein B. Serine/threonine kinase 
26, AKT. SPRY2, Sprouty RTK signaling antagonist 2. TMBIM4, transmembrane BAX 
inhibitor motif containing 4. Unnamed LncRNA, Chromosome (Ch) 8. X inactive 
specific transcript, XIST. WPC, weeks post-conception. 
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5.4 Discussion 
To date, longitudinal single-cell RNA sequencing analysis of human MGE has 
not been reported in the literature. As a result, the data presented here has 
provided the first in-depth, unbiased analysis of human MGE molecular 
profile. 
5.4.1 Human MGE developmental trajectory 
Characterising the human MGE at single-cell resolution illustrated the 
heterogeneity within the population and across time. Over the late first 
trimester to early second trimester period (10WPC to 15WPC) the MGE 
samples shared a common mix of proliferating progenitors and immature 
neurons (mainly NPY expressing interneurons). These populations can be 
spatially divided into restricted zones within the developing MGE, namely the 
ventricular/subventricular zones and mantle zones respectively (Zechel et al.
2014). The proliferating progenitors were identified by the expression of early 
interneuron markers (NKX2.1, FOXG1), transcription related genes (RRM2, 
CREB5), and cell cycle regulatory genes (CCND1). The downregulation of 
these genes, and upregulation of post-mitotic neuronal markers (MAP2, CR, 
SST, NPY)  over the developmental period reflected the shift towards a more 
neuronal rich population in the MGE. These findings at RNA level were 
supported by immunostaining performed on human MGE over the same
period (10WPC to 14WPC), which reported a significant shrinkage of the MGE 
ventricular zone (reduced abundance of newborn progenitors) (Hansen et al.
2013). Therefore, together these findings would indicate the maturation of 
the MGE was a major factor contributing to the heterogeneity over the 
developmental period.  
Furthermore, over time different subpopulations emerged within the MGE, 
which differed in the expression of signalling factors, including insulin-like 
growth factor signalling, neuroendocrine signalling protein secretogranin V, 
and activin and BMP4 signalling inhibitor follistatin like 1 (Cole et al. 2016). 
These signalling pathways may represent steps underpinning interneuron 
lineage commitment, in particular, differential levels of BMP4 signalling has 
previously been demonstrated to influence interneuron commitment to SST 
or PVALB fate (Mukhopadhyay et al. 2009). Therefore, the higher levels of 
BMP4 inhibitor, follistatin like 1, in MGE samples may be linked to the greater 
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proportion of SST expressing interneurons (at the expense of PVALB) 
detected in the MGE compared to hESC-derived interneuronal culture 
(Mukhopadhyay et al. 2009). Therefore, exploring the effects of these named 
signalling pathways during the in vitro differentiation paradigm may enrich 
the hESC-derived interneuronal cultures with subtypes that we absent or at 
low abundance (NPY and SST, respectively). 
However, due to the nature of longitudinal primary tissue analysis, and the 
small number of independent samples collected in this study (typically only 
one foetus per time point), some of the variations between different aged 
samples may be explained by between-subject variations. One example was 
the differential expression of XIST, a gene selectively expressed in females 
to regulate X-linked gene dosage (Sahakyan et al. 2018). As the foetal tissues 
were used in a gender unbiased manner, the upregulation of XIST over 
development was likely due to the change from male to female tissue samples 
rather than temporal changes in expression observed during MGE 
development (Zechel et al. 2014). Thus, gender-selective studies may be 
favourable in the future, especially as gene expression changes during brain 
development have been illustrated to be sex-dependent (Kang et al. 2011).
5.4.2 Interneuron lineage commitment in the MGE 
Details concerning interneuron diversification into specific subtypes remain to 
be conclusively determined, with several competing theories in the literature 
(Hu et al. 2017b; Wamsley & Fishell 2017). However, the data described here 
would support the conclusion that lineage dictated subpopulations emerge 
within the MGE. This is in support to the most recent single-cell RNA 
sequencing analysis in mouse MGE and CGE that named Maf and Mef2c as 
candidate lineage determining transcription factors for SST and PVALB 
lineages respectively (Mayer et al. 2018; Mi et al. 2018). Although these 
findings were not reproduced in the data presented here, a novel gene 
associated with NPY lineage commitment was named: SKP1. The known 
activity of SKP1 in regulating the protein levels of RNA polymerases, 
transcription factors and cycle cell regulatory proteins through ubiquitination, 
means SKP1 effects many downstream pathways by initiating a cascade 
effect by regulating protein levels in the cell (Galan & Peter 1999). As a result, 
this makes SKP1 a potential candidate for lineage commitment to NPY fate. 
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Although these findings favour an intrinsic preprogramming of interneuron 
commitment, initiated in the MGE, there are several caveats to this statement 
to consider. Firstly, although the data described here has detected lineage 
dictated subpopulations, this cannot rule out the possible further refinement 
of the interneuron profile in the region of destination (through extrinsic cues) 
(Kessaris et al. 2014; Wamsley & Fishell 2017). Secondly, only certain 
subtype committed subpopulations were detected (NPY, SST, CR) in the MGE. 
The absence of other MGE-derived interneuron lineages (e.g. PVALB) may be 
as a result of the developmental period selected or due to the emergence of 
this lineage only within the region of destination (Bandler et al. 2017; 
Wamsley & Fishell 2017). Therefore, depending on the interneuron subtype, 
a different interneuron lineage commitment model may better fit the true 
developmental steps (Hu et al. 2017b; Wamsley & Fishell 2017). In summary, 
this study provided favourable evidence for early interneuron lineage 
commitment, directed through intrinsic programming of cells in the MGE, but 
the importance of extrinsic cues in lineage commitment (especially for 
alternative lineages, like PVALB), and in determining the final phenotype of 
the interneuron, cannot be ruled out.
5.4.3 hPSC-derived interneuronal models – the good and the bad 
Of final consideration was the cross-comparison of the single-cell profiles of 
hESC-derived interneurons and human MGE samples. This assessment of the 
in vitro model relative to the authentic counterpart in the foetal brain provided 
insight into how PSC-derived neurons mimic some, but not all, of the gene 
expression patterns observed in vivo. Many of the genes under-represented 
in the hESC-derived interneuron cultures were transcription factors, including 
DLX5, MEG3 and NFI B, and regulators of the cell-cycle (cyclin-dependent 
kinase inhibitor 2C, CDKN2C). The low/absent expression of these genes in 
vitro may reflect the limited ability of in vitro models to recapitulate the 
generation of the distinct progenitor pools in the MGE, and the subsequent 
absence of these subtypes in the terminally differentiated culture. If the 
molecular profile of the hPSC-derived progenitors could be directed to express 
these under-represented genes, this could provide an efficient means to 
widen the variety of interneuron subtypes that can be generated in vitro. 
Furthermore, neuronatin was an additional gene consistently detected as 
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under-expressed in the hESC-derived interneuron cultures. Neuronatin 
expression has previously been detected in the mouse MGE at RNA level, 
mainly restricted to lateral boundary of the MGE mantle zone, and therefore, 
is expressed by migratory interneurons (Zechel et al. 2014). The limited 
expression of neuronatin in the hESC-derived interneuron culture may be due 
to the absence of critical morphogens in vitro needed to mimic the spatial 
patterning in the lateral MGE. In summary, these discrepancies between PSC 
neuronal models and their primary tissue derivatives have been repeatedly 
reported across PSC- neuronal models, and point to common faults of PSC 
neuronal models that need to be addressed to achieve more authentic 
neurons in vitro (Camp et al. 2015; Chen et al. 2017; Close et al. 2017). 
Nonetheless, many of the genes upregulated in vitro highlight the validity of 
PSC-derived interneurons as a neurodevelopmental model. These genes 
included neuron specific vesicular protein (CALY) and calcium signalling 
proteins (S100B, S100A13, CAMK2B), with calcium signalling known as an 
important modulator of synaptogenesis and maintenance of synaptic 
connections (Fink et al. 2003; Wayman et al. 2008). In particular, CAMK2B
is a calmodulin-dependent kinase highly expressed during early development 
and regulates actin-filament polymerisation to promote synapse formation in 
a calcium-dependent manner (Fink et al. 2003; Wayman et al. 2008). The 
higher expression of these synaptic-related markers in vitro likely reflects the 
generation of neuronal networks in the culture which are absent in the MGE. 
This would indicate that the hPSC-derived interneuron model encompasses a 
wider range of interneuron development, beyond the stages in the MGE. This 
emphasises the importance of comparing PSC-interneuronal models to 
authentic counterparts in the region of destination (e.g. cortical tissue) to 
understand the later stages of interneuron development (dendritic branching 
and synaptogenesis), as impairments in these processes have been 
implicated in numerous neuropathologies (Brennand et al. 2011; Lima 
Caldeira et al. 2019; Shao et al. 2019). Although comparisons of hPSC-
derived interneurons to cortical foetal interneurons were consistent with 
findings presented here, and also concluded a good similarity to early second 
trimester (14-15WPC) foetal tissue (Close et al. 2017). 
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5.4.4 Conclusion
In summary, human MGE single-cell transcriptome analysis has provided 
novel insight into MGE expression profile which has been utilised to critically 
evaluate the hPSC model of interneuron differentiation. Encouragingly, the 
hPSC model, in many aspects, reproduced the findings reported in the human 
MGE. However, the differences in molecular profile detected emphasised the 
need for future refinements to the differentiation paradigm, which can be 
guided from the novel cross-comparison analysis presented here. Of 
significance were pathways regulating gene expression (directly or indirectly) 
that were under-represented in vitro relative to the native MGE, and therefore 
if intrinsically or extrinsically elevated during the interneuron differentiation 
paradigm, may aid the generation of more authentic and defined interneurons 
in vitro. 
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Chapter 6 - Physiology and connectivity of hESC derived interneurons 
6.1 Introduction
As illustrated in the previous results Chapters, the expression profiles of 
hESC-derived interneurons at single-cell resolution was heterogeneous and 
displayed temporal dynamics (see Chapters 4-5).  The transcriptome is the 
foundation underpinning the phenotype of the interneuron. Thus, interneuron 
diversity goes beyond molecular profile and is also reflected in the 
morphology, connectivity and physiology of the neuron (Kepecs & Fishell 
2014). 
6.1.1 The connectivity of neurons
As introduced in Chapter 1, monosynaptic rabies viral tracers have become 
the prime tool used to identify and manipulate neuronal circuits of interest 
(Wickersham et al. 2007; Osakada et al. 2011; Osakada & Callaway 2013). 
The system is based on three main components. First, EnvA pseudotyped ΔG 
rabies tracer, which is a non-self replicating rabies virus that can only enter 
neuronal population expressing the complementary cell surface receptor TVA.
This neuronal population is termed starter neurons. Second, the viral tracer 
induces the expression of reporters and all the viral genes, except the viral 
glycoprotein, in the infected host neuron (Wickersham et al. 2007; Osakada 
et al. 2011; Osakada & Callaway 2013). The ability to choose the reporters 
has made viral tracers a highly versatile tracing platform, which can both 
label traced circuits using a fluorescent protein (e.g. mCherry) and 
manipulate the traced circuit by using neuronal modifying proteins such as 
the light-gated cation channels (Nagel et al. 2003; Osakada et al. 2011). 
Channelrhodopsin 2 (ChR2) is common example, used to stimulate neuronal 
activity, due to the optogenetic manipulation being of high temporal 
precision, reliability and sensitivity (Nagel et al. 2003; Boyden et al. 2005; 
Osakada et al. 2011). 
Third, the starter neurons are genetically engineered to express the rabies 
glycoprotein, allowing replication of the viral tracer through glycoprotein 
trans-complementation (Osakada & Callaway 2013). Once synaptically 
transferred to a non-starter neuron, the loss of the exogenous source of the 
viral glycoprotein prevents viral amplification necessary for efficient synaptic 
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transmission, thereby terminating the tracing signal to this traced neuron, 
which is directly one synapse from the starter neuron (see Figure 1.5). Hence, 
the EnvA pseudotyped ΔG rabies tracer provides information concerning the 
direct (monosynaptic) inputs onto a selected neuronal population (the starter 
neurons) (Brennand et al. 2011; Osakada et al. 2011; Wall et al. 2013; Tian 
et al. 2016; Tornero et al. 2017). 
In conclusion, this new generation of tracers has allowed the combined 
determination of neuronal connectivity and manipulation of neuronal 
physiology of selected circuits (Tian et al. 2016; Tornero et al. 2017). 
6.1.2 Neuronal physiology
Although the principle requirement of all neurons is the ability to code 
information in the form of spike patterns, neuronal physiology shows high 
neuronal class specificity. Interneurons are a classic example, with subtypes 
categorised according to differences in spike patterns and intrinsic 
physiology, such as fast spiking PVALB interneurons, delayed regular spiking 
bipolar CR/VIP interneurons, and burst spiking SST interneurons (Butt et al.
2005; Flames & Marín 2005, Kepecs & Fishell 2014).
Depending on the research questions, there are many different approaches 
to measure the physiology of neurons. Indirect measures of firing activity can 
be achieved using calcium imaging (Sun et al. 2016; Xiang et al. 2017; Mayer 
et al. 2019). Although calcium imaging has the advantage of providing a high-
throughput neuronal response to a stimulus at single-cell resolution, the 
indirectness of the measure could potentially lead to inaccurate conclusions, 
as fluctuations in intracellular Ca2+ ion levels can have numerous causes 
(Bagur & Hajnóczky 2017). Population level responses can also be gained 
from multi-electrode array (MEA) recordings, which detect extracellular 
changes in potential (termed extracellular field potentials), caused by the 
firing of neurons in that region of the array (Spira & Hai 2013). Both calcium 
imaging and MEA have been particularly useful in the understanding of 
network activity, and how neuronal dysfunction can impact the ability of 
neuronal populations to achieve rhythmic and synchronised patterns of firing 
(Hedrich et al. 2014; Sun et al. 2019). However, neither calcium imaging or 
MEA recordings allow determination of the intrinsic physiology or the evoked
spike parameters of a single neuron. 
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To functionally characterise neurons at a single-cell resolution an alternative 
approach must be taken, namely whole-cell patch clamp (Varga et al. 2015). 
Whole-cell patch clamping requires direct contact to be made to the neuron 
using a micro-pipette, by breaking into the cell the intracellular solution and 
pipette solution become one. This allows the detection of intracellular changes 
in ion concentrations, and subsequently membrane potential, that occurs on 
the generation of an action potential (Varga et al. 2015; Fuzik et al. 2015). 
6.1.3 Physiology of primary tissue derived interneurons 
Longitudinal whole-cell patch clamp recordings at different stages along 
neuronal differentiation have shown how the intrinsic and evoked parameters 
of the neuron change as the integrated circuits are moulded in an activity-
dependent manner during development (Moore et al. 2009; Calvigioni et al.
2016; Pan et al. 2016; Zhong et al. 2018). Longitudinal functional 
characterisation of interneurons derived from mouse primary tissue has 
included SST interneurons in the anterior cingulate cortex (P3 to P45) and 
CCK interneurons in the hippocampus (E12.5 to P16) (Calvigioni et al. 2016; 
Pan et al. 2016). The age-dependent changes in the intrinsic physiology of 
neurons included decreased resting membrane potential (more 
hyperpolarised) and input resistance, and increased capacitance with age 
(Calvigioni et al. 2016; Pan et al. 2016). Moreover, action potential properties 
were also found to change from the first postnatal week, with a significant 
reduction in action potential duration and consequentially, rise in maximal 
firing frequency (Calvigioni et al. 2016; Pan et al. 2016). Ultimately the 
functional differentiation trajectory of interneurons led to the diverse set of 
physiology profiles seen within the adult brain (Varga et al. 2015).
6.1.4 Physiology of hPSC-derived neurons 
Whole-cell patch clamp recordings have also been performed on PSC-derived 
interneurons (Cambray et al. 2012; Maroof et al. 2013; Sun et al. 2016; Close 
et al. 2017; Xiang et al. 2017; Noakes et al. 2019). In vitro differentiated 
PSC-derived interneurons reportedly fail to show the intrinsic physiological 
parameters observed in their authentic counterparts in the adult brain, and 
lack the full spectrum of firing patterns (often no fast-spiking or bursts spiking 
neurons) (Sun et al. 2016; Close et al. 2017; Noakes et al. 2019). However, 
there are inconsistencies across paradigms concerning the level of functional 
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maturity achieved in vitro (Cambray et al. 2012; Maroof et al. 2013; Sun et 
al. 2016; Close et al. 2017; Xiang et al. 2017; Noakes et al. 2019). 
Nevertheless, acquiring neuron-like cells with native molecular and 
physiological maturation properties remains one of the major challenges and 
limitations of in vitro neuron differentiation paradigms to date. This has 
encouraged several different approaches to obtain more functionally mature 
neuronal populations (Nicholas et al. 2013; Colasante et al. 2015; Kemp et 
al. 2016; Sun et al. 2016; Telezhkin et al. 2016).
6.1.5 Improving the functional maturity of hPSC-derived neurons  
One strategy has been the development of in vitro neuronal differentiation 
paradigms that apply a cocktail of cell cycle inhibitors (DAPT and 
PD0332991), neurogenic/neurotrophic factors (ascorbic acid, BDNF and 
LM22A4) and other factors known to directly influence neuronal physiology 
(GABA, calcium chloride, CHIR99021 and forskolin) to PSC-derived neuronal 
precursors (Kemp et al. 2016; Telezhkin et al. 2016). These protocols have 
arguably provided the simplest strategy to enhance both the speed and 
synchronicity of maturation of the PSC-derived neuronal precursors to post-
mitotic neurons in vitro (Kemp et al. 2016; Telezhkin et al. 2016). The use of 
SCM1 factors described by Telezhkin et al. has been utilised in the 
experiments described in this Chapter in an attempt to improve the functional 
maturation of the hESC-derived interneuronal culture within the 65 day 
differentiation paradigm (Telezhkin et al. 2016; Telezhkin et al. 2018). 
6.2 Aims 
To characterise the differentiation trajectory of hESC-derived interneurons at 
the functional level by performing longitudinal whole-cell patch clamp 
recording. 
To compare the longitudinal functional and molecular characterisation of 
hESC-derived interneurons (introduced in Chapter 4), to investigate whether 
any changes in physiology were mirrored by changes in expression profile. 
To provide preliminary evidence for the successful application (and non-
toxicity) of the EnvA pseudotyped ΔG ChR2-mCherry rabies viral tracer on 
hESC-derived interneurons, using immunostaining and optogenetics. 
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6.3 Results 
Refinements to the hPSC interneuron differentiation protocol were introduced 
in this Chapter to enhance functional maturation of the interneuronal culture 
in vitro. As shown in Figure 6.1A, SCM1 factors were used at the beginning 
of the neuronal maturation stage (approx. day 21 to day 27 in vitro).  As a 
result, post-mitotic neuronal-like branching was observed earlier, typically by 
the end of the SCM1 treatment, and was maintained with little to no 
contamination from proliferating progenitors over the remaining 40 days in 
vitro (Figure 6.1A). 
6.3.1 The hESC-derived interneurons had a heterogeneous, but 
overall immature physiology   
Whole-cell patch clamp recordings were conducted at days 40, 50 and 60 on 
hESC-derived interneurons to track changes in neuronal physiology over time 
(Figure 6.1B-6.1F). Moreover, the recordings from single-cells enabled the 
variation in the population to be characterised, as shown by the distribution 
of points on the graph (each point represents the results from a single patch 
neuron) (Figure 6.1B and 6.1D). The population average resting membrane 
potential was weakly hyperpolarised at all time points, but did show a slight 
(and significant, ***P<0.001) hyperpolarisation over the course of the in 
vitro differentiation paradigm to a population average resting membrane 
potential of -20mV (*p<0.05, ***p< 0.001, Figure 6.1B). In general, the 
differentiation trajectory of the hESC-derived interneurons was marked by 
the progressive increase in the membrane time constant (tau) over time, with 
a significant increase by day 60 to 90ms (***p< 0.001, Figure 6.1B). The 
capacitance for the population was overall very low at each time point 
(average between 20-30pF), with patched neurons rarely found to have a 
capacitance higher than 50pF (Figure 6.1B). Nonetheless, the population 
average capacitance significantly increased over time (*p< 0.05, Figure 
6.1B).
The evoked responses of the same patched neurons were then investigated 
through a series of different current clamp paradigms (see Appendix folder 6 
figures). These paradigms involved the injection of current in the patched 
neuron and simultaneous measure of changes in the membrane potential. 
From the patched neurons that successfully spiked on current stimulation, 
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the following properties of the evoked action potential were determined: spike 
threshold, spike amplitude and spike half-width (Figure 6.1C -6.1D). An 
illustrative example defining these action potential parameters has been 
provided in Figure 6.1C. Broadly speaking, the average evoked action 
potential parameters for responsive hESC-derived interneurons did not 
significantly change over the day 40 to day 60 period (Figure 6.1D). Although 
there was a large variation in spike parameters within the population at each 
time point, the average remained relatively constant over time (Figure 6.1D). 
The population average spike amplitude showed a small, but significant 
reduction between day 40 and day 50, but otherwise also remained relatively 
unchanged over the day 40 to day 60 in vitro differentiation period (77.63mV 
to 48.11mV *p<0.05, Figure 6.1D). The cause of this reduced spike amplitude 
at day 50 was unclear, but possibly the small sample number (n=12) at day 
40 may have led to a biased representation of the day 40 population response 
(Figure 6.1D).  
Although the spike parameters may not have changed over time, how did the 
proportion of passive to responsive neurons change? The evoked responses 
to a single injection of current were assigned to one of four categories: one, 
an attempted, but failed action potential; two, a single action potential; three, 
an attempt at generating more than one action potential (a train); four, an 
action potential train (Figure 6.1E). The proportion of patched neurons failing 
to show an action potential response remained at approx. 30% of the 
population at each of the time points (Figure 6.1F). Similarly, only a small 
proportion of patched neurons achieved a train of evoked action potentials, 
with only a small increase in this proportion over time (peak at day 50 at 9%, 
Figure 6.1E).  Whereas, there appeared to be a reciprocal increase in patched 
neurons that attempted a train of action potentials (6% to 17% day 40 to 
day 60) at the expense of those generating a single action potential (61% to 
48% day 40 to day 60) over time (Figure 6.1F).
In summary, these findings would suggest that the interneuron differentiation 
of hESC recapitulated some of the functional changes expected in terminally 
differentiating neurons. However, both the intrinsic and evoked properties of 
hESC-derived interneurons would indicate that the functional maturity 
reached was limited, and did not confer to that known of their counterparts 
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in the adult brain. Moreover, the high between-cell variation in innate and 
evoked physiological parameters corresponded to the heterogeneity within 
the culture. This may in part reflect the mixed functional maturity of the 
hESC-derived interneurons at each time point, with both passive and more 
functionally mature hESC-derived neurons maintained over time (Figure 
6.1F). In addition, this may signify differences between discrete interneuron-
like subtypes in the culture. 
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Figure 6.1 Physiological parameters of hESC-derived interneurons.
A) Schematic of the in vitro hPSC interneuron differentiation protocol utilised in this 
study, with real-time brightfield images of in vitro culture at different time points. 
The paradigms has been simply divided into three different stages. Stage 1, neural 
induction (yellow). Stage 2, interneuron fate commitment (orange). Stage 3, terminal 
differentiation with additional SCM1 factors treatment phase (green). The SCM1 
factors consisted of: neurotropic factors, BDNF, ascorbic acid and LM22A4, cell cycle 
inhibitors, DAPT and PD0332991 and factors known to directly shape neuronal 
physiology, GABA, calcium chloride, CHIR99021 and forskolin. For more information 
please refer to Chapter 2. 
B) Intrinsic physiology of patched neurons, including the immediate resting potential 
of the neuron (taken within first 30sec of breaking into neuron), membrane time 
constant (tau) and capacitance (capacitance (pF) = tau (ms) / input resistance (GΩ)). 
The graph has been plotted with each symbol on the plot representing the value of a 
single patched neuron, the mean +/- SEM have been shown for each time point. 
Biological replicates (independent differentiations) n=3. Minimum technical replicates 
per time point= 10 
C) Representative example of an evoked action potential labelled to define the 
following action potential parameters: spike threshold (mV), spike amplitude (mV) 
and spike half-width (ms)
D) Current evoked action potential properties of patched neurons, including spike 
threshold (mV), spike amplitude (mV) and spike half-width (ms). The graph has been 
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plotted with each symbol on the plot representing the value of a single patched 
neuron, the mean +/- SEM have been shown for each time point. Holding potential, 
-60mV. Biological replicates (independent differentiations) n=3. Minimum technical 
replicates per time point= 10
E) Representative examples of the four different categories of responses to current 
injection. Category 1. Attempted, but failure to generate an action potential (passive 
response). Category 2. Single action potential generated. Category 3. Attempt to 
generate a second action potential (train of action potential), but failed. Category 4. 
Two or more action potentials generated in response to a single current injection. 
Holding potential, -60mV. 
F) The proportion of patched cells at each time point within each of the four categories 
of evoked responses (described in 6.1E). The graph shows the percentage of patched 
cells with the corresponding response (attempted spike, single spike, attempted 
train, train of action potentials) out of total cells patched at that time point. minimum 
n= 12 at each time point. Holding potential, -60mV. Biological replicates 
(independent differentiations) n=3. Minimum technical replicates per time point= 10
Statistics performed to determine significant differences in physiological responses 
of patched cells over time using nonparametric, Kruskal-Wallis test and Dunn's 
Multiple Comparison Test (*p<0.05, **p<0.01, ***p<0.001). SHH, sonic hedgehog. 
BDNF, brain-derived neurotrophic factor. hESC, human embryonic stem cell. SEM, 
standard error of the mean.
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6.3.2 The differentiation trajectory of hESC-derived interneurons was 
reflected in the expression of markers associated with neuronal 
physiology
To determine whether the differences in physiology were accompanied by 
changes in expression of neuronal physiology-related genes (such as ion 
channel, ion transporters, neurotransmitter receptors), the longitudinal 
single-cell RNA sequencing data for hESC-derived interneurons (introduced 
in Chapter 4) was utilised to track changes in selected genes (Figure 6.2A-
6.2B). 
Analysis of the longitudinal single-cell RNA sequencing data for hESC-derived 
interneurons began by restricting the analysis to the post-mitotic neuronal 
population at each time point. The MAP2 expressing subpopulation was 
checked for cells expressing genes encoding for ion transporters (ATPase 
Na+/K+ transporting subunits alpha 1 ATP1A1 and beta 3 ATP1B3), vesicular 
GABA transporter (vGAT), signalling receptors (inositol 1,4,5-trisphosphate 
receptor type 1, ITPR1), and cytoskeletal proteins and cytoskeletal regulatory 
proteins (tropomyosin 4, TPM4 and cyclase associated actin cytoskeleton 
regulatory protein 2, CAP2 respectively) (Figure 6.2A). The proportion of the 
neuronal population expressing ATP1B3 and TPM4 remained high (approx. 
>80%) from day 20 to day 65, showing little temporal dynamics (Figure 
6.2A). Although the average expression level for ATP1B3 transcripts were 
much higher than TPM4 at each time point (by at least 2-fold, day 50 270 
TPM vs 500 TPM) (Figure 6.2A). The proportion of CAP2 and ATP1A1 
expressing neurons over time showed a mirrored expression trend, with both 
markers showing a progressive decrease over time and a slight increase at 
day 65 in abundance (Figure 6.2A). The high co-expression pattern of CAP2
and ATP1A1 in the population (>75%) may indicate a shared gene regulatory 
network, driving a common phenotypic trait. The proportion of ITPR1 and
vGAT expressing neurons remained low across the differentiation paradigm, 
with the proportion of vGAT expressing cells peaking at day 35 and ITPR1 at 
day 50 (at 12% and 25%, respectively Figure 6.2A). The population average 
expression level of ITPR1 and vGAT were also both at low levels (<50 TPM 
per cell average) (Figure 6.2A).
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Furthermore, the proportion of neurons expressing genes encoding for 
several different ion channel subunits including selective Na+ ion (SCN1A,  
SCN2A), K+ ion (KCNQ2, KCNK1), Ca2+ ion (CACNA1C) and Cl- ion (CLCN3) 
voltage-gated channels, was determined (Figure 6.2B). As shown in Figure 
6.2B, the temporal expression pattern of the ion channel subunits varied, 
both in terms of the direction and size of change over time. For example, the 
abundance of neurons expressing SCN1A,  SCN2A and CACNA1C, peaked at 
a later time point, although only the proportion of SCN1A expressing neurons 
progressively increased over day 20 to day 65 (approx. 2% to 40%, day 20 
vs day 65 Figure 6.2B). Whereas, KCNQ2 and CLCN3 were expressed by the 
greatest proportion of neurons at day 20, and progressively decreased over 
time (Figure 6.2B). At day 20 only PVALB and CR expressing interneuron 
subtypes were detected, with PVALB expressing neurons also declining in 
abundance over time (see Chapter 4). This may suggest a subtype biased 
expression pattern of KCNQ2 and CLCN3. Finally, K+ two pore domain 
channel KCNK1 expressing neurons were of low abundance at all time points 
of the differentiation paradigm (remained at approx. 5%) (Figure 6.2B).
Although, the proportion of marker expressing cells may have changed over 
time, the average number of transcripts per cell remained relatively 
independent of time along the differentiation (Figure 6.2B). Although some 
markers (SCN1A, SCN2A and CACNA1C) did show a small rise in population 
average transcript levels in later populations (typically from day 35 onwards) 
(Figure 6.2B).
The changes described in single-cell profiles may, in part, reflect the 
differentiation trajectory of the post-mitotic interneuron-like cells, mirroring 
the temporal changes reported in the whole-cell patch clamp recordings. In 
addition, the differences in ion channel expression patterns between 
temporally distinct cultures could signify changes in subtype diversity of 
interneuron-like population over time. 
6.3.3 hESC-derived interneurons showed subtype-dependent 
expression pattern of markers associated with neuronal physiology
To investigate whether the synaptic proteins and ion channel expression 
patterns differ between interneuron subtypes, the MAP2 expressing 
population was instead divided according to SST, CR or PVALB co-expression 
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(rather by time point) (Figure 6.2C). The proportion of SST, CR and PVALB 
expressing neurons co-expressing different voltage-gated Na+ ion channel 
subunits belonging to Nav1 family was determined, and demonstrated a small 
subtype bias in the expression of SCN1A (SST bias), SCN8A (SST bias) and 
SCN2A (CR bias) (Figure 6.2C). This coincides with the temporal expression 
data for SCN1A and SCN2A in Figure 6.2B, both of which showed greater 
expression from day 35 onwards, with this time point corresponding to the 
emergence and greater abundance of SST and CR expressing interneurons 
(with the decline in PVALB) (see Chapter 4). 
Overall, the potassium voltage-gated ion channels for Kv3 family (KCNC1, 
KCNC2) were at a low (<20%) abundance or absent in SST, CR and PVALB
expressing neuronal subpopulations (Figure 6.2C). As Kv3.1 (KCNC1) and 
Kv3.2 (KCNC2) are pan-neuronal markers, the low/absent expression would 
imply the neurons were functionally immature. Whereas, there was greater 
variability in the expression pattern of the Kv7 family of ion channels (KCNQ2, 
KCNQ3, KCNQ4, KCNQ5) (Figure 6.2C). Kv7.4 (KCNQ4) expressing neurons 
were not co-expressed by any of the SST, CR and PVALB expressing neuronal 
subpopulations (Figure 6.2C). Similarly, Kv7.5 (KCNQ5) expressing neurons 
were either absent or at very low abundance (<5%) (Figure 6.2C). Whereas, 
Kv7.2 (KCNQ2) and Kv7.3 (KCNQ3) expressing cells were detected in each 
subpopulation, with KCNQ2 being the most abundant K+ ion channel subunit 
for all subtypes (Figure 6.2C). Moreover, KCNQ2 showed greatest co-
expression with PVALB (approx. 75% of PVALB positive post-mitotic neurons
Figure 6.2C). This reflected the temporal expression data for KCNQ2
described above in Figure 6.2B, and PVALB described in Chapter 4, both of 
which had peak abundance in the MAP2 positive population at day 20. 
In a similar manner reported for the Kv7 family of ion channels, the
proportion of neurons expressing voltage-gated L-type Cav1 family of ion 
channel subunits (CACNA1C, CACNA1D, CACNA1F, CACNA1S) showed high 
variability between subunits. For example, in hESC-derived post-mitotic 
neurons CACNA1S and CACNA1F were either absent or at low proportion 
within SST, PVALB, CR subpopulations (both at <5%, Figure 6.2C). Whereas, 
CACNA1C and CACNA1D showed similar co-expression with each subtype
(Figure 6.2C). 
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Finally, the proportion of subtype marker positive cells expressing glutamate 
ionotropic receptor subunits (NMDA or AMPA receptors) was determined. 
NMDA receptor subunit GRIN2B and AMPA receptor subunit GRIA3 were the 
most highly expressed by all subtypes (45-50% and 25-35% respectively, 
Figure 6.2C). Although, this expression pattern was subtype dependent, with
a slight PVALB biased co-expression pattern with GRIA3 (Figure 6.2C).
Moreover, GRIN2B displayed a clear co-expression bias with SST and CR, but 
no co-expression reported with PVALB (Figure 6.2C). 
Overall, hESC-derived PVALB expressing neurons co-expressed the smallest 
number and diversity of the ion channels, ion transporters and 
neurotransmitter receptor subunits checked (Figure 6.2C). Furthermore, 
often the proportion of PVALB /marker co-expressing neurons was lower 
relative to CR and SST expressing interneurons (Figure 6.2C). This would 
suggest the hESC-derived PVALB expressing interneurons were less 
functionally mature than CR/SST interneurons, likely due to the emergence 
of PVALB expressing interneurons at an earlier time point in vitro and loss by 
later time points (see Chapter 4). 
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Figure 6.2 Longitudinal trajectories of molecular markers associated with 
neuronal physiology, obtained from single-cell RNA sequencing of hESC-
derived interneurons.
A-B) Quantification of the expression level and proportion of marker positive cells for 
selected genes using single-cell RNA sequencing data (see Chapter 4). 6.2A) Markers 
indirectly linked to neuronal physiology, ITPR1, ATP1B3, ATP1A1, CAP2, TPM4 and 
vGAT. 6.2B) Ion channels, SCN2A, KCNQ2, CACNA1C, SCN1A, CLCN3 and KCNK1. 
Gene expression level data has been presented as TPM, with each symbol plotted 
representing the expression value of that marker for a single cell. The line graphs 
plotted show the proportion of cells expressing each named marker at each time 
point along the hESC-derived interneuron differentiation protocol. The marker 
positive cells have been counted if the cells also co-expressing MAP2, to restrict 
analysis to post-mitotic neurons. Total MAP2 expressing cells at day 20=132 cells, 
day 35=177, day 50=124 cells and day 65 = 129 cells. Biological replicates 
(independent differentiations) n=2.
C) Expression pattern of Na+ ion channels (SCN2A, SCN1A, SCN8A), K+ ion channels 
(Kv3 KCNC1, KCNC2, and Kv7 KCNQ2, KCNQ3, KCNQ4, KCNQ5) and Ca2+ ion 
channels (CACNA1S, CACNA1C, CACNA1D, CACNA1F), and ionotropic glutamate 
receptor subunits (GRIA3, GRIN2C, GRIN2A, GRIA3) by SST or PVALB or CR positive 
interneurons (all cells included in analysis were MAP2 positive). The graphs plotted 
show the proportion of cells expressing each named marker for each interneuron 
subtype (CR, SST, PVALB). Total MAP2 expressing cells co-expressing SST = 35 cells, 
CR= 67 cells and PVALB= 12 cells. Biological replicates (independent differentiations) 
n=2.
TPM, transcripts per million. vGAT, vesicular GABA transporter. ATP1A1, ATPase 
Na+/K+ transporting subunit alpha 1. ATP1B3, ATPase Na+/K+ transporting subunit 
beta 3. CACNA1C, voltage-gated L-Type calcium channel Cav1.2 alpha 1 subunit. 
CACNA1, voltage-gated L-Type calcium channel Cav1.3 alpha 1 subunit. CACNA1F, 
voltage-gated L-Type calcium channel Cav1.4 Alpha 1 Subunit. CACNA1S, voltage-
gated L-Type calcium channel Cav1.1 alpha 1 subunit. CAP2, cyclase associated actin 
cytoskeleton regulatory protein 2. CLCN3, chloride voltage-gated channel 3. CR, 
calretinin. GRIA3, glutamate ionotropic receptor AMPA type subunit 3. GRIN2A, 
glutamate ionotropic receptor NMDA type subunit 2A. GRIN2B, glutamate ionotropic 
receptor NMDA type subunit 2B. GRIN2C, glutamate ionotropic receptor NMDA type 
subunit 2C. ITPR1, inositol 1,4,5-trisphosphate receptor type 1. KCNC1, potassium 
voltage-gated channel subfamily C member 1. KCNC2, potassium voltage-gated 
channel subfamily C member 2. KCNK1, potassium two pore domain channel 
subfamily K member 1. KCNQ2, voltage-gated potassium channel subunit Kv7.2. 
KCNQ3, voltage-gated potassium channel subunit Kv7.3. KCNQ4, voltage-gated 
potassium channel subunit Kv7.4. KCNQ5, voltage-gated potassium channel subunit 
Kv7.5. MAP2, microtubule associated protein 2. PVALB, parvalbumin . SCN1A,
voltage-gated sodium channel subunit alpha Nav1.1. SCN2A, voltage-gated sodium 
channel subunit alpha Nav1.2. SCN8A, voltage-gated sodium channel subunit alpha 
Nav1.8. SST, somatostatin . TPM4, tropomyosin 4. 
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6.3.4 Lentiviral transduction efficiently generated hESC-derived 
starter neuron population 
Through the longitudinal molecular and functional characterisation described 
above, the hPSC model of interneuron differentiation would appear to give 
rise to functionally immature interneuron-like cells. However, whether the 
hESC-derived neurons underwent the stage of synaptogenesis to form viable 
neuronal circuits in vitro, is unknown. The pseudotyped EnvA ΔG ChR2-
mCherry viral tracer system was used to selectively identify and manipulate 
the circuits containing starter and traced neurons. The generation of starter 
neuron population required lentiviral transduction to induce the inheritable 
expression of TVA, rabies glycoprotein and histone-GFP under the human 
synapsin promoter (Figure 6.3A and Appendix folder 5 figures). The nuclear 
GFP reporter allowed titering of the lentivirus (number of transducing units 
(TU)/ml) through the proportion of GFP positive neurons in the culture. 
Lentiviral transduction was carried out as either a single or double 
administration of the lentivirus, and a range of different lentiviral dilutions 
were trialled to allow titering (Figure 6.3B-6.3C). After 7-10 days post 
lentiviral transduction the hESC-derived interneuron cultures were checked 
by independent approaches for GFP positive cells. First, by eye under a 
fluorescent microscope to gauge an estimate of GFP expression in live cells. 
Second, by flow cytometry to determine the proportion of GFP positive cells 
(see Appendix folder 5 figures). Both these approaches demonstrated a 
variation in GFP fluorescent intensity between GFP positive starter neurons. 
The consequence of which for the viral tracer system is unclear. Third, 
immunohistochemistry staining of the hESC-derived cultures for GFP. No GFP 
positive cells were detected in the negative control (virus-free media 
exchange on transduction days) in any of the detection methods (Figure 
6.3B). 
Lentiviral treatment successfully generated GFP positive cells, the proportion 
of which was dependent on the dilution factor used (Figure 6.3B and Appendix 
folder 5 figures). A progressive decrease in GFP positive population occurred 
with the increase in dilution factor (more dilute lentiviral stock used), which 
became significant by 1:750 dilution factor (single hit 1:250, 45% to 30%  
**p< 0.01, double hit 1:250, 75% to 30% ***p< 0.001 Figure 6.3B-6.3C). 
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The repeated transduction with the lentiviral vector resulted in a significantly 
greater proportion of GFP positive cell relative to the equivalent single hit 
treatment for 1:250 (single hit 45% vs double hit 75% ***p< 0.001) and 
1:500 dilution factors (single hit 40% vs double hit 60% **p< 0.01) (Figure 
6.3C). In summary, these approaches led to a calculated lentiviral titer of 
4.5x106 TU/ml, and indicated that a double hit was not necessary to efficiently 
generate a 30-40% abundant starter cell population (Figure 6.3B-6.3C).
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Figure 6.3 hESC-derived starter neurons: lentiviral transduction and titering.
A) Linearised schematic of lentiviral vector. Human synapsin promoter-driven 
expression of the avian TVA receptor, the B19 rabies glycoprotein and histone 2B-
green fluorescent protein (H2B.GFP) fusion protein. The three proteins are kept as 
three separate entities by 2A self-cleaving peptide linker sequence joining each of 
the proteins. 
B) Transduction of hESC-derived interneurons with lentiviral vector to generate 
starter neuron population for viral tracer system. The data has been presented in the 
form of a panel of immunohistochemistry deconvoluted images, with different 
lentiviral transduction treatments. As described in detail in Chapter 2, hESC-derived 
interneurons were first transfected at approx. day 35 with either lentiviral stock 
diluted to 1:250, 1:500 and 1:750. A proportion of these cultures were then 
transduced a second time (double hit) 7 days later with the same dilution factor as 
used previously. At day 50 all cultures were fixed for immunohistochemistry staining. 
For both single and double hit treatments, a negative control was used (virus-free 
media added). Biological replicates (independent differentiations) n=3. Minimum 
technical replicates n=6.
C) Percentage of GFP expressing cells out of the total cell population (total cell count 
measured using DAPI count) for each of the lentiviral transduction treatments. The 
graph plotted shows the mean percentage of GFP expressing cells for each treatment, 
along with +/- SEM. Biological replicates (independent differentiations) n=3. 
Minimum technical replicates n=6. The average total number of cells counted per 
technical replicate can be found in Appendix folder 7. 
Statistics performed to determine significant differences in percentage of GFP 
expressing cells, within each treatment condition (single hit or double hit) relative to 
the highest dilution factor (1:250 either single or double hit) using nonparametric, 
Kruskal-Wallis test and Dunn's Multiple Comparison Test (*p<0.05, **p<0.01, 
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***p<0.001, light green text for single hit, dark green text for double hit). Mann-
Whitney test was performed to determine significant differences in percentage of GFP 
expressing cells between corresponding single and double hit treatments, (e.g. 1:250 
single hit vs 1:250 double hit) with ns p>0.05, *p<0.05, **p<0.01, ***p<0.001 
(black text). GFP, green fluorescent protein. H2B, histone-2B.  hESC, human 
embryonic stem cell. SEM, standard error of the mean.
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6.3.5 EnvA pseudotyped ΔG ChR2-mCherry viral tracer showed 
restricted uptake to TVA expressing cells
The starter cells had enforced expression of TVA to match the complementary 
envelope protein (EnvA) displayed on the surface of the EnvA pseudotyped 
ΔG ChR2-mCherry rabies tracer. The generation of the EnvA pseudotyped ΔG 
ChR2-mCherry rabies virus required the ΔG ChR2-mCherry rabies virus to be 
taken up and amplified by BHK-EnvA packaging cells (see Chapter 2). 
However, as the unpseudotyped ΔG ChR2-mCherry rabies virus was the 
precursor to the pseudotyped viral tracer, there could be contamination from 
the unpseudotyped viral tracer in the viral harvest collected. As the 
unpseudotyped virus can enter all cells (TVA expressing or not) it was 
necessary to determine whether there was any contaminating unpseudotyped 
viral tracer in the pseudotyped viral tracer stock. This was achieved by 
determining the transduction efficiency of the unpseudotyped and EnvA 
pseudotyped ΔG ChR2-mCherry rabies virus in HEK cell line with and without 
TVA receptor expression (Figure 6.4A-6.4C). 
Investigations began with determining the proportion of mCherry positive 
HEK TVA expressing cells after 7-10 days post-infection with the pseudotyped 
and unpseudotyped viral tracer, over a range of dilution factors (Figure 6.4B-
6.4C).  Immunohistochemistry staining of HEK TVA cultures for mCherry 
confirmed the efficient transduction of both viruses in this cell line, which was 
also seen by eye (under the fluorescent microscope) and using flow cytometry 
(Figure 6.4B, and Appendix folder 5 figures). The proportion of mCherry 
positive HEK TVA cells significantly decreased with progressively higher 
dilution factors for the EnvA pseudotyped ΔG ChR2-mCherry rabies virus 
(35% to 15% 1:100 vs 1:250 *p<0.05, 35% to 10% 1:100 vs 1:750 
**p<0.01, Figure 6.4C). Although a similar trend was seen for the 
unpseudotyped viral tracer, the proportion of mCherry positive cells was 
higher for 1:500 dilution factor (15% vs 30% **p<0.01), and only showed a 
significant decrease relative to 1:100 dilution only for 1:750 dilution (35% to 
10%, 1:100 vs 1:750 ***p<0.001, Figure 6.4C). The higher proportion of 
mCherry positive HEK TVA cells for the unpseudotyped ΔG ChR2-mCherry 
rabies viral treatments meant that the titer for unpseudotyped viral tracer 
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(3.2 x106 TU/ml) was higher relative to the EnvA pseudotyped viral tracer 
(2.8 x106 TU/ml) (as would be expected, see Chapter 2). 
Finally, to determine whether the EnvA pseudotyped or unpseudotyped ΔG 
ChR2-mCherry viral tracer uptake was selective to TVA positive cells, the viral
tracer treatments were repeated in HEK cells. A similar trend in proportion of 
mCherry positive cells across dilution factors was reported for unpseudotyped 
rabies viral tracer transductions of HEK cells (as seen in HEK TVA cell line). 
This result was predicted, as unpseudotyped viral tracer has no restrictions 
on cell entry. Therefore the titer calculated was similar across the two cell 
lines (3.2 - 3.6 x106 TU/ml) (Figure 6.4B-6.4E). In contrast, for every dilution 
factor of EnvA pseudotyped ΔG ChR2-mCherry viral tracer treatment (from 
1:100 to 1:750) no mCherry positive cells were detected by eye, flow 
cytometry or immunohistochemistry staining (Figure 6.4D-6.4E, and 
Appendix folder 5 figures). This would indicate that pseudotyping of the viral 
tracer was successful, with no contaminating unpseudotyped viral tracer 
present, but efficient transduction required a high dosage (1:100, Figure 
6.4C). 
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Figure 6.4 The EnvA pseudotyped ΔG ChR2-mCherry rabies viral tracer: viral 
transduction and titering.
A) Linearised schematic of the rabies viral vector, the first showing the five genes 
encoded by the wild-type RB and the second showing the modified ΔG rabies tracer 
with glycoprotein gene sequence replaced with sequence encoding for 
channelrhodopsin 2 (ChR2) and fluorescent protein mCherry fusion protein (ChR2-
mCherry). 
B) Transduction of HEK TVA cells with unpseudotyped and EnvA pseudotyped ΔG 
ChR2-mCherry RB. The data has been presented in the form of a panel of 
immunohistochemistry deconvoluted images, with different 
pseudotyped/unpseudotyped ΔG ChR2-mCherry RB transduction treatments labelled. 
As described in detail in Chapter 2, HEK TVA cells were either transduced with stock 
diluted in 1:100, 1:250, 1:500 and 1:750 unpseudotyped or EnvA pseudotyped ΔG 
ChR2-mCherry RB. After 7-14 days all cultures were fixed for immunohistochemistry 
staining. All experiment had a corresponding negative control (virus-free media 
added). Biological replicates (independent differentiations) n=3. Minimum technical 
replicates n=6. 
C) Percentage of mCherry expressing HEK TVA cells out of the total cell population 
(total cell count measured using DAPI count) for each of the unpseudotyped and EnvA 
pseudotyped ΔG ChR2-mCherry RB transduction treatments. The graph plotted 
shows the mean percentage of mCherry expressing cells for each treatment, along 
with +/- SEM. Note 1:500 treatment is missing due to detachment of cells on fixing. 
Biological replicates (independent differentiations) n=3. Minimum technical replicates 
n=6. The average total number of cells counted per technical replicate can be found 
in Appendix folder 7. 
D) Transduction of HEK cells with unpseudotyped and EnvA pseudotyped ΔG ChR2-
mCherry RB. The data has been presented in the form of a panel of 
immunohistochemistry deconvoluted images, with different ΔG ChR2-mCherry RB 
transduction treatments labelled. As described in detail in Chapter 2, HEK cells were 
either transduced with stock diluted in 1:100, 1:250, 1:500 and 1:750 
unpseudotyped or EnvA pseudotyped ΔG ChR2-mCherry RB. As no mCherry positive 
cells were detected in any of the pseudotyped ΔG ChR2-mCherry RB treatment, 
1:100 dilution factor example has been shown only. After 7-14 days all cultures were 
fixed for immunohistochemistry staining. All experiment had a corresponding 
negative control (virus-free media added). Biological replicates (independent 
differentiations) n=3. Minimum technical replicates n=6. The average total number 
of cells counted per technical replicate can be found in Appendix folder 7. 
E) Percentage of mCherry expressing HEK cells out of the total cell population (total 
cell count measured using DAPI count) for each of the unpseudotyped and EnvA 
pseudotyped ΔG ChR2-mCherry rabies virus transduction treatments. The graph 
plotted shows the mean percentage of mCherry expressing HEK cells for each 
treatment, along with +/- SEM. Biological replicates (independent differentiations) 
n=3. Minimum technical replicates n=6. The average total number of cells counted 
per technical replicate can be found in Appendix folder 7. 
Statistics performed to determine significant differences in percentage of mCherry 
expressing cells between each treatment condition relative to the highest dilution 
factor (1:100 either pseudotyped or non-pseudotyped viral tracer) using 
nonparametric, Kruskal-Wallis test and Dunn's Multiple Comparison Test (*p<0.05, 
**p<0.01, ***p<0.001, red text pseudotyped, black text unpseudotyped). Mann-
Whitney test was performed to determine significant differences in percentage of 
mCherry expressing cells between corresponding pseudotyped or non-pseudotyped 
ΔG ChR2-mCherry RB treatments, (e.g. 1:100 unpseudotyped vs 1:100 
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pseudotyped) with ns p>0.05, *p<0.05, **p<0.01, ***p<0.001. Channelrhodopsin 
2, ChR2. RB, rabies virus. HEK, human embryonic kidney. Glycoprotein deficient, ΔG. 
SEM, standard error of the mean.
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6.3.6 Monosynaptic viral tracer revealed the existence of small 
neuronal circuits within hESC-derived interneuronal cultures
With the monosynaptic viral tracer system generated, the EnvA pseudotyped 
ΔG ChR2-mCherry rabies tracer and hESC-derived starter neurons, the next 
stage involved the application of the system to hESC-derived interneuron 
cultures. The hESC-derived interneurons were transduced with the lentiviral 
vector, which led to 40-50% abundance of starter neurons by day 50 in vitro 
(Figure 6.5A). The culture was then infected with the pseudotyped viral 
tracer. By eye the hESC-derived interneuron cultures appeared healthy up to 
14 days post-infection, with mCherry positive cells detected from 5 days post-
infection onwards. All starter neurons were identified as MAP2 and GFP double 
positive on immunostaining (Figure 6.3A and 6.5A). The restricted expression 
of GFP to MAP2 positive cells confirmed the fidelity of the lentiviral vector 
which encoded the genes (TVA, histone-GFP, glycoprotein) under human 
synapsin promoter (Figure 6.3A and 6.5A). The synaptic inputs onto starter 
neurons were detected by immunostaining for GFP and mCherry, with 
infected starter neurons (GFP/mCherry double positive) found to have a 
relatively small number of inputs (presynaptic partners), typically between 3-
5 inputs per starter neuron (Figure 6.5A). A representative immunostaining 
has been shown in Figure 6.5A, which clearly demonstrates the greater 
proportion of mCherry positive cells relative to GFP/mCherry double positive 
cells. Moreover, all mCherry positive traced neurons were identified in close 
proximity to GFP/mCherry double positive cells, which supports the 
monosynaptic nature of the tracer (Figure 6.5A). Finally, the restricted uptake 
of EnvA pseudotyped rabies tracer was confirmed in the hESC-derived 
interneuron culture using negative control with no starter cells (no lentiviral
transduction step), but treated with pseudotyped rabies tracer (Figure 6.5A). 
The negative control had no GFP or mCherry positive cells, hence the EnvA 
pseudotyped ΔG ChR2-mCherry rabies tracer could not transduce TVA 
negative hESC-derived neurons (Figure 6.5A).  
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6.3.7 The monosynaptic ChR2-mCherry viral tracer system had no 
consequence on the intrinsic physiology of hESC-derived 
interneurons
To evaluate the physiology of the traced circuits, the monosynaptic viral 
tracer system was used in combination with optogenetics to exploit the ChR2-
mCherry co-expression in rabies tracer infected neurons. However, this 
ChR2-mCherry viral tracer system has not been previously used in hPSC 
neuronal cultures. Therefore, preliminary investigations were carried out to 
check whether either lentiviral transduction to generate starter neurons or 
infection by the rabies viral tracer had any negative effects on the physiology 
of the neuronal culture (Figure 6.5B). This was determined by measuring the 
intrinsic parameters of the patched neurons from the viral free culture (non-
transduced neurons), starter neurons (GFP positive) and traced neurons 
(mCherry positive).  As shown in Figure 6.5B, there was no significant 
difference between any of the groups in their intrinsic physiology. Hence, the 
resting membrane potential (-19.19mV non-transduced, -22.74mV starter, -
17.41mV traced p>0.05 Figure 6.5B), membrane time constant (86ms non-
transduced, 71ms starter, 75ms  traced p>0.05 Figure 6.5B),  and 
capacitance (35pF non-transduced, 25pF starter, 37pF traced p>0.05 Figure 
6.5B) were unchanged by using the viral tracing platform. In addition, a high 
proportion of the patched neurons (independent of identity) displayed 
spontaneous activity, both spontaneous mini-excitatory postsynaptic 
potentials and, less commonly, spontaneous action potentials (see Appendix 
folder 6 figures). This would support the conclusion that hESC-derived 
interneurons were successfully forming viable synaptic connections. 
6.3.8 Photostimulation efficiently and consistently evoked action 
potential response in hESC-derived traced neurons
Optogenetics was performed on hESC-derived interneurons 7-14 days post-
infection with the pseudotyped ΔG ChR2-mCherry rabies tracer. The traced 
(mCherry positive) neurons were selected as the recording population, due 
to their illustrated ability to form synaptic connections (Figure 6.5A). In order 
to evaluate the efficiency of the ChR2 driven response, traced neurons were 
stimulated through both current injection and blue light (to activate ChR2) 
(Figure 6.5C-6.5D). The photostimulated response in traced neurons was 
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found to be equally efficient as current injection, in terms of action potential 
amplitude, half-width and threshold (Figure 6.5D). This would demonstrate 
the efficient expression of ChR2 in the traced neurons. However, the 
photostimulated evoked responses appeared to be more consistent across 
patched neurons, with a greater variation observed in the current injection 
responses (Figure 6.5D). The reason for the smaller between-cell variation to 
photostimulation is unclear. However, a possible explanation may relate to 
the cell-wide distribution and activation of ChR2, generating a consistent 
change in membrane potential over the entire cell membrane when exposed 
to blue light. Whereas, current injection would generate an immediate 
response in voltage-gated ion channels closest to the patch site, that then 
propagates over the remaining cell body. Therefore, depending on the ion 
channel composition closest to this patched site, this may result in a different 
strength of response, thus causing between-cell variation in spike 
parameters. 
Overall, the monosynaptic viral tracer was successfully applied to hESC-
derived interneuron culture. By the general health of the culture, and by the 
physiology of the neurons, the viral tracer system was concluded to be non-
toxic to these cells over 14 day period post-infection with the pseudotyped 
viral tracer.
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Figure 6.5 Application of EnvA pseudotyped ΔG ChR2-mCherry rabies viral 
tracer system on hESC-derived interneurons.
A) Day 65 hESC-derived interneurons complete with starter neuron population and 
up to 14 days post-transduction with EnvA pseudotyped ΔG ChR2-mCherry RB. The 
data has been presented in the form of a panel of immunohistochemistry 
deconvoluted images. First starter neuron free culture treated with EnvA 
pseudotyped ΔG ChR2-mCherry RB (negative control). Second GFP and MAP2 
immunohistochemistry staining to confirm restricted co-expression of GFP to MAP2 
positive population (due to lentiviral vector driven by synapsin promoter). Third, GFP 
and mCherry staining to identify non-infected starter neurons (GFP positive), infected 
starter neurons (GFP/mCherry double positive) and traced neurons (mCherry 
positive). 
B) Intrinsic physiology of patched neurons identified as GFP and mCherry negative 
(non-transduced population), GFP positive (starter neurons) and mCherry positive 
(traced neurons). These parameters measured included the immediate resting 
potential of the neuron (taken within first 30sec of breaking into neuron), membrane 
time constant (tau) and capacitance (capacitance (pF) = tau (ms) / input resistance 
(GΩ)). The graph has been plotted with each symbol on the plot representing the 
value of a single patched neuron, the mean +/- SEM have been shown for each time 
point. Holding potential, -60mV. Recording conducted from 7 to 14 days post-
transduction with EnvA pseudotyped ΔG ChR2-mCherry RB. Biological replicates 
(independent differentiations) n=3. Technical replicates per group n= 8.
C) Representative example of blue-light evoked action potentials, along with labelled 
brightfield and fluorescent images of a mCherry positive patched neuron. Holding 
potential, -60mV. Recording conducted from 7 to 14 days post-transduction with 
EnvA pseudotyped ΔG ChR2-mCherry RB. 
D) Comparison of blue-light and current evoked action potential properties of patched 
neurons, including spike threshold (mV), spike amplitude (mV) and spike half-width 
(ms). The graph has been plotted with each symbol on the plot representing the 
value of a single patched neuron, the mean +/- SEM have been shown for each time 
point. Holding potential, -60mV. Recording conducted from 7 to 14 days post-
transduction with EnvA pseudotyped ΔG ChR2-mCherry RB. Biological replicates 
(independent differentiations) n=3. Technical replicates per group n= 25.
Statistics performed to determine significant differences in physiological responses 
of patched cells over time using nonparametric, Kruskal-Wallis test and Dunn's 
Multiple Comparison Test (*p<0.05, **p<0.01, ***p<0.001). Mann-Whitney test 
was performed to determine significant differences in evoked responses of patched 
cells to current injection or blue-light photostimulation (ns p>0.05, *p<0.05, 
**p<0.01, ***p<0.001). channelrhodopsin 2, ChR2. RB, rabies virus. GFP, green 
fluorescent protein. hESC, human embryonic stem cell. Glycoprotein deficient, ΔG. 
SEM, standard error of the mean.
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6.4 Discussion 
This Chapter has provided an understanding of the functional properties of 
hESC-derived interneurons cultured under SCM1 treatment (Telezhkin et al.
2016; Telezhkin et al. 2018). A longitudinal assessment of the intrinsic and 
evoked physiology of hESC-derived interneurons was determined, along with 
preliminary evidence of neuronal networks in the in vitro culture using a 
retrograde monosynaptically spreading viral tracer. 
6.4.1 Comparative assessment of the physiology of hPSC-derived 
interneurons 
When considered in relation to similar interneuron differentiation protocols 
using an extrinsic cue strategy to drive differentiation, the physiology of 
hPSC-derived interneurons in this study was broadly consistent with previous 
reports (Cambray et al. 2012; Bardy et al. 2016; Close et al. 2017; Xiang et 
al. 2017). Overall, whole-cell patch clamp recordings have demonstrated the 
limited ability of cell cycle inhibitors and neurotrophic/neurogenic factors to 
generate highly functional hESC-derived interneurons in vitro (Cambray et al.
2012; Bardy et al. 2016; Close et al. 2017; Xiang et al. 2017). Instead hPSC-
derived interneuronal cultures remain abundant in neuron-like cells that were 
weakly hyperpolarised, had low complexity branching pattern (and thus, low 
capacitance), and incapable of generating high frequency trains of action 
potentials (Cambray et al. 2012; Bardy et al. 2016; Close et al. 2017; Xiang 
et al. 2017). Moreover, by the end of the paradigm there was still a proportion 
of neuron-like cells that remained passive to stimulation, as reported 
previously (Xiang et al. 2017). Hence, these findings reported in this Chapter 
and independently, emphasise the need for alternative measures to promote 
functional maturation. 
Previous work has demonstrated the successful use of co-cultures of primary 
rodent derived glial or cortical glutamatergic neurons in generating 
interneuron-like cells with physiology closer to authentic counterparts 
(Maroof et al. 2013; Sun et al. 2016; Noakes et al. 2019). Although, arguably 
the most effective strategy has been in vivo transplantation into the rodent 
brain (typically neocortex) (Goulburn et al. 2011; Nicholas et al. 2013). 
However, completing interneuron differentiation in vivo often extends the 
duration of the experiment (>5 months), requires additional skill sets and 
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expenses (for animal husbandry and surgery) (Goulburn et al. 2011; Nicholas 
et al. 2013; Yuan et al. 2018). With clear pros and cons of each strategy, 
compromises may have to be made when working with PSC-derived neuronal 
models. 
6.4.2 Molecular and functional similarities of hPSC-derived 
interneurons and primary foetal tissue
Although hESC-derived interneuron physiology described here did not 
recapitulate that of the endogenous interneurons in the adult brain, how did 
the physiology profile compare to foetal derived interneurons? Ex vivo 
recordings have been performed on foetal cortical brain slices across 9WPC-
26WPC developmental period (Moore et al. 2009; Moore et al. 2011; Zhong 
et al. 2018). Overall, these findings reported intrinsic and evoked physiology 
parameters characteristic of immature neurons, with patch neurons having 
high input resistance, weakly hyperpolarised resting membrane potentials 
and weak/absent evoked responses to current injection (Moore et al. 2009; 
Moore et al. 2011; Zhong et al. 2018). Moreover, at this stage of development 
cortical neurons had very few neuronal partners (5 or less) and low 
capacitance (20-30pF) (Moore et al. 2009; Moore et al. 2011). Thus, foetal 
derived neurons, from the early second trimester period, had a connectivity 
and physiological profile similar to those reported for in vitro derived 
interneurons in this study, and reported independently (Moore et al. 2009; 
Moore et al. 2011; Cambray et al. 2012; Bardy et al. 2016; Close et al. 2017; 
Xiang et al. 2017). 
6.4.3 Bridging the gap between neuron molecular and functional 
profiles 
The shared phenotypic properties of hESC-derived interneurons and human 
foetal derived interneurons (from the early second trimester) reflects the 
similar expression profile of these two sources of interneurons, reported in 
Chapter 5 and independently in the literature (Close et al. 2017; Xiang et al.
2017; Yuan et al. 2018). The functional immaturity of neurons can be 
observed in the limited range and low expression level of ion channels, 
synaptic proteins and neurotransmitter receptors (Close et al. 2017; Mayer 
et al. 2019). This was especially true for PVALB interneurons generated in 
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this paradigm, emphasising the difficulty of authentically generating this 
subtype in vitro (Close et al. 2017; Xiang et al. 2017; Yuan et al. 2018).
Although this study was able to assess the hESC-derived interneuron profile 
at the functional and molecular level, a more sophisticated approach would 
have been to carry out patch-seq analysis (Bardy et al. 2016; Cadwell et al.
2016; Földy et al. 2016; Fuzik et al. 2015; Cadwell et al. 2017; Tripathy et
al. 2017; van den Hurk et al. 2018). The advantage of the patch-seq protocol 
is that the single-cell physiology data, collected in whole-cell patch clamp 
recordings, can be directly traced to the single-cell RNA sequencing data of 
the corresponding cell (van den Hurk et al. 2018). With a large enough 
sample, reliable and reproducible predictions can be made about the neuron 
physiology profile from the expression of selected genes (Tripathy et al.
2017). 
The expression profile of hESC-derived interneurons in this study included 
genes previously named through patch-seq analysis as significantly 
correlated within a phenotypic trait (Fuzik et al. 2015; Tripathy et al. 2017). 
For example, ATPase Na+/K+ transporter subunits encoded by ATP1A1 and 
ATP1B3, voltage-gated Cl- ion channel subunit (CLCN3), inositol 1,4,5-
trisphosphate receptor type 1 (ITPR1) and K+ ion two pore domain channel 
subfamily K member 1 (KCNK1) were all reported as negatively correlated 
with resting membrane potential (Fuzik et al. 2015; Tripathy et al. 2017). 
Although this study detected a small, but significant hyperpolarisation of the 
resting membrane potential for hESC-derived interneurons over time, this 
was not accompanied by the expression pattern changes in CLCN3, KCNK1, 
ATP1A1 and ATP1B3 predicted by the previous patch-seq data (Fuzik et al.
2015; Tripathy et al. 2017). Moreover, patch-seq analysis would suggest 
CAP2 and ATP1A1 expression are unrelated predictors of neuronal physiology, 
which leaves it unclear why CAP2 and ATP1A1 had high co-expression, 
leading to the mirrored temporal changes in abundance of CAP2 and ATP1A1 
expressing cells in hESC-derived interneurons. The inability of the work 
described in this Chapter to reproduce previous patch-seq analysis findings 
may be due to species-differences, with these previous studies being 
conducted on mouse primary tissue (Fuzik et al. 2015; Tripathy et al. 2017). 
Moreover, Fuzik et al. study was carried out on a selected interneuron subtype 
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(CCK interneurons), which were not abundant in the in vitro culture analysed 
here (Fuzik et al. 2015). Nevertheless, as this was not a like-for-like 
comparison between mouse and human data, and only a small sample size, 
a conclusive reason cannot be stated for the differences.
The expression of glutamate ionotropic receptor subunits in neuronal 
populations also provides a predictive marker of neuronal maturity. AMPA, 
kainate and NMDA receptor subunits in human cortical foetal tissue (8WPC -
22WPC) show an age-dependent expression pattern (Mayer et al. 2019). 
During earlier ages of foetal development, cortical neurons were found to 
express GRIN2A, which becomes downregulated later in development, with 
the reciprocal rise in the expression of GRIN2B (Mayer et al. 2019). hESC-
derived interneuronal culture generated in this paradigm showed 
heterogeneity in the expression of GRIN2A and GRIN2B, suggesting a mixed 
maturity of the neuron-like cells, corresponding to early-mid second trimester 
(Mayer et al. 2019). Furthermore, this heterogeneity could in part be
explained by subtype-dependent differences, with a higher proportion of SST 
and CR interneuron-like cells co-expressing GRIN2B. Whereas, the PVALB 
interneuron-like cells failed to express this marker. This could be a genuine 
subtype-dependent difference, or reflect the relative immaturity of the PVALB 
interneuron-like cells made in vitro (compared to SST and CR interneuron-
like cells). 
In addition, hESC-derived interneurons had a high abundance of AMPA 
receptor subunit GRIA3 expressing cells, which had a subtype-dependent 
expression pattern, biased to PVALB interneurons. Supporting evidence for 
this finding has come from calcium imaging responses of ex vivo human foetal 
cortical tissue (14WPC-22WPC) to AMPA mediated-stimulation (Mayer et al.
2019). Mayer et al. reported a strong AMPA signalling response by MGE-
derived cortical interneurons compared to CGE-derived cortical interneurons 
at the same age (Mayer et al. 2019). Moreover, the level of GRIA3 expression 
has been positively correlated with firing frequency (e.g. fast spiking PVALB 
interneurons) (Földy et al. 2016).
Additional molecular markers used to predict neuronal physiology are 
voltage-gated ion channel subunits. For inhibitory interneurons, voltage-
gated ion channels show both an age-dependent and subtype-dependent 
209
expression pattern (Földy et al. 2016; Close et al. 2017; Telezhkin et al.
2018; Mayer et al. 2019). The Kv3 family of ion channels, in particular Kv3.1 
(KCNC1) and Kv3.2 (KCNC2), which are predominantly expressed by 
interneurons (rather than excitatory neurons), are both positively correlated 
with high frequency spike patterns typical of PVALB interneurons (Martina et 
al. 1998; Földy et al. 2016; Muñoz-Manchado et al. 2018). The low abundance 
of PVALB, SST and CR hESC-derived interneurons co-expressing KCNC1 and
KCNC2 likely accounts (in part) for the patched neurons having high action 
potential half-widths and absence of high frequency trains in response to 
current injections. Whereas, Kv7 family of ion channels show region-selective 
expression, with only Kv7.2 (KCNQ2) and Kv7.3 (KCNQ3) being abundant in 
the brain (Telezhkin et al. 2018). This study reported a similar biased 
expression pattern, with hESC-derived neurons preferentially abundant in 
KCNQ2 and KCNQ3 expressing neurons, with much lower/absent expression 
of KCNQ4 and KCNQ5. Moreover, the single-cell RNA sequencing data 
presented here would indicate a PVALB interneuron subtype bias in KCNQ2
expression. Although this is a novel report, conditional (Nkx2.1::Cre driven) 
Kcnq2 KO mice have inappropriately excitable PVALB interneurons, with SST 
interneuron function left intact (Soh et al. 2018). The PVALB dysfunction led 
to a higher susceptibility to seizures in the conditional Nkx2.1::Cre and
Pvalb::Cre driven Kcnq2 KO mice (Soh et al. 2018). This mouse data would 
provide supporting evidence for the biased expression of KCNQ2 in hESC-
derived PVALB interneurons reported in this study (Soh et al. 2018).
The absence/low abundance of Cav1.1 (CACNA1S) and Cav1.4 (CACNA1F) 
expressing hESC-derived interneurons would be predicted from rodent work 
demonstrating relatively low neuronal expression of CACNA1S (which is 
mainly restricted to skeletal muscle) and largely retinal restricted expression 
of CACNA1F (Heyes et al. 2015). Whereas, Cav1.2 (CACNA1C) and Cav1.3 
(CACNA1D) were equally co-expressed among PVALB, CR and SST expressing 
hESC-derived interneurons (although at a low proportion). This subtype 
independent expression pattern was consistent with rodent primary brain 
tissue immunostaining illustrating a brain-wide distribution of these genes 
(Heyes et al. 2015). Furthermore, L-type Cav1.2/1.3 ion channels have been 
implicated in the regulation of interneuronal growth and maturation (Jiang & 
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Swann 2005). On agonist-mediated activation of Cav1.2/1.3 ion channel 
activity in ex vivo mouse hippocampal slice cultures, PVALB interneurons 
displayed upregulated expression of Vgat and Gad1, and grew more extensive 
dendritic branches (Jiang & Swann 2005). The reciprocal was true when 
Cav1.2/1.3 ion channel activity was dampened using selective Cav1.2/1.3 
antagonists (Jiang & Swann 2005). Therefore, the low abundance of 
CACNA1C and CACNA1D expressing hESC-derived interneurons may account 
for the small proportion of vGAT expressing cells, and absence of complex 
branch patterns and connectivity. 
6.4.4 Viral tracers and insight into in vitro network activity and 
connectivity  
The application of the EnvA pseudotyped ΔG ChR2-mCherry rabies tracer 
system on hESC-derived interneurons provided novel proof-of-principle data 
demonstrating selective and efficient uptake and monosynaptic transmission 
of the viral tracer within this in vitro culture. Previous reports have suggested 
a restricted timeframe for analysis of the rabies viral tracer of 5-7 days post-
transduction, but this data demonstrated the non-toxicity of the viral tracer 
up to 14 days (Wickersham et al. 2007; Osakada et al. 2011; Osakada & 
Callaway 2013). Although this may be cell line and/or neuronal-type specific. 
Moreover, the traced circuits were limited to infected starter neurons and 
their presynaptic partners, with a higher abundance of traced neurons to 
infected starter neurons in the population. Although multiple synaptic 
connections were made onto starter neurons, the overall morphology and 
branch pattern observed in traced neurons typically lacked the complexity of 
mature interneurons. This branching pattern and connectivity may have been 
enhanced by co-culturing the hESC-derived interneurons with endogenous 
partners, such as hESC-derived cortical glutamatergic neurons (Sun et al.
2016).  In addition, such experiments exploring the network connectivity of 
hESC-derived interneurons with native synaptic partners would provide a 
more translatable and authentic measure of the connectivity of hESC-derived 
interneurons. 
Although all traced neurons displayed evoked responses to both current and 
blue light stimulation, the experiments did not directly demonstrate the viable 
nature of the synaptic connection made between traced and infected starter 
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neurons. Previous work with rabies viral tracers has shown that trans-
synaptic spread of the viral tracer does not require the synapse to be viable 
(Wickersham et al. 2007). Furthermore, the exact mechanism of viral trans-
synaptic transmission is still unclear, with unanswered concerns over whether 
strength/activity of the synapse affects the efficiency of trans-synaptic 
transmission (Wickersham et al. 2007; Ginger et al. 2013). Hence, a future 
requirement would be to conduct paired recordings stimulating (through 
current injection/blue light) traced neurons and recording from 
monosynaptically connected infected starter neurons. Only if a parallel 
response was detected in the downstream starter neuron could the synapse 
be confirmed as viable. Although direct evidence of functional connectivity is 
a critical accompaniment to viral tracing, the viable nature of the connections 
would be predicted due to the detection of spontaneous activity (an indication 
of synaptic stimulation) in the majority of patched neurons from day 50 
onwards. 
6.4.5 Conclusion
In conclusion, post-mitotic hESC-derived interneurons closely recapitulate 
both the molecular and functional profile of early second trimester (15WPC) 
human foetal derived interneurons (Close et al. 2017; Xiang et al. 2017; Yuan 
et al. 2018). This highlights a shortcoming of hPSC-derived neurons as a 
representative model of adult brain neuronal activity, which may be improved 
by co-culturing with native neuronal partners. Nonetheless, hPSC-derived 
interneurons hold promise as a neurodevelopmental model, mimicking many 
of the molecular and functional changes observed in early human foetal 
development.   
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Chapter 7 - General Discussion
7.1 Summary
The molecular steps underpinning interneuron diversification into the 
spectrum of subtypes present in the adult human brain has proved 
challenging to define. Within this thesis a hPSC model depiction of human 
interneuron development has been described. The study focused on exploring 
the utility of hESC-derived interneurons as a neurodevelopment model, with 
the overall aim to determine whether the molecular and functional transition 
that marks interneuron differentiation trajectory can be recapitulated in vitro. 
The evaluation began with a longitudinal characterisation of the hESC-derived 
interneurons (Chapter 3-4). In order to tease apart the molecular 
heterogeneity within and across populations, longitudinal single-cell RNA 
sequencing was performed. Overall, these findings were promising, 
demonstrating the ability to generate an enriched culture of MGE-like 
progenitors that gave rise to a diverse set of interneuron subtypes in vitro 
(Chapter 4). Moreover, temporal modifications to the paradigm may provide 
a means to further refine the hESC-derived interneuron subtype composition 
(Chapter 3).
However, with valid concerns over how true the in vitro representation of 
interneuron differentiation is, a novel cross-comparison of the model was 
made to their authentic counterparts in the human MGE (Chapter 5).  The 
foetal tissue was obtained across the late first trimester to early second 
trimester (10WPC to 15WPC), a developmental period which encompassed 
the emergence of subtype committed interneuron precursors in the MGE. The 
single-cell RNA sequencing analysis enabled novel age and subtype-
dependent expression patterns to be detected, leading to candidate lineage 
determining genes to be named. Moreover, encouraging similarities were 
found between the molecular profiles of hESC-derived interneurons and 
human MGE. However, clear distinctions were also detected, which marked 
the shortcomings of the in vitro model.
To expand upon the longitudinal molecular characterisation, the in vitro 
model was also evaluated based on the physiology and connectivity of the 
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post-mitotic neuronal cultures (Chapter 6). Through whole-cell patch clamp 
recordings, functional characterisation of the interneuron-like cells was 
achieved. The molecular heterogeneity in hESC-derived interneurons was 
also reflected in the diversity of physiology profiles recorded. Although, the 
intrinsic and evoked neuronal responses of hESC-derived interneurons poorly 
recapitulated that of their counterparts in the adult brain. Instead, the 
differentiation trajectory of the interneuron-like cells was marked by the 
transition to a modestly higher functional maturity, closely resembling that of 
native foetal cortical interneurons. In addition, hESC-derived interneurons 
were capable of forming small neuronal networks, as demonstrated using the 
monosynaptic viral tracer system. Although the connectivity was not 
extensive, the ability of interneuron-like cells to form synaptic connections 
marked the successful recapitulation of a late stage of interneuron 
development in vitro.
In summary, the interneuron differentiation of hESC has potential as a 
platform for neurodevelopmental research. However, certain refinements to 
the paradigm would be required in the future to help close the gap between 
hESC-derived interneurons and their native counterparts.  This work could be 
guided by the novel cross-comparison reported between the in vitro model 
and the human MGE.  
7.2 Questions, limitations and future studies 
7.2.1 Exploring the changes driven by serial expansions 
Sequential serial expansions of hESC-derived interneuron progenitor cultures 
were explored as a means to recapitulate the generation of temporally distinct 
newborn progenitors in the MGE over development. Fate-mapping studies of 
grafts derived from different aged MGE and CGE would indicate that early and 
late-born progenitors have different lineage commitment biases (Butt et al.
2005; Miyoshi et al. 2010; Inan et al. 2012). Therefore, this manipulation 
could enable a wider spectrum of interneuron subtypes to be generated in 
vitro.  As described in Chapter 3, changes in the molecular profile of both the
progenitor and terminally differentiated cultures were identified. Ultimately, 
this led to an elevation of SST:CR interneuron subtype composition in the 
terminally differentiated cultures. However, the experimental design used 
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could not distinguish between this shift being caused by the change in the 
lineage commitment of the progenitors (e.g. from CR to SST lineage), or the 
selective survival of SST interneuron precursors in the culture (Figure 7.1). 
To answer this question the experimental design would need to be modified 
to allow tracing of the progeny from the same clonal expansion (progenitors 
born from divisions originating from the same ancestral progenitor) across 
sequential cultures.
7.2.1.1 Combining lineage tracing and single-cell RNA sequencing
Retroviral barcoding is the ideal tool for clonal lineage studies, providing a 
high throughput method to follow the differentiation trajectory of a parent 
cell and all its progeny (Yao et al. 2016; Biddy et al. 2018). The barcodes are 
short sequences of nucleotides that become integrated into the cell genome 
using lentiviral vectors, and are therefore heritable across generations (Biddy 
et al. 2018; Kester & van Oudenaarden 2018). By using a variety of different 
barcode sequences, the progeny derived from different ancestral progenitors 
can be independently traced. Furthermore, use of barcodes that are 
transcribed (e.g. sequence placed under an ubiquitous promoter), lineage 
tracing and single-cell RNA sequencing can be combined to characterise the 
molecular identity of the population and understand how cells are clonally 
related to one another (Kester & van Oudenaarden 2018). By implementing 
this combinational approach during the serial expansion experiment in 
Chapter 3, by first retrovirally labelling the day 20 hESC-derived interneuron 
progenitors and then performing single-cell RNA sequencing analysis on each 
subsequent culture generated by serial expansion, one could tease apart the 
possible causes of the elevated SST:CR (Figure 7.1). 
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Figure 7.1 Clonal lineage and fate restrictions.
Questions still remain over how restricted the lineage commitment of interneuron 
precursors is, and if there is flexibility in the interneuron fate, what factors can 
influence this? In an attempt to recapitulate the generation of early and late-born 
progenitors in the developing CGE/MGE, serial expansion of hESC-derived 
interneuron progenitors was performed (see Chapter 3). On characterising the 
terminally differentiated cultures from each serial expansion, a change in subtype 
composition was detected, an elevation in SST:CR in later expansions. This could be 
explained by alternative mechanisms, which have been depicted in left and right-
hand schematics in Figure 7.1. Mechanism one, interneuron precursors from the 
same clonal lineage are restricted to one fate, and SST:CR shift was simply due to 
the death of CR interneuron precursors in later serial cultures. Mechanism two, 
interneuron precursors derived from the same ancestor have the potential to become 
different interneuron subtypes (e.g. SST and CR), and the serial expansions triggered 
this change in favour of SST lineage. 
SST, somatostatin. CR, calretinin. CGE, caudal ganglionic eminence. MGE, medial 
ganglionic eminence. hESC, human embryonic stem cells. 
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7.2.1.2 Dual reporter hESC lines  
Another question raised through molecular characterisation of each serial 
expansion of the interneuron-like progenitors was how well the expansion led 
to newborn progenitors being generated. By later serial expansions it was 
generally concluded that the progenitors were failing to divide, and were 
transitioning to a post-mitotic state even under SHH treatment (Chapter 3). 
Using dual reporter hPSC line that differentially labelled progenitors from 
immature neurons would be an ideal and simple method to selectively enrich 
the next progenitor culture with only proliferating progenitors. A prime 
example of a dual reporter PSC line used to distinguish between interneurons 
at different stages of differentiation was the mESC dual reporter line 
Nkx2.1::mCherry, Lhx6::GFP (Tyson et al. 2015). In this case the mESC line 
was exploited to specifically distinguish between earlier-born (older) MGE-like 
immature neurons (Lhx6::GFP positive) from later-born (younger) MGE-like 
progenitors (Nkx2.1::mCherry positive) (Tyson et al. 2015). However, this 
exact reporter strategy may not be ideal for the hESC-derived interneuron 
culture generated in this study, due to the greater mix of MGE-like and CGE-
like progenitors. Therefore, ideally hPSC line with region of origin independent 
markers, which also display temporal dynamics across interneuron 
development, would be used to drive the reporter expression (potentially 
SOX2 and DLX5).
7.2.2 Exploring the means to better bridge the gap between 
transcriptome and physiology   
The longitudinal single-cell RNA sequencing performed on hESC-derived 
interneurons was presented and analysed in Chapter 4. The molecular 
characterisation was then subsequently examined in parallel to the 
physiology of hESC-derived interneurons determined using whole-cell patch 
clamping (Chapter 6). However, the independent collection of the molecular 
and functional characterisation data raised several caveats. One issue of 
particular relevance was the inability to directly pair the gene expression 
profile of the neuron to the physiology of the same neuron (Bardy et al. 2016; 
Cadwell et al. 2016; Tripathy et al. 2017; van den Hurk et al. 2018). This 
restricted our understanding of how the molecular heterogeneity of post-
mitotic interneuron-like cells shaped the diverse electrophysiology profiles 
recorded in the population. 
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7.2.2.1 Patch-seq 
To achieve a more refined understanding of the link between the expression 
profile and neuronal physiology, a strategy combining whole-cell patch clamp 
recordings with single-cell RNA sequencing has been developed (Bardy et al.
2016; Cadwell et al. 2016; van den Hurk et al. 2018). As introduced in 
Chapter 6, this methodology is named patch-seq (Bardy et al. 2016; Cadwell 
et al. 2016; van den Hurk et al. 2018). In contrast to the C1 Fluidigm 
microfluidic system, patch-seq protocols rely on following up whole-cell patch 
clamp recordings with the careful manual isolation of the neuron (Figure 7.2). 
However, once the cells are captured the reaction chemistry for generating 
single-cell cDNA is conducted in a similar manner, with parallel reactions 
carried out on the isolated cells in the chosen reaction chemistry (e.g. SMART-
seq). Moreover, the addition of unique barcodes (short nucleotide sequences) 
to each reaction chemistry acts to tag the cDNA fragments (Figure 7.2). The 
barcode is used to correctly assign the single-cell RNA sequencing data to the 
electrophysiology data collected from the same cell (van den Hurk et al.
2018). By identifying any relationship between genes and physiology across 
the single-cell samples, prediction models can be generated that allows a 
particular neuronal trait (e.g. firing frequency) to be predicted by the 
expression level of a specific gene (Figure 7.2). However, caution should be 
placed over such prediction models with too small sample sizes (Cadwell et 
al. 2016).  
In summary, patch-seq data has the potential to provide an enhanced, novel 
understanding of the link between the transcriptome and physiology of hESC-
derived interneurons. Moreover, patch-seq data compared between different 
neuronal classes from adult mouse primary tissue would indicate that the 
gene-physiology patterns are well conserved across neuronal lineages 
(Tripathy et al. 2017). Therefore, this work could be applied beyond 
interneurons. Overall, this line of work would be worth pursuing in the future. 
Although, fine-tuning and optimisation of the patch-seq protocol would be 
required to ensure that the single-cell libraries were at the same high 
standards as achieved with the Fluidigm system.
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Figure 7.2 The principle of patch-seq.
The basic methodology of patch-seq involves carrying out whole-cell patch clamp 
recordings, and on completing recordings, manually picking the patched neuron 
(using positive pressure through the patch-pipette). The neuron is then immediately 
transferred into an isolated tube/well with the appropriate reaction chemistry (e.g. 
SMART-seq) that marks the start of the single-cell RNA sequencing steps. These steps 
involved lysing the cell to extract RNA, which is then reverse transcribed to generate 
cDNA that is uniquely barcoded and preamplified ready for downstream application 
(e.g. quality control checks and single-cell library preparation) (Bardy et al. 2016; 
Cadwell et al. 2016; Fuzik et al. 2016; Cadwell et al. 2017; van den Hurk et al. 2018). 
On repeating the steps described above, a large number of single-cell cDNA samples 
can be generated, each with their own unique barcode. The barcode is then used to 
back-trace the single cell expression data to the electrophysiology profile of the same 
cell. The final step involves performing a cross-comparison between the physiology 
parameters and expression profile for each cell, any comparisons with a significant 
gene-physiology correlation across the single cell samples can be used as a means 
to make predictions about the physiology of a neuron from the expression profile 
(and visa versa). Figures were adapted from Tripathy et al. 2017.
TPM, transcripts per million.
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7.2.3 Exploring the reasons behind the MGE and in vitro model 
discrepancies  
The first account of the longitudinal molecular characterisation of human MGE 
at single-cell resolution was presented in Chapter 5. The human MGE single-
cell profiles were used as the gold-standard to measure the hESC-derived 
interneuron single-cell profiles to. Although this did demonstrate many 
common features between the in vivo and in vitro derived cell expression 
profiles, in other respects the profiles did not match. Why? 
7.2.3.1 MGE developmental period
There are many factors that could have contributed to the mismatch between 
the MGE and hESC-derived interneurons. One possible factor that could have 
augmented the differences was the limited range of MGE ages selected for 
comparison (10WPC to 15WPC). During human development, the ganglionic 
eminence becomes established in the ventral telencephalon at 7WPC, and 
then spatial patterning divides the ganglionic eminence into the three regions 
(MGE, CGE, LGE) by 8WPC (Zecevic et al. 2011; Onorati et al. 2014). The 
MGE continues to generate newborn interneurons into the late second 
trimester. Therefore, to encompass the full period of human MGE 
development would be challenging, both in terms of labour, cost and time. 
However, with an incomplete profile of MGE development, it is hard to fully 
assess the overall similarity of hESC-derived interneurons to the native 
counterparts in the MGE. 
To help narrow down how large an expanded developmental period would be 
necessary, previous foetal primary tissue to PSC-derived neuronal model 
cross-comparisons can be used. These independently reported comparisons 
shared the same conclusion that at the molecular level post-mitotic hPSC-
derived neurons most closely resembled their counterparts in early second 
trimester cortical foetal tissue (14WPC – 16WPC) (Close et al. 2017; Xiang et 
al. 2017; Yuan et al. 2018). Therefore, extending the developmental period 
beyond 15WPC may not be of high enough value to justify the additional 
expenditure. Whereas, evaluation of the hESC-derived interneuron 
progenitors (which was poorly matched to all MGE ages sampled) may benefit 
from collecting earlier MGE ages (from 8WPC) when the 
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ventricular/subventricular zones were more extensive in the MGE (Hansen et 
al. 2013). 
7.2.3.2 MGE vs CGE
An additional question of significance was whether a comparison between 
hESC-derived interneurons and human MGE alone could fairly evaluate the in 
vitro cultures. As demonstrated at protein and RNA level, the hPSC 
interneuronal differentiation paradigm utilised here gave rise to a mix of MGE-
like and CGE-like progenitors (Chapter 3 and 4). Although the culture was 
significantly biased towards NKX2.1 positive MGE-like progenitors, the most 
abundant subtypes in the terminally differentiated cultures were CR, SST and 
RELN. These are classically viewed as more dorsal MGE and CGE-derived 
interneurons (Flames et al. 2007; Wonders et al. 2008; Miyoshi et al. 2010). 
Therefore, future work carrying out single-cell RNA sequencing analysis 
independently on human dorsal and ventral MGE and CGE would be 
encouraged, and has already proved fruitful in mouse (Mayer et al. 2018; Mi 
et al. 2018). From this work there is the potential of understanding the 
molecular mechanism of interneuron diversification for a much wider 
spectrum of interneuron subtypes. Hence, this data would be the optimal 
comparison to the mixed CGE and MGE-like cells obtained in vitro, and may 
provide a better guide for refinements to the in vitro protocol. 
7.2.4 Exploring ways to improve hESC-derived interneuron functional 
maturity 
A principle aim of Chapter 6 was to monitor the developmental trajectory of 
the interneuron-like cells at the functional level, both as a population 
(network connectivity) and on a single-cell basis (physiology parameters). 
Although early spatial and temporal factors, within the region of origin, 
influence the lineage commitment of interneurons, the final moulding of the 
interneuron molecular and physiological profile is likely subject to extrinsic 
cues in the region of destination (Kessaris et al. 2014; Ishino et al. 2017; 
Quattrocolo et al. 2017; Wamsley & Fishell 2017; Mayer et al. 2018). 
However, in light of the immature functional status of the interneuron-like 
cells demonstrated in Chapter 6, to successfully model this late stage of
interneuron development in vitro would require refinements to the paradigm 
used. 
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7.2.4.1 Co-cultures of native partners
One proposed strategy to generate more functionally mature PSC-derived 
neurons in vitro has been to co-culture neurons with their native synaptic 
partners (Maroof et al. 2013; Fantuzzo et al. 2017; Sarkar et al. 2018). In 
addition to this co-culturing potentially enhancing the functional maturity of 
the hESC-derived interneurons,  the platform also opens up the avenue to 
explore how co-culturing early post-mitotic hESC-derived interneurons with 
different synaptic partners (typical of different brain regions) may affect the 
differentiation potential of the interneuronal culture (Bele et al. 1995; 
Rolando et al. 2010; Quattrocolo et al. 2017). Within the adult brain there 
are brain region-dependent differences in interneuron subtype diversity and 
abundance, which also coincides with differences in synaptic partners and 
extracellular infrastructure (e.g. perineuronal nets) (Zeisel et al. 2015; Lake 
et al. 2016; Muñoz-Manchado et al. 2018). However, questions still remain 
over whether the region-dependent differences in interneurons was already 
intrinsically programmed in the interneuron precursor or driven by region-
dependent extrinsic cues (Bele et al. 1995; Rolando et al. 2010; Ishino et al.
2017; Quattrocolo et al. 2017). 
The malleable nature of in vitro co-cultures would make the system ideal to 
explore the influence of extrinsic cues, in the form of different synaptic 
partners. With efficient hPSC differentiation paradigms for multiple 
interneuron synaptic partners, including cortical pyramidal cells, hippocampal 
pyramidal cells and striatal MSNs, multiple region-specific circuits can be 
reproduced in vitro (Arber et al. 2015; Sarkar et al. 2018). Moreover, novel 
microfluidic cell culture platforms can be used to restrict co-cultured 
populations to contact only, with no shared media (Fantuzzo et al. 2017; 
Sarkar et al. 2018; Virlogeux et al. 2018). This is achieved by the co-culture 
plate consisting of two adjacent and independent chambers connected by 
short (450μm long) grooves that allow neuronal processes to pass between 
chambers. This design enables synaptic connections to be made, between the 
two otherwise isolated neuronal cultures (Fantuzzo et al. 2017; Sarkar et al.
2018; Virlogeux et al. 2018). Therefore, the effect of different synaptic 
inputs/outputs alone can be monitored. Overall, this tool has expanded the 
manipulation possible in neuronal co-cultures.
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7.3 Wider application 
7.3.1 Understanding the vulnerability of interneurons in 
neurodevelopmental disorders
The longitudinal single-cell RNA sequencing analysis of human MGE  has a 
wide scope of application, beyond what was explored here. Although not the 
primary focus of this study the data could be analysed in relation to known 
neuropsychiatric risk genes, a line of investigation successfully explored using 
single-cell RNA sequencing of mouse foetal cortical tissue (Loo et al. 2019). 
Interneurons have been implicated in neuropathologies underpinned by the 
proposed excitation-inhibition imbalance theory (Rutter et al. 2009; Hirano 
et al. 2008; Haenschel et al. 2009). However, whether interneuron 
dysfunction/loss was a primary cause of the pathology, or a downstream 
effect remains uncertain. If known risk genes were expressed during native 
interneuron development, this would give support for the primary role of 
interneuron dysfunction/deficit in the disorder, and encourage interneuron 
targeted therapeutic approaches. Furthermore, the reason for the selective 
vulnerability of interneuron subtypes in neuropathology is unknown (Robbins 
et al. 1991; Reynolds et al. 2002; Lewis et al. 2005). By exploring the risk 
gene expression pattern in the human MGE at single-cell resolution, evidence 
for subtype-selective expression may arise, therefore explaining the 
phenomenon. 
7.3.2 Refining the interneuron differentiation of hPSC
The comparative assessment of hESC-derived interneurons to the human 
MGE single-cell profiles in Chapter 5 brought potential avenues to refine and 
optimise the hPSC interneuron differentiation paradigm to light. The 
longitudinal single-cell RNA sequencing analysis named signalling pathways 
active in the human MGE. Therefore, activation of these named pathways, 
including insulin-like growth factor signalling and secretogranin V 
neuroendocrine signalling, during the in vitro differentiation paradigm, may 
provide a more complete recapitulation of the native MGE environment, 
thereby giving rise to more authentic interneuron-like cells. Confidence in the 
candidate signalling pathways named was drawn from the inclusion of activin 
and BMP4 signalling inhibition, which has been previously demonstrated in 
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mouse to promote interneuron differentiation (especially towards SST fate) 
(Mukhopadhyay et al. 2009).
Alternatively, an intrinsic cue approach could be taken to enforce the 
expression of transcription factors associated with interneuron fate, but were 
poorly expressed in the hESC-derived interneuron culture, such as MEG3, 
DLX5, POU3F4, NFI B (Chapter 5). These transcription factors have been 
repeatedly named across mouse CGE and MGE single-cell RNA sequencing 
analysis, and in the human MGE data presented here (Chen et al. 2017; 
Mayer et al. 2018; Mi et al. 2018). Although these genes were not shown to 
be selective to one particular interneuron lineage, these genes may overall 
enhance the authenticity of the interneuron-like cells generated. On the other 
hand, SKP1 was detected as a gene specifically associated with NPY
expressing subpopulation in the MGE. To determine whether the association 
was causal,  future experiments manipulating the expression of  SKP1 in 
interneuron-like progenitors would be required. 
One means to perform targeted manipulation of gene expression is through 
the use of the dead Cas9 (dCas9)– transcriptional effector system (Figure 
7.3). This sophisticated system takes advantage of the precise and high 
fidelity DNA targeting possible with endonuclease Cas9- guide RNA complex, 
which has been extensively used as a genomic editing tool (Anton et al.
2018). Through modifications to the Cas9-complex to inactive the 
endonuclease activity, and to include a transcriptional activator/repressor 
protein fused to the dCas9, a versatile tool has been generated to modify the 
expression level of one or more genes of interest (Qi et al. 2013; Kearns et 
al. 2014; Chavez et al. 2015; Anton et al. 2018). This approach has been 
successfully applied to reprogram hPSC to a neuronal fate by targeting the 
promoter regions of NGN2 and neurogenic differentiation factor 1 (NEUROD1) 
in hPSC using dCas9-transcriptional activator system (Chavez et al. 2015).  
By applying the dCas9- transcriptional effector system to upregulate 
candidate lineage determining genes named in this study, this may provide a 
means to generate interneuron subtype-selective cultures. Research pursuing 
the establishment of differentiation paradigms that give rise to a more defined 
interneuron subtype composition would be of high value for both research 
and regenerative medicine. This is largely due to the subtype-dependent 
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implication of interneurons in different neuropathologies (Robbins et al. 1991; 
Reynolds et al. 2002; Lewis et al. 2005; Ito-Ishida et al. 2015).
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Figure 7.3 Application of the dCas9 – transcriptional effector system for 
targeted manipulation of gene expression.
The catalytically inactive endonuclease, dCas9, complex can target regions of the 
genome using complementary guide RNA sequences. By modifying the dCas9 gene 
to encode for dCas9 – transcription effector fusion protein has provided an elegant 
means to modify the expression of targeted genes. The target gene expression levels 
can be driven up or down depending on the choice of transcriptional effector 
(repressor or activator respectively). This is achieved by the repressor and activators 
acting to block or recruit the assembly of the RNA polymerase complex, respectively. 
Examples of repressor domains successfully used in the system are Krüppel-
asociated box or four-linked mSin3 interaction domains (Qi et al. 2013). Examples of 
activator domains are VP64 or p65 (Qi et al. 2013). The use of the dCas9 –
transcriptional effector system provides an ideal means to directly test the effect of 
candidate lineage determining transcription factors, and other genes of interest, on 
the differentiation potential of hESC-derived interneuron precursors. 
hESC, human embryonic stem cell. dCas9, endonuclease inactive/dead Cas9. TE, 
transcriptional effector. 
228
7.3.3 In vitro disease modelling and drug development  
Although a purely neurodevelopmental focused application of hPSC-derived
interneurons was used here, in vitro interneuronal models have a much wider 
scope of applications (Figure 7.4). In particular hPSC-derived interneurons 
have been an invaluable tool in investigating the interneuron-specific deficits 
in different neurodevelopmental disorders, including Rett syndrome, ASD and 
schizophrenia (Li et al. 2013; Patriarchi et al. 2016;  Shao et al. 2019). This 
is particularly true since hPSC platform expanded to include induced 
pluripotent stem cells (iPSC). iPSC are generated from somatic cells (typically 
fibroblasts) taken from patients or healthy controls, and these specialised 
cells are reprogrammed using a specific set of transcription factors 
(“Yamanaka factors”) to convert the somatic cells back into PSC (Yu et al.
2007). Through the use of patient iPSC derived or mutant hESC derived 
interneurons an understanding of how unknown and known genetic insults 
affect different stages of the neuronal differentiation has been achieved (Li et 
al. 2013; Patriarchi et al. 2016; Shao et al. 2019) (Figure 7.4). Once deficits 
in the disease model are determined, different tools can be used to determine 
the molecular mechanism underpinning the mutant phenotype, leading to the 
identification of novel, candidate therapeutic targets (Shao et al. 2019). 
Genetic and pharmacological approaches can then be applied in attempt to 
correct the phenotype (Shao et al. 2019).  In summary, the nature of hPSC-
derived neuronal models enables high throughput screening of candidate 
therapeutic treatments, thus making the platform a valuable asset in drug 
development. 
7.3.4 Regenerative medicine   
Finally, hPSC-derived interneuron progenitors hold promise within 
regenerative medicine (Figure 7.4). Cell replacement therapy has been 
proposed as a therapeutic strategy in patients with traumatic brain injury 
(e.g. stroke) or neurodegenerative disorders (e.g. Parkinson’s disease) were 
pharmacological approaches are not available and/or have undesirable side-
effects. Classically, cell replacement therapy was coined as a means to deliver 
the appropriate neuronal progenitors into the atrophied region of the host 
brain, which could then integrate into the host circuits to rebuild the 
deteriorated circuits. Over time, cell replacement therapy benefits have 
229
expanded beyond this initial principle, by using grafts as a vehicle to deliver 
neurotrophic, neurogenic and anti-inflammatory small molecule factors, 
which can help reduce the rate of further deterioration in the brain (Ebert et 
al. 2008; Akhtar et al. 2018). Although the use of hPSC-derived interneuron 
progenitors in regenerative medicine has not reached clinical use, current 
findings in the literature have demonstrated the promise of such a use in the 
future, with hPSC-derived interneuronal grafts being a potential therapeutic
strategy for refractory epilepsies and traumatic brain injury (Cunningham et 
al. 2014; Tornero et al. 2017). With the help of tools that allow the 
identification and manipulation of circuits formed between host and graft, 
such as viral tracer systems, a better evaluation of graft efficacy and potential 
side-effects at the behavioural level can be obtained in rodent models. Thus, 
helping to guide improvements to aid progress in making hPSC-derived 
interneuronal grafts a viable therapeutic strategy (Figure 7.4).
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Figure 7.4 The application of hPSC-derived neurons.
iPSC are derived from somatic cells that have been reprogrammed to revert back to 
pluripotent state. Patient derived iPSC can be differentiated in vitro into various 
neuronal lineages to understand the neurodevelopmental potential of patient derived 
neuronal progenitors, and the functional deficits in the neurons generated. This can 
lead to the understanding of disease mechanisms, and in turn flag potential 
therapeutic targets. Refer to Shao et al. for example with schizophrenia patient 
derived iPSC lines (Shao et al. 2019). Alternatively, hiPSC lines can be generated for 
the investigation into monogenetic diseases, where the patient derived hiPSC can be 
genetically edited to the non-pathogenic (healthy control) variant. Please see Xu et 
al. for example on Huntington’s disease patient derived iPSC line (Xu et al. 2017). 
The patient derived hiPSC are now referred to as “repaired”, and can be directed in 
vitro into neuronal committed progenitors that can be used for personalised cell 
replacement therapies. hESC are derived from human blastocyst inner mass cells and 
are not used for patient-specific in vitro disease models, but can be genomically 
modified to mimic the disease state. These cell lines are referred to as “edited” hESC, 
Li et al. presented an example of hESC-derived Rett syndrome model (Li et al. 2013). 
Together hPSC-derived neuronal models provide a global in vitro model of 
neurodevelopment, and a promising source of neuronal progenitors for regenerative 
medicine. Cartoon illustrations of human figure, blastocyst and neurons were 
collected from https://www.motifolio.com (Motifolio 2018). 
hESC, human embryonic stem cells. iPSC, induced pluripotent stem cells. hPSC, 
human pluripotent stem cells.
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7.4 Concluding remarks
In the research presented in this thesis complementary approaches have 
been taken to characterise both the molecular and functional basis of 
interneuron differentiation trajectory using hPSC-derived interneurons. The 
work presented has both answered and raised new questions, which will act 
to guide future experiments. Ultimately, by combining inter-disciplinary and 
inter-species studies, the multi-faceted features of this neuronal class can be 
teased apart, which will be of great benefit to both research and regenerative 
medicine. 
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Appendix 
The appendix has been provided as online content organised according to the 
theme of the content. Provided below is the list of tables and figures within 
each Appendix folder to guide the reader to content of interest. The data in 
full has been provided electronically in the Dropbox folder named “PhD thesis 
- Appendix”. Please open the following link to the shared Dropbox folders 1 
to 8 below: 
https://www.dropbox.com/sh/8ua9h2nzho924ss/AAAHL3LS-
ddBAv_I89AXqAmJa?dl=0
FOLDER 1. Reagents list
Tables list:
Table 1. List of primary antibodies used in immunohistochemistry. 
Table 2. List of secondary antibodies used in immunohistochemistry. 
Table 3. List of primers used in QPCR reactions. 
FOLDER 2. hESC-derived interneurons single-cell RNA sequencing 
and quality control checks
Tables list:
Table 4. Summary of the libraries sequenced on Illumina HiSeq for 
hESC-derived interneuron single-cell RNA sequencing study. 
Table 5. List of differentially expressed genes generated by performing 
ANOVA pair-wise analysis between clusters on tSNE plot for each 
hESC-derived interneuron sample, figures 4.1C.
Table 6. List of differentially expressed genes generated by performing 
ANOVA pair-wise analysis between two hESC-derived interneuron 
samples.
Table 7. List of genes uniquely co-expressed by SST expressing hESC-
derived neurons. 
Table 8. List of genes uniquely co-expressed by CR expressing hESC-
derived neurons. 
Table 9. List of genes uniquely co-expressed by PVALB expressing 
hESC-derived. interneurons. 
Figures list:
A) Schematic of the in vitro hESC interneuron differentiation protocol.
B) Representative examples of electropherograms generated from 
single-cell cDNA before and after library clean up.
C) Heatmap of relative gene expression of hESC-derived interneurons 
– at single-cell RNA level, day 20.
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D) tSNE plot of the relative similarity in single-cell profiles of hESC-
derived interneurons at day 20 (progenitors) and day 65 (post-
mitotic neurons).
FOLDER 3. Human MGE single-cell RNA sequencing and quality 
control checks 
Tables list:
Table 10. Summary of the libraries sequenced on Illumina HiSeq for 
human primary foetal MGE single-cell RNA sequencing study. 
Table 11. List of differentially expressed genes generated by 
performing ANOVA pair-wise analysis between clusters on tSNE plot 
for each human MGE sample, figure 5.2C.
Table 12. List of differentially expressed genes generated by 
performing ANOVA pair-wise analysis between two human MGE 
samples.
Table 13. List of genes uniquely co-expressed by SST expressing 
human MGE-derived interneurons. 
Table 14. List of genes uniquely co-expressed by CR expressing human 
MGE-derived interneurons. 
Table 15. List of genes uniquely co-expressed by NPY expressing 
human MGE-derived interneurons. 
Figures list:
E) Representative examples of electropherograms generated from 
single-cell cDNA before and after library clean up.
F) Heatmap of relative gene expression of primary human MGE– at 
single-cell RNA level, 10WPC and 15WPC.
G) tSNE plot of the relative similarity in single-cell profiles of primary 
human foetal MGE at 10WPC and 15WPC.
H) Relative gene expression values of known LGE, CGE and MGE 
enriched markers, in human MGE, CGE and LGE at 10WPC and 
15WPC.
I) Longitudinal analysis of SST and LHX6 gene expression changes in 
LGE, CGE and MGE over 10WPC to 15WPC.
J) Molecular characterisation of primary human CGE ex vivo cultures–
at protein level, immunostaining of 10WPC and 15WPC CGE.
K) Molecular characterisation of primary human LGE ex vivo cultures–
at protein level, immunostaining of 10WPC and 15WPC LGE.
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L) Molecular characterisation of primary human MGE ex vivo cultures–
at protein level, immunostaining of 15WPC MGE.
FOLDER 4. In vivo vs in vitro single-cell RNA sequencing analysis
Tables list:
Table 16. List of differentially expressed genes generated by 
performing ANOVA pair-wise analysis between 10WPC human foetal 
MGE and hESC-derived interneuron samples.
Table 17. List of differentially expressed genes generated by 
performing ANOVA pair-wise analysis between 15WPC human foetal 
MGE and hESC-derived interneuron samples.
FOLDER 5. Plasmid digestions and viral transductions 
Tables list:
Table 18. The entire list of plasmids used to generate lentiviral vector 
and digestion products. 
Table 19. The entire list of plasmids used to generate the ChR2-
mCherry glycoprotein-deficient rabies tracer and digestion products. 
Figure list:
M) Gel electrophoresis displaying the products of the restriction 
enzyme digestion of the plasmids used to generate the lentiviral 
vector.
N) Gel electrophoresis displaying the products of the restriction 
enzyme digestion of the plasmids used to generate the viral tracer.
O) Flow cytometry measure of the proportion GFP positive neurons 
(starter neurons) in alive hESC-derived interneuron cultures 
treated with the lentiviral vector.
P) Flow cytometry measure of the proportion mCherry positive cells 
in alive HEK TVA cells treated with the unpseudotyped and EnvA 
pseudotyped ΔG ChR2-mCherry viral tracer.
Q) Flow cytometry measure of the proportion mCherry positive cells 
in alive HEK cells treated with the unpseudotyped and EnvA 
pseudotyped ΔG ChR2-mCherry viral tracer.
R) Flow cytometry measure of the proportion mCherry positive cells 
in alive HEK or HEK TVA cells in the negative controls (no viral 
treatment).
FOLDER 6. Electrophysiology traces
Figure list:
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S-U) Representative illustrations of physiological responses of patched 
hESC-derived neurons to different whole-cell patch clamp paradigms, 
in current clamp mode.
V) Representative illustrations of spontaneous action potential 
recorded from a patched hESC-derived neuron in current clamp mode 
– at day 60.
W) Representative illustrations of spontaneous mini excitatory 
postsynaptic potentials recorded from a patched hESC-derived neuron 
– at day 60.
FOLDER 7. Cell counts
Figure list:
X) Average total cell count measured using DAPI count for interneuron 
differentiation of hESC analysed in Chapter 3, figure 3.1D-3.1E. 
Y) Average total cell count measured using DAPI count for interneuron 
differentiation of hESC analysed in Chapter 3, figure 3.2B-3.2E. 
Z) Average total cell count measured using DAPI count for interneuron 
differentiation of hESC analysed in Chapter 3, figure 3.3A-3.3E.. 
AA) Average total cell count measured using DAPI count for human 
foetal MGE, CGE and LGE analysed in Chapter 5, figure 5.1C. 
AB) Average total cell count measured using DAPI count for the 
lentiviral transduced interneuron differentiation of hESC analysed 
analysed in Chapter 6, figure 6.3C. 
AC) Average total cell count measured using DAPI count for viral tracer 
application HEK cells analysed analysed in Chapter 6, figure 6.4E. 
AD) Average total cell count measured using DAPI count for viral tracer 
application to HEK-TVA cells analysed analysed in Chapter 6, figure 
6.4C.
FOLDER 8. Academic publications 
During the 4-year PhD programme at Cardiff University, the research I have 
carried out has contributed to the following publications: Noakes et al. 2019 
(second author on research article) and Keefe & Li 2020 (pre-press review 
article, first author). Electronic copies of these articles have been provided in 
the Dropbox folder 8. 
 
